"gene_symbol","geneid","ensemblid","geneNcbiType","geneDSI","geneDPI","genepLI","uniprotids","protein_classid","protein_class_name","disease_name","diseaseType","diseaseUMLSCUI","diseaseClasses_MSH","diseaseClasses_UMLS_ST","diseaseClasses_DO","diseaseClasses_HPO","source","associationType","text","sentence","pmYear","score","chemsInSentence","reference_type","reference","ancestry_name","ancestry_id","chemical_effect","polarity"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","RGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","The inherited macular degeneration Doyne honeycomb retinal dystrophy/Malattia Leventinese is thought to be caused by an R345W mutation in the EFEMP1 gene (also called fibulin-3).","The inherited macular degeneration <span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>Malattia Leventinese</span> is thought to be caused by an R345W mutation in the <span class='gene' en_id='2202'>EFEMP1</span> gene (also called <span class='gene' en_id='2202'>fibulin-3</span>).",2007,1,NA,"PMID","17666404","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Long-Range PCR-Based NGS Applications to Diagnose Mendelian Retinal Diseases.","Long-Range PCR-Based NGS Applications to Diagnose Mendelian Retinal Diseases.",2021,1,NA,"PMID","33546218","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","ML is caused by a mutation (R345W) in the gene EFEMP1 which encodes fibulin-3, a protein of unknown function.","<span class='disease' en_id='C1832174'>ML</span> is caused by a mutation (R345W) in the gene <span class='gene' en_id='2202'>EFEMP1</span> which encodes <span class='gene' en_id='2202'>fibulin-3</span>, a protein of unknown function.",2007,1,NA,"PMID","17664227","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,1,NA,"PMID","10369267","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.","Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.",2014,1,NA,"PMID","25111685","Chinese","HANCESTRO:0021",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,1,NA,"PMID","10369267","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","A novel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family.","A novel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family.",2010,1,NA,"PMID","19850834","Japanese","HANCESTRO:0019",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","These data present evidence that misfolding and aberrant accumulation of EFEMP1 may cause drusen formation and cellular degeneration and play an important role in the etiology of both ML and AMD.","These data present evidence that misfolding and aberrant accumulation of <span class='gene' en_id='2202'>EFEMP1</span> may cause drusen formation and cellular degeneration and play an important role in the etiology of both <span class='disease' en_id='C1832174'>ML</span> and AMD.",2002,1,NA,"PMID","12242346","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Dominant radial drusen and Arg345Trp EFEMP1 mutation.","Dominant radial drusen and Arg345Trp EFEMP1 mutation.",2001,1,NA,"PMID","11384588","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy.","Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy.",1997,1,NA,"PMID","9230832","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","RGD_HUMAN","CausalOrContributing","AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells.","AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells.",2021,1,NA,"PMID","33070465","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family.","Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family.",2003,1,NA,"PMID","14694043","Dutch","HANCESTRO:0320",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","These findings document that SCA14 is caused by mutations in the PRKCG gene.","These findings document that <span class='disease' en_id='C1854369'>SCA14</span> is caused by mutations in the <span class='gene' en_id='5582'>PRKCG</span> gene.",2003,1,NA,"PMID","14676051","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.","Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.",2003,1,NA,"PMID","12644968","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Acute lymphocytic leukemia","[disease]","C0023449","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the immune system (02715) | Abnormality of blood and blood-forming tissues (01871) | Neoplasm (02664)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.","Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.",2015,1,NA,"PMID","25979592","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Pregnancy Outcomes in Females With Dilated Cardiomyopathy-Associated Rare Genetic Variants.","Pregnancy Outcomes in Females With Dilated Cardiomyopathy-Associated Rare Genetic Variants.",2022,1,NA,"PMID","35113650","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Our findings establish RBM20 as a DCM gene and reveal a mutation hotspot in the RS domain.","Our findings establish <span class='gene' en_id='282996'>RBM20</span> as a <span class='disease' en_id='C0007193'>DCM</span> gene and reveal a mutation hotspot in the RS domain.",2009,1,NA,"PMID","19712804","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.",2018,1,NA,"PMID","29447731","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations.","Phenotype and progression among patients with <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span> and <span class='gene' en_id='282996'>RBM20</span> mutations.",2021,1,NA,"PMID","34174465","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Our findings establish RBM20 as a DCM gene and reveal a mutation hotspot in the RS domain.","Our findings establish <span class='gene' en_id='282996'>RBM20</span> as a <span class='disease' en_id='C0007193'>DCM</span> gene and reveal a mutation hotspot in the RS domain.",2009,1,NA,"PMID","19712804","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,1,NA,"PMID","22466703","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Whole exome sequencing of remotely related dilated cardiomyopathy subjects from a large, multiplex family, followed by systematic filtering, identified a causal RBM20 mutation without the need for linkage analysis.","Whole exome sequencing of remotely related <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span> subjects from a large, multiplex family, followed by systematic filtering, identified a causal <span class='gene' en_id='282996'>RBM20</span> mutation without the need for linkage analysis.",2013,1,NA,"PMID","23861363","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,1,NA,"PMID","22466703","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Whole exome sequencing of remotely related dilated cardiomyopathy subjects from a large, multiplex family, followed by systematic filtering, identified a causal RBM20 mutation without the need for linkage analysis.","Whole exome sequencing of remotely related <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span> subjects from a large, multiplex family, followed by systematic filtering, identified a causal <span class='gene' en_id='282996'>RBM20</span> mutation without the need for linkage analysis.",2013,1,NA,"PMID","23861363","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Atlas of the clinical genetics of human dilated cardiomyopathy.","Atlas of the clinical genetics of human dilated cardiomyopathy.",2015,1,NA,"PMID","25163546","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,1,NA,"PMID","22466703","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.",2019,1,NA,"PMID","31514951","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,1,NA,"PMID","10369267","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family.","<span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>malattia leventinese</span> induced by <span class='gene' en_id='2202'>EFEMP1</span> mutation in a Chinese family.",2018,1,NA,"PMID","30541486","Chinese","HANCESTRO:0021",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Autosomal dominant radial drusen (ADRD), also termed Malattia Leventinese and Doyne honeycomb retinal dystrophy, causes early-onset vision loss because of mutation in EFEMP1.","<span class='disease' en_id='C1832174'>Autosomal dominant radial drusen</span> (<span class='disease' en_id='C1832174'>ADRD</span>), also termed Malattia Leventinese and Doyne honeycomb retinal dystrophy, causes early-onset vision loss because of mutation in <span class='gene' en_id='2202'>EFEMP1</span>.",2015,1,NA,"PMID","25077532","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","A novel EFEMP1 variant was identified in one DHRD patient.","A novel <span class='gene' en_id='2202'>EFEMP1</span> variant was identified in one <span class='disease' en_id='C1832174'>DHRD</span> patient.",2014,1,NA,"PMID","25082885","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","These data present evidence that misfolding and aberrant accumulation of EFEMP1 may cause drusen formation and cellular degeneration and play an important role in the etiology of both ML and AMD.","These data present evidence that misfolding and aberrant accumulation of <span class='gene' en_id='2202'>EFEMP1</span> may cause drusen formation and cellular degeneration and play an important role in the etiology of both <span class='disease' en_id='C1832174'>ML</span> and AMD.",2002,1,NA,"PMID","12242346","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Malattia Leventinese: EFEMP1 R345W Variant Is a Hot Spot Mutation, Not a Founder Mutation.","Malattia Leventinese: EFEMP1 R345W Variant Is a Hot Spot Mutation, Not a Founder Mutation.",2020,1,NA,"PMID","33019987","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","The inherited macular degeneration Doyne honeycomb retinal dystrophy/Malattia Leventinese is thought to be caused by an R345W mutation in the EFEMP1 gene (also called fibulin-3).","The inherited macular degeneration <span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>Malattia Leventinese</span> is thought to be caused by an R345W mutation in the <span class='gene' en_id='2202'>EFEMP1</span> gene (also called <span class='gene' en_id='2202'>fibulin-3</span>).",2007,1,NA,"PMID","17666404","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.","Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.",2014,1,NA,"PMID","25111685","Chinese","HANCESTRO:0021",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","These data present evidence that misfolding and aberrant accumulation of EFEMP1 may cause drusen formation and cellular degeneration and play an important role in the etiology of both ML and AMD.","These data present evidence that misfolding and aberrant accumulation of <span class='gene' en_id='2202'>EFEMP1</span> may cause drusen formation and cellular degeneration and play an important role in the etiology of both <span class='disease' en_id='C1832174'>ML</span> and AMD.",2002,1,NA,"PMID","12242346","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","The inherited macular degeneration Doyne honeycomb retinal dystrophy/Malattia Leventinese is thought to be caused by an R345W mutation in the EFEMP1 gene (also called fibulin-3).","The inherited macular degeneration <span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>Malattia Leventinese</span> is thought to be caused by an R345W mutation in the <span class='gene' en_id='2202'>EFEMP1</span> gene (also called <span class='gene' en_id='2202'>fibulin-3</span>).",2007,1,NA,"PMID","17666404","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","To investigate functional effects, we transfected COS7 cells with vectors expressing the three novel EFEMP1 variants and showed that all three variants found in JOAG patients caused significant intracellular protein aggregation and retention compared to wild type and also compared to EFEMP1 variants associated with other ocular phenotypes including an early-onset form of macular degeneration, Malattia Leventinese/Doyne's Honeycomb retinal dystrophy.","To investigate functional effects, we transfected COS7 cells with vectors expressing the three novel <span class='gene' en_id='2202'>EFEMP1</span> variants and showed that all three variants found in JOAG patients caused significant intracellular protein aggregation and retention compared to wild type and also compared to <span class='gene' en_id='2202'>EFEMP1</span> variants associated with other ocular phenotypes including an early-onset form of macular degeneration, <span class='disease' en_id='C1832174'>Malattia Leventinese</span>/<span class='disease' en_id='C1832174'>Doyne's Honeycomb retinal dystrophy</span>.",2022,1,NA,"PMID","34923728","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.","Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.",2003,1,NA,"PMID","12644968","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","These results point to specific alterations in mutant PKCgamma function that could lead to the selective neuronal degeneration of SCA14.","These results point to specific alterations in mutant <span class='gene' en_id='5582'>PKCgamma</span> function that could lead to the selective neuronal degeneration of <span class='disease' en_id='C1854369'>SCA14</span>.",2005,1,NA,"PMID","15618281","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A Japanese case of SCA14 with the Gly128Asp mutation.","A Japanese case of SCA14 with the Gly128Asp mutation.",2006,1,NA,"PMID","17024314","Japanese","HANCESTRO:0019",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","A Japanese case of SCA14 with the Gly128Asp mutation.","A Japanese case of SCA14 with the Gly128Asp mutation.",2006,1,NA,"PMID","17024314","Japanese","HANCESTRO:0019",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC gamma mutant mice.","Impaired motor coordination correlates with persistent multiple climbing fiber innervation in PKC gamma mutant mice.",1995,1,NA,"PMID","8548809","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Together, these results show that SCA14 mutations located in the C1B subdomain ;open' PKCgamma protein conformation leading to increased C1 domain accessibility, but inefficient activation of downstream signaling pathways.","Together, these results show that <span class='disease' en_id='C1854369'>SCA14</span> mutations located in the C1B subdomain ;open' <span class='gene' en_id='5582'>PKCgamma</span> protein conformation leading to increased C1 domain accessibility, but inefficient activation of downstream signaling pathways.",2008,1,NA,"PMID","18577575","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Automated variant re-evaluation is labor-balanced and gives clinically relevant results: Hereditary cardiac disease as a use case.","Automated variant re-evaluation is labor-balanced and gives clinically relevant results: Hereditary cardiac disease as a use case.",2024,1,NA,"PMID","39481677","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","GENCC","CausalMutation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.",2020,1,NA,"PMID","32840935","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.",2019,1,NA,"PMID","30871351","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","DNA-sequence-variants within RBM20 were considered suitable for genetic testing when they fulfilled the criteria of (1) being pathogenic according to the American College of Medical Genetics and Genomics-classification, (2) appeared with an allele frequency of <1:10.000, and (3) segregated with DCM in ≥7 affected individuals.","DNA-sequence-variants within <span class='gene' en_id='282996'>RBM20</span> were considered suitable for genetic testing when they fulfilled the criteria of (1) being pathogenic according to the American College of Medical Genetics and Genomics-classification, (2) appeared with an allele frequency of <1:10.000, and (3) segregated with <span class='disease' en_id='C0007193'>DCM</span> in ≥7 affected individuals.",2019,1,NA,"PMID","30871348","American","HANCESTRO:0463",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","King of hearts: a splicing factor rules cardiac proteins.","King of hearts: a splicing factor rules cardiac proteins.",2012,1,NA,"PMID","22561820","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Cardiomyopathy, familial dilated.","Cardiomyopathy, familial dilated.",2006,1,NA,"PMID","16839424","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","These effects may contribute to the early onset, and malignant course of DCM caused by RBM20 mutations.","These effects may contribute to the early onset, and malignant course of <span class='disease' en_id='C0007193'>DCM</span> caused by <span class='gene' en_id='282996'>RBM20</span> mutations.",2016,1,NA,"PMID","27496873","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","This article concludes that DCM in patients with RBM20 mutations is associated with advanced disease.","This article concludes that <span class='disease' en_id='C0007193'>DCM</span> in patients with <span class='gene' en_id='282996'>RBM20</span> mutations is associated with advanced disease.",2010,1,NA,"PMID","20590677","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.",2018,1,NA,"PMID","29447731","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.","Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.",2019,1,NA,"PMID","31568572","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Mutations in RBM20 (RNA-binding motif protein 20) cause a clinically aggressive form of dilated cardiomyopathy, with an increased risk of malignant ventricular arrhythmias.","Mutations in <span class='gene' en_id='282996'>RBM20</span> (<span class='gene' en_id='282996'>RNA-binding motif protein 20</span>) cause a clinically aggressive form of <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>, with an increased risk of malignant ventricular arrhythmias.",2018,1,NA,"PMID","29650543","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Mutations in RBM20 were observed in approximately 3% of subjects with DCM.","Mutations in <span class='gene' en_id='282996'>RBM20</span> were observed in approximately 3% of subjects with <span class='disease' en_id='C0007193'>DCM</span>.",2012,1,NA,"PMID","22004663","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","DNA-sequence-variants within RBM20 were considered suitable for genetic testing when they fulfilled the criteria of (1) being pathogenic according to the American College of Medical Genetics and Genomics-classification, (2) appeared with an allele frequency of <1:10.000, and (3) segregated with DCM in ≥7 affected individuals.","DNA-sequence-variants within <span class='gene' en_id='282996'>RBM20</span> were considered suitable for genetic testing when they fulfilled the criteria of (1) being pathogenic according to the American College of Medical Genetics and Genomics-classification, (2) appeared with an allele frequency of <1:10.000, and (3) segregated with <span class='disease' en_id='C0007193'>DCM</span> in ≥7 affected individuals.",2019,1,NA,"PMID","30871348","American","HANCESTRO:0463",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.","Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.",2021,1,NA,"PMID","34540771","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Recording light-evoked postsynaptic responses in neurons in dark-adapted, mouse retinal slice preparations using patch clamp techniques.","Recording light-evoked postsynaptic responses in neurons in dark-adapted, mouse retinal slice preparations using patch clamp techniques.",2015,1,NA,"PMID","25741904","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","This article concludes that DCM in patients with RBM20 mutations is associated with advanced disease.","This article concludes that <span class='disease' en_id='C0007193'>DCM</span> in patients with <span class='gene' en_id='282996'>RBM20</span> mutations is associated with advanced disease.",2010,1,NA,"PMID","20590677","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Dominant radial drusen and Arg345Trp EFEMP1 mutation.","Dominant radial drusen and Arg345Trp EFEMP1 mutation.",2001,1,NA,"PMID","11384588","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","The inherited macular degeneration Doyne honeycomb retinal dystrophy/Malattia Leventinese is thought to be caused by an R345W mutation in the EFEMP1 gene (also called fibulin-3).","The inherited macular degeneration <span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>Malattia Leventinese</span> is thought to be caused by an R345W mutation in the <span class='gene' en_id='2202'>EFEMP1</span> gene (also called <span class='gene' en_id='2202'>fibulin-3</span>).",2007,1,NA,"PMID","17666404","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family.","<span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>malattia leventinese</span> induced by <span class='gene' en_id='2202'>EFEMP1</span> mutation in a Chinese family.",2018,1,NA,"PMID","30541486","Chinese","HANCESTRO:0021",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.",2011,1,NA,"PMID","22031286","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.","New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.",2005,1,NA,"PMID","16193476","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Recently, mutations have been identified in the PRKCG gene in families with SCA14.","Recently, mutations have been identified in the <span class='gene' en_id='5582'>PRKCG</span> gene in families with <span class='disease' en_id='C1854369'>SCA14</span>.",2005,1,NA,"PMID","16189624","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","CLINVAR","GeneticVariation","Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.","Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.",2014,1,NA,"PMID","24976289","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","RGD_HUMAN","CausalOrContributing","Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.","Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.",2005,1,NA,"PMID","15604220","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","RGD_HUMAN","CausalOrContributing","The BCR-ABL35INS insertion/truncation mutant is kinase-inactive and does not contribute to tyrosine kinase inhibitor resistance in chronic myeloid leukemia.","The <span class='gene' en_id='613'>BCR-</span>ABL35INS insertion/truncation mutant is kinase-inactive and does <span class='negation_marker' en_id=''>not contribute</span> to tyrosine kinase inhibitor resistance in <span class='disease' en_id='C0279543,C1292771'>chronic myeloid leukemia</span>.",2011,1,NA,"PMID","21908430","","",NA,"Negative"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","As a result, 7 novel mutations (MYPN, p.E630K; TNNT2, p.G180A; MYH6, p.R1047C; TNNC1, p.D3V; DES, p.R386H; MYBPC3, p.C1124F; and MYL3, p.D126G), 3 variants of uncertain significance (RBM20, p.R1182H; MYH6, p.T1253M; and VCL, p.M209L), and 2 known mutations (MYH7, p.A26V and MYBPC3, p.R160W) were revealed to be associated with DCM.","As a result, 7 novel mutations (MYPN, p.E630K; TNNT2, p.G180A; MYH6, p.R1047C; TNNC1, p.D3V; DES, p.R386H; MYBPC3, p.C1124F; and MYL3, p.D126G), 3 variants of uncertain significance (<span class='gene' en_id='282996'>RBM20</span>, p.R1182H; MYH6, p.T1253M; and VCL, p.M209L), and 2 known mutations (MYH7, p.A26V and MYBPC3, p.R160W) were revealed to be associated with <span class='disease' en_id='C0007193'>DCM</span>.",2015,1,NA,"PMID","26458567","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Mutations in RBM20 were observed in approximately 3% of subjects with DCM.","Mutations in <span class='gene' en_id='282996'>RBM20</span> were observed in approximately 3% of subjects with <span class='disease' en_id='C0007193'>DCM</span>.",2012,1,NA,"PMID","22004663","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.",2017,1,NA,"PMID","27532257","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees.","Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees.",2018,1,NA,"PMID","30012837","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","This article concludes that DCM in patients with RBM20 mutations is associated with advanced disease.","This article concludes that <span class='disease' en_id='C0007193'>DCM</span> in patients with <span class='gene' en_id='282996'>RBM20</span> mutations is associated with advanced disease.",2010,1,NA,"PMID","20590677","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Validation of Concentric Rings Method as a Topographic Measure of Retinal Nonperfusion in Ultra-widefield Fluorescein Angiography.","Validation of Concentric Rings Method as a Topographic Measure of Retinal Nonperfusion in Ultra-widefield Fluorescein Angiography.",2016,1,NA,"PMID","26604126","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","RNA-binding motif protein 20 (RBM20) is essential for normal splicing of many cardiac genes, and loss of RBM20 causes dilated cardiomyopathy.","<span class='gene' en_id='282996'>RNA-binding motif protein 20</span> (<span class='gene' en_id='282996'>RBM20</span>) is essential for normal splicing of many cardiac genes, and loss of <span class='gene' en_id='282996'>RBM20</span> causes <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>.",2016,1,NA,"PMID","27531932","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Variants in RBM20 are reported in 2% to 6% of familial cases of dilated cardiomyopathy and may be associated with fatal ventricular arrhythmia and rapid heart failure progression.","Variants in <span class='gene' en_id='282996'>RBM20</span> are reported in 2% to 6% of familial cases of <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span> and may be associated with fatal ventricular arrhythmia and rapid heart failure progression.",2023,1,NA,"PMID","37593875","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Mutation in RBM20 is linked to autosomal-dominant familial dilated cardiomyopathy (DCM), yet most of the RBM20 missense mutations in familial and sporadic cases were mapped to an RSRSP stretch in an arginine/serine-rich region of which function remains unknown.","Mutation in <span class='gene' en_id='282996'>RBM20</span> is linked to autosomal-dominant familial <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span> (<span class='disease' en_id='C0007193'>DCM</span>), yet most of the <span class='gene' en_id='282996'>RBM20</span> missense mutations in familial and sporadic cases were mapped to an RSRSP stretch in an arginine/serine-rich region of which function remains unknown.",2018,1,NA,"PMID","29895960","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Pregnancy Outcomes in Females With Dilated Cardiomyopathy-Associated Rare Genetic Variants.","Pregnancy Outcomes in Females With Dilated Cardiomyopathy-Associated Rare Genetic Variants.",2022,1,NA,"PMID","35113650","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","These effects may contribute to the early onset, and malignant course of DCM caused by RBM20 mutations.","These effects may contribute to the early onset, and malignant course of <span class='disease' en_id='C0007193'>DCM</span> caused by <span class='gene' en_id='282996'>RBM20</span> mutations.",2016,1,NA,"PMID","27496873","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Mutations in RBM20 were observed in approximately 3% of subjects with DCM.","Mutations in <span class='gene' en_id='282996'>RBM20</span> were observed in approximately 3% of subjects with <span class='disease' en_id='C0007193'>DCM</span>.",2012,1,NA,"PMID","22004663","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.","Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.",2019,1,NA,"PMID","30847666","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","By monitoring human cardiac disease according to stage-specific cardiogenesis, this study demonstrates RBM20 familial DCM is a developmental disorder initiated by molecular defects that pattern maladaptive cellular mechanisms of pathological cardiac remodeling.","By monitoring human cardiac disease according to stage-specific cardiogenesis, this study demonstrates <span class='gene' en_id='282996'>RBM20</span> familial <span class='disease' en_id='C0007193'>DCM</span> is a developmental disorder initiated by molecular defects that pattern maladaptive cellular mechanisms of pathological cardiac remodeling.",2016,1,NA,"PMID","26604136","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","leukemia","[disease]","C0023418","Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the immune system (02715) | Abnormality of blood and blood-forming tissues (01871) | Neoplasm (02664)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Spinocerebellar Ataxia Type 14","Spinocerebellar Ataxia Type 14",1993,1,NA,"PMID","20301573","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Spinocerebellar Ataxia Type 14","Spinocerebellar Ataxia Type 14",1993,1,NA,"PMID","20301573","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning.","PKC gamma mutant mice exhibit mild deficits in spatial and contextual learning.",1993,1,NA,"PMID","8269510","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death.","Mutant protein kinase Cgamma found in spinocerebellar ataxia type 14 is susceptible to aggregation and causes cell death.",2005,1,NA,"PMID","15964845","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Spinocerebellar ataxia type 14 (SCA14) is a relatively pure form of autosomal dominant cerebellar ataxia mapped to chromosome 19q and caused by missense mutations in the gene encoding protein kinase C gamma (PRKCG), which are all located in the regulatory domain.","<span class='disease' en_id='C1854369'>Spinocerebellar ataxia type 14</span> (<span class='disease' en_id='C1854369'>SCA14</span>) is a relatively pure form of autosomal dominant cerebellar ataxia mapped to chromosome 19q and caused by missense mutations in the gene encoding <span class='gene' en_id='5582'>protein kinase C gamma</span> (<span class='gene' en_id='5582'>PRKCG</span>), which are all located in the regulatory domain.",2004,1,NA,"PMID","15313841","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia.","Exome sequencing and network analysis identifies shared mechanisms underlying spinocerebellar ataxia.",2017,1,NA,"PMID","29053796","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","These results point to specific alterations in mutant PKCgamma function that could lead to the selective neuronal degeneration of SCA14.","These results point to specific alterations in mutant <span class='gene' en_id='5582'>PKCgamma</span> function that could lead to the selective neuronal degeneration of <span class='disease' en_id='C1854369'>SCA14</span>.",2005,1,NA,"PMID","15618281","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Here, we describe the first familial cases of SCA14 with a G128D mutation in PRKCG.","Here, we describe the first familial cases of <span class='disease' en_id='C1854369'>SCA14</span> with a G128D mutation in <span class='gene' en_id='5582'>PRKCG</span>.",2009,1,NA,"PMID","18986758","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Deep sequencing reveals 50 novel genes for recessive cognitive disorders.","Deep sequencing reveals 50 novel genes for recessive cognitive disorders.",2011,1,NA,"PMID","21937992","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.","Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia.",2003,1,NA,"PMID","12644968","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","These findings document that SCA14 is caused by mutations in the PRKCG gene.","These findings document that <span class='disease' en_id='C1854369'>SCA14</span> is caused by mutations in the <span class='gene' en_id='5582'>PRKCG</span> gene.",2003,1,NA,"PMID","14676051","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","ORPHANET","FusionGene",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation","A novel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family.","A novel haplotype with the R345W mutation in the EFEMP1 gene associated with autosomal dominant drusen in a Japanese family.",2010,1,NA,"PMID","19850834","Japanese","HANCESTRO:0019",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.","First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.",2021,1,NA,"PMID","33689237","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,1,NA,"PMID","10369267","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","The inherited macular degeneration Doyne honeycomb retinal dystrophy/Malattia Leventinese is thought to be caused by an R345W mutation in the EFEMP1 gene (also called fibulin-3).","The inherited macular degeneration <span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>Malattia Leventinese</span> is thought to be caused by an R345W mutation in the <span class='gene' en_id='2202'>EFEMP1</span> gene (also called <span class='gene' en_id='2202'>fibulin-3</span>).",2007,1,NA,"PMID","17666404","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Acute lymphocytic leukemia","[disease]","C0023449","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the immune system (02715) | Abnormality of blood and blood-forming tissues (01871) | Neoplasm (02664)","CLINVAR","GeneticVariation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Obesity","[disease]","C0028754","Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","disease of metabolism (0014667)","Growth abnormality (01507)","RGD_HUMAN","CausalOrContributing","Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.","Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.",2009,1,NA,"PMID","19079261","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.",2019,1,NA,"PMID","30871351","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.","Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.",2021,1,NA,"PMID","34540771","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Cardiomyopathy, familial dilated.","Cardiomyopathy, familial dilated.",2006,1,NA,"PMID","16839424","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.","Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.",2011,1,NA,"PMID","21846512","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Heterozygous mutations in human protein coding genes NKX2-5 and RBM20 are associated with a wide array of pathological phenotypes some of which are sudden cardiac death, unexplained syncope and either combined or isolated congenital heart diseases such as dilated cardiomyopathy.","Heterozygous mutations in human protein coding genes NKX2-5 and <span class='gene' en_id='282996'>RBM20</span> are associated with a wide array of pathological phenotypes some of which are sudden cardiac death, unexplained syncope and either combined or isolated congenital heart diseases such as <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>.",2019,1,NA,"PMID","30611920","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians.","Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians.",2014,1,NA,"PMID","25448463","Canadian,French","HANCESTRO:0354,HANCESTRO:0363",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","RNA-binding motif protein 20 (RBM20) is essential for normal splicing of many cardiac genes, and loss of RBM20 causes dilated cardiomyopathy.","<span class='gene' en_id='282996'>RNA-binding motif protein 20</span> (<span class='gene' en_id='282996'>RBM20</span>) is essential for normal splicing of many cardiac genes, and loss of <span class='gene' en_id='282996'>RBM20</span> causes <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>.",2016,1,NA,"PMID","27531932","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.",2017,1,NA,"PMID","27532257","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Implications of Genetic Testing in Dilated Cardiomyopathy.","Implications of Genetic Testing in Dilated Cardiomyopathy.",2020,1,NA,"PMID","32880476","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel.","Genes Associated With Hypertrophic Cardiomyopathy: A Reappraisal by the ClinGen Hereditary Cardiovascular Disease Gene Curation Expert Panel.",2025,1,NA,"PMID","39971408","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","RIKADA Study Reveals Risk Factors in Pediatric Primary Cardiomyopathy.","RIKADA Study Reveals Risk Factors in Pediatric Primary Cardiomyopathy.",2019,1,NA,"PMID","31333075","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Mutations in RBM20 (RNA-binding motif protein 20) cause a clinically aggressive form of dilated cardiomyopathy, with an increased risk of malignant ventricular arrhythmias.","Mutations in <span class='gene' en_id='282996'>RBM20</span> (<span class='gene' en_id='282996'>RNA-binding motif protein 20</span>) cause a clinically aggressive form of <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>, with an increased risk of malignant ventricular arrhythmias.",2018,1,NA,"PMID","29650543","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Spinocerebellar Ataxia Type 14","Spinocerebellar Ataxia Type 14",1993,1,NA,"PMID","20301573","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","We also observed that SCA14-associated mutations in PKCγ accelerate the amyloid-like fibril formation both in cultured cells and in vitro.","We also observed that <span class='disease' en_id='C1854369'>SCA14</span>-associated mutations in <span class='gene' en_id='5582'>PKCγ</span> accelerate the amyloid-like fibril formation both in cultured cells and in vitro.",2015,1,NA,"PMID","25217572","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Spinocerebellar ataxia 14 (SCA14) is associated with missense mutations in the protein kinase C gamma gene (PRKCG), rather than a nucleotide repeat expansion.","<span class='disease' en_id='C1854369'>Spinocerebellar ataxia 14</span> (<span class='disease' en_id='C1854369'>SCA14</span>) is associated with missense mutations in the <span class='gene' en_id='5582'>protein kinase C gamma gene</span> (<span class='gene' en_id='5582'>PRKCG</span>), rather than a nucleotide repeat expansion.",2005,1,NA,"PMID","15824357","","",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","We subsequently screened the current Dutch ataxia cohort (approximately 900 individuals) for SCA14 mutations in the Cys2 region of the PRKCG gene.","We subsequently screened the current Dutch ataxia cohort (approximately 900 individuals) for <span class='disease' en_id='C1854369'>SCA14</span> mutations in the Cys2 region of the <span class='gene' en_id='5582'>PRKCG</span> gene.",2005,1,NA,"PMID","15841389","Dutch","HANCESTRO:0320",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Codon 101 of PRKCG, a preferential mutation site in SCA14.","Codon 101 of PRKCG, a preferential mutation site in SCA14.",2007,1,NA,"PMID","17659643","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.","Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.",2025,1,NA,"PMID","39825153","European","HANCESTRO:0005",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter.","A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter.",2002,1,NA,"PMID","12164726","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spinocerebellar ataxia 14","[disease]","C1854369","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Together, these results show that SCA14 mutations located in the C1B subdomain ;open' PKCgamma protein conformation leading to increased C1 domain accessibility, but inefficient activation of downstream signaling pathways.","Together, these results show that <span class='disease' en_id='C1854369'>SCA14</span> mutations located in the C1B subdomain ;open' <span class='gene' en_id='5582'>PKCgamma</span> protein conformation leading to increased C1 domain accessibility, but inefficient activation of downstream signaling pathways.",2008,1,NA,"PMID","18577575","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Molecular genetic heterogeneity in autosomal dominant drusen.","Molecular genetic heterogeneity in autosomal dominant drusen.",2001,1,NA,"PMID","11389162","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.",2011,1,NA,"PMID","22031286","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family.","<span class='disease' en_id='C1832174'>Doyne honeycomb retinal dystrophy</span>/<span class='disease' en_id='C1832174'>malattia leventinese</span> induced by <span class='gene' en_id='2202'>EFEMP1</span> mutation in a Chinese family.",2018,1,NA,"PMID","30541486","Chinese","HANCESTRO:0021",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","CES1 knockdown or overexpression of EFEMP1R345W, a variant of EGF-containing fibulin extracellular matrix protein 1 that is associated with DHRD and attenuated cholesterol efflux and led to lipid droplet accumulation.","CES1 knockdown or overexpression of EFEMP1R345W, a variant of <span class='gene' en_id='2202'>EGF-containing fibulin extracellular matrix protein 1</span> that is associated with <span class='disease' en_id='C1832174'>DHRD</span> and attenuated cholesterol efflux and led to lipid droplet accumulation.",2021,1,NA,"PMID","33909993","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.",2011,1,NA,"PMID","22031286","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,1,NA,"PMID","10369267","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","DOYNE HONEYCOMB RETINAL DYSTROPHY","[disease]","C1832174","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Molecular genetic heterogeneity in autosomal dominant drusen.","Molecular genetic heterogeneity in autosomal dominant drusen.",2001,1,NA,"PMID","11389162","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Philadelphia chromosome positive chronic myelogenous leukemia","[disease]","C0279543","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","RGD_HUMAN","CausalOrContributing","Inhibitors of ABL and the ABL-T315I mutation.","Inhibitors of ABL and the ABL-T315I mutation.",2008,1,NA,"PMID","18673174","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Acute lymphocytic leukemia","[disease]","C0023449","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the immune system (02715) | Abnormality of blood and blood-forming tissues (01871) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing",NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.",2015,1,NA,"PMID","26084686","Finnish","HANCESTRO:0321",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","These effects may contribute to the early onset, and malignant course of DCM caused by RBM20 mutations.","These effects may contribute to the early onset, and malignant course of <span class='disease' en_id='C0007193'>DCM</span> caused by <span class='gene' en_id='282996'>RBM20</span> mutations.",2016,1,NA,"PMID","27496873","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Our findings establish RBM20 as a DCM gene and reveal a mutation hotspot in the RS domain.","Our findings establish <span class='gene' en_id='282996'>RBM20</span> as a <span class='disease' en_id='C0007193'>DCM</span> gene and reveal a mutation hotspot in the RS domain.",2009,1,NA,"PMID","19712804","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","By monitoring human cardiac disease according to stage-specific cardiogenesis, this study demonstrates RBM20 familial DCM is a developmental disorder initiated by molecular defects that pattern maladaptive cellular mechanisms of pathological cardiac remodeling.","By monitoring human cardiac disease according to stage-specific cardiogenesis, this study demonstrates <span class='gene' en_id='282996'>RBM20</span> familial <span class='disease' en_id='C0007193'>DCM</span> is a developmental disorder initiated by molecular defects that pattern maladaptive cellular mechanisms of pathological cardiac remodeling.",2016,1,NA,"PMID","26604136","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","CausalMutation","Severe DCM phenotype of patient harboring RBM20 mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.","Severe <span class='disease' en_id='C0007193'>DCM</span> phenotype of patient harboring <span class='gene' en_id='282996'>RBM20</span> mutation S635A can be modeled by patient-specific induced pluripotent stem cell-derived cardiomyocytes.",2017,1,NA,"PMID","28941705","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","This review aims to give an update on recent findings related to the cardiac splicing factor RNA-binding motif protein 20 (RBM20) and RBM20 cardiomyopathy, a form of dilated cardiomyopathy caused by mutations in RBM20.","This review aims to give an update on recent findings related to the cardiac splicing factor <span class='gene' en_id='282996'>RNA-binding motif protein 20</span> (<span class='gene' en_id='282996'>RBM20</span>) and <span class='gene' en_id='282996'>RBM20</span> cardiomyopathy, a form of <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span> caused by mutations in <span class='gene' en_id='282996'>RBM20</span>.",2020,1,NA,"PMID","32789749","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Mutations in RBM20 (RNA-binding motif protein 20) cause a clinically aggressive form of dilated cardiomyopathy, with an increased risk of malignant ventricular arrhythmias.","Mutations in <span class='gene' en_id='282996'>RBM20</span> (<span class='gene' en_id='282996'>RNA-binding motif protein 20</span>) cause a clinically aggressive form of <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>, with an increased risk of malignant ventricular arrhythmias.",2018,1,NA,"PMID","29650543","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","DNA-sequence-variants within RBM20 were considered suitable for genetic testing when they fulfilled the criteria of (1) being pathogenic according to the American College of Medical Genetics and Genomics-classification, (2) appeared with an allele frequency of <1:10.000, and (3) segregated with DCM in ≥7 affected individuals.","DNA-sequence-variants within <span class='gene' en_id='282996'>RBM20</span> were considered suitable for genetic testing when they fulfilled the criteria of (1) being pathogenic according to the American College of Medical Genetics and Genomics-classification, (2) appeared with an allele frequency of <1:10.000, and (3) segregated with <span class='disease' en_id='C0007193'>DCM</span> in ≥7 affected individuals.",2019,1,NA,"PMID","30871348","American","HANCESTRO:0463",NA,"Positive"
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","CAD mutations and uridine-responsive epileptic encephalopathy.","CAD mutations and uridine-responsive epileptic encephalopathy.",2017,0.95,NA,"PMID","28007989","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","A Patient With CAD Deficiency Responsive to Uridine and Literature Review.","A Patient With CAD Deficiency Responsive to Uridine and Literature Review.",2020,0.95,NA,"PMID","32117025","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.","Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.",2020,0.95,NA,"PMID","32820246","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.",2015,0.95,NA,"PMID","25678555","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation",NA,NA,NA,0.95,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","CAD mutations and uridine-responsive epileptic encephalopathy.","CAD mutations and uridine-responsive epileptic encephalopathy.",2017,0.95,NA,"PMID","28007989","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy.","Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy.",2020,0.95,NA,"PMID","32461667","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.",2015,0.95,NA,"PMID","25678555","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.","Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.",2023,0.95,NA,"PMID","37540500","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.","Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.",2018,0.95,NA,"PMID","29396846","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.95,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.95,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation",NA,NA,NA,0.95,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.95,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.","Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.",2020,0.95,NA,"PMID","32820246","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","CAD mutations and uridine-responsive epileptic encephalopathy.","CAD mutations and uridine-responsive epileptic encephalopathy.",2017,0.95,NA,"PMID","28007989","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.",2015,0.95,NA,"PMID","25678555","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans.","Novel GNB1 mutations disrupt assembly and function of G protein heterotrimers and cause global developmental delay in humans.",2017,0.95,NA,"PMID","28087732","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings.","Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings.",2021,0.95,NA,"PMID","33497533","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","CAD mutations and uridine-responsive epileptic encephalopathy.","CAD mutations and uridine-responsive epileptic encephalopathy.",2017,0.95,NA,"PMID","28007989","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Deciphering CAD: Structure and function of a mega-enzymatic pyrimidine factory in health and disease.","Deciphering CAD: Structure and function of a mega-enzymatic pyrimidine factory in health and disease.",2021,0.95,NA,"PMID","34288185","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.",2015,0.95,NA,"PMID","25678555","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.","Multi-gene panel testing improves diagnosis and management of patients with hereditary anemias.",2018,0.95,NA,"PMID","29396846","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Exome sequencing efficacy and phenotypic expansions involving esophageal atresia/tracheoesophageal fistula plus.","Exome sequencing efficacy and phenotypic expansions involving esophageal atresia/tracheoesophageal fistula plus.",2022,0.95,NA,"PMID","36135330","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.",2015,0.95,NA,"PMID","25678555","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.","Expanding the clinical and genetic spectrum of CAD deficiency: an epileptic encephalopathy treatable with uridine supplementation.",2020,0.95,NA,"PMID","32820246","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","A specific nutritional requirement for pyrimidines in rudimentary mutants of Drosophila melanogaster.","A specific nutritional requirement for pyrimidines in rudimentary mutants of Drosophila melanogaster.",1970,0.95,NA,"PMID","5004701","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.","Biallelic mutations in CAD, impair de novo pyrimidine biosynthesis and decrease glycosylation precursors.",2015,0.95,NA,"PMID","25678555","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase congenital disorder of glycosylation (disorder)","[disease]","C4225320","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Analysis of the Zebrafish perplexed mutation reveals tissue-specific roles for de novo pyrimidine synthesis during development.","Analysis of the Zebrafish perplexed mutation reveals tissue-specific roles for de novo pyrimidine synthesis during development.",2005,0.95,NA,"PMID","15937129","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients.","Whole-exome sequencing identifies novel pathogenic mutations and putative phenotype-influencing variants in Polish limb-girdle muscular dystrophy patients.",2018,0.9,NA,"PMID","29970176","Polish","HANCESTRO:0381",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy.","Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy.",2014,0.9,NA,"PMID","24594375","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Characteristic Posterior-dominant Lower Limb Muscle Involvement in Limb-girdle Muscular Dystrophy due to a DNAJB6 Phe93Leu Mutation.","Characteristic Posterior-dominant Lower Limb Muscle Involvement in Limb-girdle Muscular Dystrophy due to a DNAJB6 Phe93Leu Mutation.",2017,0.9,NA,"PMID","28794355","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy.","Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy.",1995,0.9,NA,"PMID","8533766","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.","Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.",2015,0.9,NA,"PMID","26205529","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.","A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene.",2016,0.9,NA,"PMID","27642634","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease.","Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease.",2015,0.9,NA,"PMID","26338452","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients.","Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients.",2018,0.9,NA,"PMID","30564623","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease.","Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease.",2015,0.9,NA,"PMID","26338452","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.9,NA,"PMID","22366786","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.9,NA,"PMID","22366786","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","Spatio-temporal transcriptome of the human brain.","Spatio-temporal transcriptome of the human brain.",2013,0.9,NA,"PMID","22031440","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.",2016,0.9,NA,"PMID","27694961","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Mutations in the HECT domain of NEDD4L have recently been identified in a cohort of eight patients with a syndromic form of bilateral periventricular nodular heterotopia (PVNH) in association with neurodevelopmental delay, cleft palate, and toe syndactyly (PVNH7).","Mutations in the HECT domain of <span class='gene' en_id='23327'>NEDD4L</span> have recently been identified in a cohort of eight patients with a syndromic form of bilateral periventricular nodular heterotopia (PVNH) in association with neurodevelopmental delay, cleft palate, and toe syndactyly (<span class='disease' en_id='C4310669'>PVNH7</span>).",2018,0.9,NA,"PMID","30393983","","",NA,"Positive"
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Recurrent NEDD4L Variant in Periventricular Nodular Heterotopia, Polymicrogyria and Syndactyly.","Recurrent NEDD4L Variant in Periventricular Nodular Heterotopia, Polymicrogyria and Syndactyly.",2020,0.9,NA,"PMID","32117442","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Hernia, Inguinal","[disease]","C0019294","Pathological Conditions, Signs and Symptoms (C23)","Anatomical Abnormality (T190)","disease of anatomical entity (7)","Abnormality of the digestive system (25031) | Abnormality of the musculoskeletal system (33127)","CLINVAR","CausalMutation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Heterozygous missense mutations in syt1 have recently been associated with a severe but heterogeneous developmental syndrome, termed syt1-associated neurodevelopmental disorder.","Heterozygous missense mutations in <span class='gene' en_id='6857'>syt1</span> have recently been associated with a severe but heterogeneous developmental syndrome, termed <span class='disease' en_id='C4748715'>syt1-associated neurodevelopmental disorder</span>.",2020,0.9,NA,"PMID","32362337","","",NA,"Positive"
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.",2015,0.9,NA,"PMID","25712080","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.9,NA,"PMID","30107533","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.",2015,0.9,NA,"PMID","25705886","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.9,NA,"PMID","30107533","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Periventricular nodular heterotopia-7 (PVNH7) is a neurodevelopmental disorder associated with improper neuronal migration during neurogenesis in cortex development caused by pathogenic variants in the NEDD4L gene.","<span class='disease' en_id='C4310669'>Periventricular nodular heterotopia-7</span> (<span class='disease' en_id='C4310669'>PVNH7</span>) is a neurodevelopmental disorder associated with improper neuronal migration during neurogenesis in cortex development caused by pathogenic variants in the <span class='gene' en_id='23327'>NEDD4L</span> gene.",2021,0.9,NA,"PMID","34087865","","",NA,"Positive"
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability.","A comparison of genomic diagnostics in adults and children with epilepsy and comorbid intellectual disability.",2020,0.9,NA,"PMID","32238909","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Recurrent NEDD4L Variant in Periventricular Nodular Heterotopia, Polymicrogyria and Syndactyly.","Recurrent NEDD4L Variant in Periventricular Nodular Heterotopia, Polymicrogyria and Syndactyly.",2020,0.9,NA,"PMID","32117442","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.",2016,0.9,NA,"PMID","27694961","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","GENCC","CausalMutation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D.","Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D.",2016,0.9,NA,"PMID","26847086","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutations in the J domain of DNAJB6 cause dominant distal myopathy.","Mutations in the J domain of DNAJB6 cause dominant distal myopathy.",2020,0.9,NA,"PMID","31955980","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Intrafamilial variability of limb-girdle muscular dystrophy, LGMD1D type.","Intrafamilial variability of limb-girdle muscular dystrophy, LGMD1D type.",2020,0.9,NA,"PMID","31034989","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.9,NA,"PMID","22366786","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutations in the J domain of DNAJB6 cause dominant distal myopathy.","Mutations in the J domain of DNAJB6 cause dominant distal myopathy.",2020,0.9,NA,"PMID","31955980","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.","A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.",2017,0.9,NA,"PMID","28515470","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","High molecular diagnostic yields and novel phenotypic expansions involving syndromic anorectal malformations.","High molecular diagnostic yields and novel phenotypic expansions involving syndromic anorectal malformations.",2023,0.9,NA,"PMID","36474027","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Periventricular nodular heterotopia-7 (PVNH7) is a neurodevelopmental disorder associated with improper neuronal migration during neurogenesis in cortex development caused by pathogenic variants in the NEDD4L gene.","<span class='disease' en_id='C4310669'>Periventricular nodular heterotopia-7</span> (<span class='disease' en_id='C4310669'>PVNH7</span>) is a neurodevelopmental disorder associated with improper neuronal migration during neurogenesis in cortex development caused by pathogenic variants in the <span class='gene' en_id='23327'>NEDD4L</span> gene.",2021,0.9,NA,"PMID","34087865","","",NA,"Positive"
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.",2015,0.9,NA,"PMID","25705886","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.",2015,0.9,NA,"PMID","25712080","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Prevalence and architecture of de novo mutations in developmental disorders.","Prevalence and architecture of de novo mutations in developmental disorders.",2017,0.9,NA,"PMID","28135719","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.9,NA,"PMID","30107533","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.9,NA,"PMID","30107533","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.",2012,0.9,NA,"PMID","22334415","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients.","Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients.",2018,0.9,NA,"PMID","30564623","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A novel DNAJB6 mutation causes dominantly inherited distal-onset myopathy and compromises DNAJB6 function.","A novel DNAJB6 mutation causes dominantly inherited distal-onset myopathy and compromises DNAJB6 function.",2017,0.9,NA,"PMID","28233300","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A novel mutation in DNAJB6, p.(Phe91Leu), in childhood-onset LGMD1D with a severe phenotype.","A novel mutation in DNAJB6, p.(Phe91Leu), in childhood-onset LGMD1D with a severe phenotype.",2015,0.9,NA,"PMID","26371419","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","A novel mutation in DNAJB6, p.(Phe91Leu), in childhood-onset LGMD1D with a severe phenotype.","A novel mutation in DNAJB6, p.(Phe91Leu), in childhood-onset LGMD1D with a severe phenotype.",2015,0.9,NA,"PMID","26371419","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A distinctive autosomal dominant vacuolar neuromyopathy linked to 19p13.","A distinctive autosomal dominant vacuolar neuromyopathy linked to 19p13.",1999,0.9,NA,"PMID","10489050","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Four new Finnish families with LGMD1D; refinement of the clinical phenotype and the linked 7q36 locus.","Four new Finnish families with LGMD1D; refinement of the clinical phenotype and the linked 7q36 locus.",2011,0.9,NA,"PMID","21376592","Finnish","HANCESTRO:0321",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscular Dystrophies, Limb-Girdle","[disease]","C0686353","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127) | Abnormality of limbs (40064)","RGD_HUMAN","CausalOrContributing","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone <span class='gene' en_id='10049'>DNAJB6</span> cause <span class='disease' en_id='C0686353'>limb-girdle muscular dystrophy</span>.",2012,0.9,NA,"PMID","22366786","","",NA,"Positive"
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","The data indicate a significant association between longer CAG repeats in second polymorphic KCNN3 region and schizophrenia in the Serbian population.","The data indicate a significant association between longer CAG repeats in second polymorphic <span class='gene' en_id='3782'>KCNN3</span> region and <span class='disease' en_id='C0036341'>schizophrenia</span> in the Serbian population.",2006,0.9,NA,"PMID","16393881","","",NA,"Positive"
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","GENCC","GeneticVariation","Targeted Gene Resequencing (Astrochip) to Explore the Tripartite Synapse in Autism-Epilepsy Phenotype with Macrocephaly.","Targeted Gene Resequencing (Astrochip) to Explore the Tripartite Synapse in Autism-Epilepsy Phenotype with Macrocephaly.",2016,0.9,NA,"PMID","26537360","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.",2016,0.9,NA,"PMID","27694961","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.",2016,0.9,NA,"PMID","27694961","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.",2012,0.9,NA,"PMID","22334415","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","LGMD1D myopathy with cytoplasmic and nuclear inclusions in a Saudi family due to DNAJB6 mutation.","LGMD1D myopathy with cytoplasmic and nuclear inclusions in a Saudi family due to DNAJB6 mutation.",2018,0.9,NA,"PMID","30838352","Saudi","HANCESTRO:0449",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.","Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.",2015,0.9,NA,"PMID","26205529","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy.","Exome sequencing identifies a DNAJB6 mutation in a family with dominantly-inherited limb-girdle muscular dystrophy.",2014,0.9,NA,"PMID","24594375","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","DNAJB6 Myopathies: Focused Review on an Emerging and Expanding Group of Myopathies.","DNAJB6 Myopathies: Focused Review on an Emerging and Expanding Group of Myopathies.",2016,0.9,NA,"PMID","27747217","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness.","Sequential targeted exome sequencing of 1001 patients affected by unexplained limb-girdle weakness.",2020,0.9,NA,"PMID","32528171","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7.","Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7.",1999,0.9,NA,"PMID","9973293","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscular Dystrophies, Limb-Girdle","[disease]","C0686353","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127) | Abnormality of limbs (40064)","CLINVAR","GeneticVariation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.",2015,0.9,NA,"PMID","25712080","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.","Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome.",2015,0.9,NA,"PMID","25712080","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","CausalMutation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.9,NA,"PMID","30107533","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","GENCC","GeneticVariation","Mutation screening of the KCNN3 gene reveals a rare frameshift mutation.","Mutation screening of the KCNN3 gene reveals a rare frameshift mutation.",2001,0.9,NA,"PMID","11326292","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","GENCC","CausalMutation",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.9,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.","Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.",2014,0.9,NA,"PMID","24920671","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","The enigma of 7q36 linked autosomal dominant limb girdle muscular dystrophy.","The enigma of 7q36 linked autosomal dominant limb girdle muscular dystrophy.",2010,0.9,NA,"PMID","20682716","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","A novel DNAJB6 mutation causes dominantly inherited distal-onset myopathy and compromises DNAJB6 function.","A novel DNAJB6 mutation causes dominantly inherited distal-onset myopathy and compromises DNAJB6 function.",2017,0.9,NA,"PMID","28233300","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.9,NA,"PMID","22366786","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Intrafamilial variability of limb-girdle muscular dystrophy, LGMD1D type.","Intrafamilial variability of limb-girdle muscular dystrophy, LGMD1D type.",2020,0.9,NA,"PMID","31034989","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.9,NA,"PMID","22366786","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.","Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.",2014,0.9,NA,"PMID","24920671","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies.","A first-line diagnostic assay for limb-girdle muscular dystrophy and other myopathies.",2016,0.9,NA,"PMID","27671536","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples.","MotorPlex provides accurate variant detection across large muscle genes both in single myopathic patients and in pools of DNA samples.",2014,0.9,NA,"PMID","25214167","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 1","[disease]","C4721885","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.",2012,0.9,NA,"PMID","22334415","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.",2015,0.9,NA,"PMID","25705886","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.",2015,0.9,NA,"PMID","25705886","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.9,NA,"PMID","30107533","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.","Identification of a human synaptotagmin-1 mutation that perturbs synaptic vesicle cycling.",2015,0.9,NA,"PMID","25705886","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Infantile hypotonia, oculomotor anomalies, hyperkinetic movements, developmental delay syndrome","[disease]","C4748715","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.","Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses.",2025,0.9,NA,"PMID","39825153","European","HANCESTRO:0005",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","PERIVENTRICULAR NODULAR HETEROTOPIA 7","[disease]","C4310669","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.","A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate.",2017,0.9,NA,"PMID","28515470","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","The small-conductance calcium-activated K(+) channel SK3 (SKCa3/KCNN3) regulates electrical excitability and neurotransmitter release in monoaminergic neurons, and has been implicated in schizophrenia, ataxia and anorexia nervosa.","The small-conductance calcium-activated K(+) channel SK3 (SKCa3/<span class='gene' en_id='3782'>KCNN3</span>) regulates electrical excitability and neurotransmitter release in monoaminergic neurons, and has been implicated in <span class='disease' en_id='C0036341'>schizophrenia</span>, ataxia and anorexia nervosa.",2003,0.9,NA,"PMID","12808432","","",NA,"Positive"
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","GENCC","GeneticVariation","Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.","Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation.",2014,0.9,NA,"PMID","24206670","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscular Dystrophy","[disease]","C0026850","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127)","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","Together, our findings suggest that activating RRAS2 mutations can cause NS and expand the involvement of RRAS2 proto-oncogene to rare germline disorders.","Together, our findings suggest that activating <span class='gene' en_id='22800'>RRAS2</span> mutations can cause <span class='disease' en_id='C0028326'>NS</span> and expand the involvement of <span class='gene' en_id='22800'>RRAS2</span> proto-oncogene to rare germline disorders.",2019,0.85,NA,"PMID","31130285","","",NA,"Positive"
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINGEN","CausalMutation","By using a mixed strategy of functional candidacy and exome sequencing, we identify RRAS2 as a gene implicated in NS in six unrelated subjects/families.","By using a mixed strategy of functional candidacy and exome sequencing, we identify <span class='gene' en_id='22800'>RRAS2</span> as a gene implicated in <span class='disease' en_id='C0028326'>NS</span> in six unrelated subjects/families.",2019,0.85,NA,"PMID","31130282","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.85,NA,"PMID","19838196","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Periventricular Nodular Heterotopia","[disease]","C1868720","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation","Here we show that missense mutations in NEDD4L mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, cleft palate and neurodevelopmental delay.","Here we show that missense mutations in <span class='gene' en_id='23327'>NEDD4L</span> mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to <span class='disease' en_id='C1868720'>PNH</span> associated with toe syndactyly, cleft palate and neurodevelopmental delay.",2016,0.85,NA,"PMID","27694961","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Malignant mesothelioma","[disease]","C0345967","Respiratory Tract Diseases (C08) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.",2016,0.85,NA,"PMID","27032653","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINGEN","CausalMutation","High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study.","High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study.",2021,0.85,NA,"PMID","33686258","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINGEN","CausalMutation","Together, our findings suggest that activating RRAS2 mutations can cause NS and expand the involvement of RRAS2 proto-oncogene to rare germline disorders.","Together, our findings suggest that activating <span class='gene' en_id='22800'>RRAS2</span> mutations can cause <span class='disease' en_id='C0028326'>NS</span> and expand the involvement of <span class='gene' en_id='22800'>RRAS2</span> proto-oncogene to rare germline disorders.",2019,0.85,NA,"PMID","31130285","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathies","[disease]","C0878544","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","GeneticVariation","Noonan Syndrome","Noonan Syndrome",1993,0.85,NA,"PMID","20301303","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINGEN","CausalMutation","Follow-up rapid whole exome sequencing revealed a de novo p.Q72L variant in RRAS2, a poorly studied gene recently identified as a cause of NS.","Follow-up rapid whole exome sequencing revealed a de novo p.Q72L variant in <span class='gene' en_id='22800'>RRAS2</span>, a poorly studied gene recently identified as a cause of <span class='disease' en_id='C0028326'>NS</span>.",2022,0.85,NA,"PMID","34648682","","",NA,"Positive"
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","ORPHANET","GermlineCausalMutation","Together, our findings suggest that activating RRAS2 mutations can cause NS and expand the involvement of RRAS2 proto-oncogene to rare germline disorders.","Together, our findings suggest that activating <span class='gene' en_id='22800'>RRAS2</span> mutations can cause <span class='disease' en_id='C0028326'>NS</span> and expand the involvement of <span class='gene' en_id='22800'>RRAS2</span> proto-oncogene to rare germline disorders.",2019,0.85,NA,"PMID","31130285","","",NA,"Positive"
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","Noonan syndrome: clinical features, diagnosis, and management guidelines.","Noonan syndrome: clinical features, diagnosis, and management guidelines.",2010,0.85,NA,"PMID","20876176","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Periventricular Nodular Heterotopia","[disease]","C1868720","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","GENCC","GeneticVariation","Here we show that missense mutations in NEDD4L mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, cleft palate and neurodevelopmental delay.","Here we show that missense mutations in <span class='gene' en_id='23327'>NEDD4L</span> mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to <span class='disease' en_id='C1868720'>PNH</span> associated with toe syndactyly, cleft palate and neurodevelopmental delay.",2016,0.85,NA,"PMID","27694961","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathies","[disease]","C0878544","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscular Dystrophy","[disease]","C0026850","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","CausalMutation",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","GeneticVariation","Together, our findings suggest that activating RRAS2 mutations can cause NS and expand the involvement of RRAS2 proto-oncogene to rare germline disorders.","Together, our findings suggest that activating <span class='gene' en_id='22800'>RRAS2</span> mutations can cause <span class='disease' en_id='C0028326'>NS</span> and expand the involvement of <span class='gene' en_id='22800'>RRAS2</span> proto-oncogene to rare germline disorders.",2019,0.85,NA,"PMID","31130285","","",NA,"Positive"
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","GeneticVariation","Noonan syndrome: clinical features, diagnosis, and management guidelines.","Noonan syndrome: clinical features, diagnosis, and management guidelines.",2010,0.85,NA,"PMID","20876176","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Periventricular Nodular Heterotopia","[disease]","C1868720","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.85,NA,NA,NA,NA,NA,NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Hereditary Sensory and Autonomic Neuropathy Type II","Hereditary Sensory and Autonomic Neuropathy Type II",1993,0.85,NA,"PMID","21089229","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Hereditary Sensory and Autonomic Neuropathy Type II","Hereditary Sensory and Autonomic Neuropathy Type II",1993,0.85,NA,"PMID","21089229","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Periventricular Nodular Heterotopia","[disease]","C1868720","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Here we show that missense mutations in NEDD4L mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, cleft palate and neurodevelopmental delay.","Here we show that missense mutations in <span class='gene' en_id='23327'>NEDD4L</span> mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to <span class='disease' en_id='C1868720'>PNH</span> associated with toe syndactyly, cleft palate and neurodevelopmental delay.",2016,0.85,NA,"PMID","27694961","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.",2014,0.85,NA,"PMID","24327336","Turkish","HANCESTRO:0451",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIB","[disease]","C2751092","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.85,NA,"PMID","19838196","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","Noonan Syndrome","Noonan Syndrome",1993,0.85,NA,"PMID","20301303","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Noonan Syndrome","[disease]","C0028326","Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study.","High diagnosis rate for nonimmune hydrops fetalis with prenatal clinical exome from the Hydrops-Yielding Diagnostic Results of Prenatal Sequencing (HYDROPS) Study.",2021,0.85,NA,"PMID","33686258","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Ataxia, Spinocerebellar","[disease]","C0087012","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy.","Mutant protein kinase C gamma that causes spinocerebellar ataxia type 14 (SCA14) is selectively degraded by autophagy.",2010,0.8,NA,"PMID","20398063","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.","Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.",2018,0.8,NA,"PMID","29451896","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum.","RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum.",2020,0.8,NA,"PMID","31814314","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Atrial Fibrillation","[disease]","C0004238","Pathological Conditions, Signs and Symptoms (C23) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Common variants in KCNN3 are associated with lone atrial fibrillation.","Common variants in <span class='gene' en_id='3782'>KCNN3</span> are associated with lone <span class='disease' en_id='C0004238'>atrial fibrillation</span>.",2010,0.8,NA,"PMID","20173747","","",NA,"Positive"
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease.","Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease.",2021,0.8,NA,"PMID","33515434","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation","Mutations in RARS cause hypomyelination.","Mutations in RARS cause hypomyelination.",2014,0.8,NA,"PMID","24777941","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.","Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.",2017,0.8,NA,"PMID","28905880","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease.","Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease.",2016,0.8,NA,"PMID","26736064","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.","Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.",2017,0.8,NA,"PMID","28905880","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutations in RARS cause hypomyelination.","Mutations in RARS cause hypomyelination.",2014,0.8,NA,"PMID","24777941","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Diabetes Mellitus, Insulin-Dependent","[disease]","C0011854","Immune System Diseases (C20) | Endocrine System Diseases (C19) | Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630) | disease of anatomical entity (7)","Abnormality of metabolism/homeostasis (01939) | Abnormality of the endocrine system (00818)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.8,NA,NA,NA,NA,NA,NA,NA
"MICA",100507436,"ENSG00000204520","protein-coding",0.405,0.913,0.0031713,"Q29983","","","Liver carcinoma","[disease]","C2239176","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the digestive system (25031) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.","Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.",2011,0.8,NA,"PMID","21499248","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Mutations in RARS cause hypomyelination.","Mutations in RARS cause hypomyelination.",2014,0.8,NA,"PMID","24777941","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Identification of candidate gene FAM183A and novel pathogenic variants in known genes: High genetic heterogeneity for autosomal recessive intellectual disability.","Identification of candidate gene FAM183A and novel pathogenic variants in known genes: High genetic heterogeneity for autosomal recessive intellectual disability.",2018,0.8,NA,"PMID","30500859","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.","Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.",2019,0.8,NA,"PMID","31737794","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","Mutations in RARS cause hypomyelination.","Mutations in RARS cause hypomyelination.",2014,0.8,NA,"PMID","24777941","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Clinical exome sequencing: results from 2819 samples reflecting 1000 families.","Clinical exome sequencing: results from 2819 samples reflecting 1000 families.",2017,0.8,NA,"PMID","27848944","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutations in RARS cause hypomyelination.","Mutations in RARS cause hypomyelination.",2014,0.8,NA,"PMID","24777941","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Hypomyelinating Leukodystrophy with Spinal Cord Involvement Caused by a Novel Variant in RARS: Report of Two Unrelated Patients.","Hypomyelinating Leukodystrophy with Spinal Cord Involvement Caused by a Novel Variant in RARS: Report of Two Unrelated Patients.",2019,0.8,NA,"PMID","30791064","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.","Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: structural brain anomalies and myelofibrosis.",2013,0.8,NA,"PMID","23918763","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.","Hypomyelinating leukodystrophy-associated mutation of RARS leads it to the lysosome, inhibiting oligodendroglial morphological differentiation.",2019,0.8,NA,"PMID","31737794","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease.","Distinct pathogenic mechanisms of various RARS1 mutations in Pelizaeus-Merzbacher-like disease.",2021,0.8,NA,"PMID","33515434","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.","Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair.",2009,0.8,NA,"PMID","19684605","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum.","RARS1-related hypomyelinating leukodystrophy: Expanding the spectrum.",2020,0.8,NA,"PMID","31814314","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Atrial Fibrillation","[disease]","C0004238","Pathological Conditions, Signs and Symptoms (C23) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.","Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.",2018,0.8,NA,"PMID","30061737","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutations in RARS cause hypomyelination.","Mutations in RARS cause hypomyelination.",2014,0.8,NA,"PMID","24777941","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","RARS-related autosomal recessive hypomyelinating leukodystrophy","[disease]","C4015323","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.","Mutations in RARS cause a hypomyelination disorder akin to Pelizaeus-Merzbacher disease.",2017,0.8,NA,"PMID","28905880","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","Differentially expressed genes that were confirmed by qPCR included others at genome-wide significant risk loci for schizophrenia (MAD1L1 and DPYD) and BDNF.","Differentially expressed genes that were confirmed by qPCR included others at genome-wide significant risk loci for <span class='disease' en_id='C0036341'>schizophrenia</span> (<span class='gene' en_id='8379'>MAD1L1</span> and DPYD) and BDNF.",2014,0.8,NA,"PMID","24556472","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy.","Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy.",2019,0.75,NA,"PMID","30871348","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.",2017,0.75,NA,"PMID","27532257","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Clinical and Genetic Investigations of 109 Index Patients With Dilated Cardiomyopathy and 445 of Their Relatives.","Clinical and Genetic Investigations of 109 Index Patients With Dilated Cardiomyopathy and 445 of Their Relatives.",2020,0.75,NA,"PMID","33019804","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RBM20-Related Cardiomyopathy: Current Understanding and Future Options.","RBM20-Related Cardiomyopathy: Current Understanding and Future Options.",2021,0.75,NA,"PMID","34575212","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy.","Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy.",2018,0.75,NA,"PMID","29540472","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.","Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.",2018,0.75,NA,"PMID","29895960","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs.","Dysregulated ribonucleoprotein granules promote cardiomyopathy in RBM20 gene-edited pigs.",2020,0.75,NA,"PMID","33188278","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.","Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy.",2011,0.75,NA,"PMID","21846512","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Variant panorama in 1,385 index patients and sensitivity of expanded next-generation sequencing panels in arrhythmogenic disorders.","Variant panorama in 1,385 index patients and sensitivity of expanded next-generation sequencing panels in arrhythmogenic disorders.",2019,0.75,NA,"PMID","31737537","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic Profile of Left Ventricular Noncompaction Cardiomyopathy in Children-A Single Reference Center Experience.","Genetic Profile of Left Ventricular Noncompaction Cardiomyopathy in Children-A Single Reference Center Experience.",2022,0.75,NA,"PMID","35893073","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies.","Prognostic Prediction of Genotype vs Phenotype in Genetic Cardiomyopathies.",2022,0.75,NA,"PMID","36396199","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in RBM20.","Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in RBM20.",2020,0.75,NA,"PMID","31583969","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Alternative Splicing Regulator RBM20 and Cardiomyopathy.","Alternative Splicing Regulator RBM20 and Cardiomyopathy.",2018,0.75,NA,"PMID","30547036","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.","Targeted panel sequencing in pediatric primary cardiomyopathy supports a critical role of TNNI3.",2019,0.75,NA,"PMID","31568572","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy.","Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy.",2022,0.75,NA,"PMID","36367695","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Variant panorama in 1,385 index patients and sensitivity of expanded next-generation sequencing panels in arrhythmogenic disorders.","Variant panorama in 1,385 index patients and sensitivity of expanded next-generation sequencing panels in arrhythmogenic disorders.",2019,0.75,NA,"PMID","31737537","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction.","Phenotype/Genotype Relationship in Left Ventricular Noncompaction: Ion Channel Gene Mutations Are Associated With Preserved Left Ventricular Systolic Function and Biventricular Noncompaction: Phenotype/Genotype of Noncompaction.",2021,0.75,NA,"PMID","34088380","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity.","Targeted panel sequencing in adult patients with left ventricular non-compaction reveals a large genetic heterogeneity.",2019,0.75,NA,"PMID","30471092","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies.","Gain-of-function cardiomyopathic mutations in RBM20 rewire splicing regulation and re-distribute ribonucleoprotein granules within processing bodies.",2021,0.75,NA,"PMID","34732726","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory.","Molecular genetics in 4408 cardiomyopathy probands and 3008 relatives in Norway: 17 years of genetic testing in a national laboratory.",2022,0.75,NA,"PMID","35653365","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.",2020,0.75,NA,"PMID","32840935","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.","Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.",2017,0.75,NA,"PMID","29029073","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Functional analysis of DES-p.L398P and RBM20-p.R636C.","Functional analysis of DES-p.L398P and RBM20-p.R636C.",2019,0.75,NA,"PMID","30262925","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Post-mortem genetic investigation of cardiac disease-associated genes in sudden infant death syndrome (SIDS) cases.","Post-mortem genetic investigation of cardiac disease-associated genes in sudden infant death syndrome (SIDS) cases.",2021,0.75,NA,"PMID","32789579","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations.","Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations.",2021,0.75,NA,"PMID","34174465","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.","The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.",2023,0.75,NA,"PMID","37652022","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.",2019,0.75,NA,"PMID","31514951","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.",2010,0.75,NA,"PMID","20590677","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.75,NA,"PMID","28520360","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Meta-analysis of Genome-Wide Association Studies Identifies Novel Loci Associated With Optic Disc Morphology.","Meta-analysis of Genome-Wide Association Studies Identifies Novel Loci Associated With Optic Disc Morphology.",2015,0.75,NA,"PMID","25631615","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.",2012,0.75,NA,"PMID","22983686","Chinese,Tibetan,Han in China (HGDP)","HANCESTRO:0021,HANCESTRO:0582,HANCESTRO:0715",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.","Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.",2013,0.75,NA,"PMID","23403257","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.75,NA,"PMID","18004206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms.","Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms.",2002,0.75,NA,"PMID","12208142","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.75,NA,"PMID","9446675","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.",1984,0.75,NA,"PMID","6480579","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.",2011,0.75,NA,"PMID","21342357","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.75,NA,"PMID","15372086","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","A polymorphism in the promoter of the UDP-glucuronosyltransferase 1 (UGT1A1) gene has been shown to cause Gilbert syndrome, a benign form of unconjugated bilirubinemia.","A polymorphism in the promoter of the <span class='gene' en_id='54575'>UDP-glucuronosyltransferase 1</span> (UGT1A1) gene has been shown to cause <span class='disease' en_id='C0017551'>Gilbert syndrome</span>, a benign form of unconjugated bilirubinemia.",1998,0.75,NA,"PMID","9653159","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.",2013,0.75,NA,"PMID","23997956","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.",2011,0.75,NA,"PMID","21272068","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.",1998,0.75,NA,"PMID","9784835","Japanese,Korean,Chinese","HANCESTRO:0019,HANCESTRO:0022,HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.75,NA,"PMID","12859413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.",2021,0.75,NA,"PMID","32860008","","",NA,NA
"VIPR2",7434,"ENSG00000106018","protein-coding",0.565,0.87,8.2204e-13,"P41587","DTO_02300001","G-protein coupled receptor","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications.","Copy number variants in <span class='disease' en_id='C0036341'>schizophrenia</span>: confirmation of five previous findings and new evidence for 3q29 microdeletions and <span class='gene' en_id='7434'>VIPR2</span> duplications.",2011,0.75,NA,"PMID","21285140","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.","The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.",2014,0.75,NA,"PMID","24503780","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases.","Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases.",2023,0.75,NA,"PMID","36788754","Italian","HANCESTRO:0307",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.","Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.",2011,0.75,NA,"PMID","21483645","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.","Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.",2017,0.75,NA,"PMID","27532257","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Emerging concepts in arrhythmogenic dilated cardiomyopathy.","Emerging concepts in arrhythmogenic dilated cardiomyopathy.",2021,0.75,NA,"PMID","32056050","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.",2019,0.75,NA,"PMID","30871351","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Phenotypic Heterogeneity within Members of a Family Carrying the Same RBM20 Mutation R634W.","Phenotypic Heterogeneity within Members of a Family Carrying the Same RBM20 Mutation R634W.",2018,0.75,NA,"PMID","30557877","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Diagnostic yield of targeted next generation sequencing in 2002 Dutch cardiomyopathy patients.","Diagnostic yield of targeted next generation sequencing in 2002 Dutch cardiomyopathy patients.",2021,0.75,NA,"PMID","33662488","Dutch","HANCESTRO:0320",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.","The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.",2014,0.75,NA,"PMID","24503780","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.","Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.",2016,0.75,NA,"PMID","26604136","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study.","Genetic variants in Chinese patients with sporadic dilated cardiomyopathy: a cross-sectional study.",2022,0.75,NA,"PMID","35284542","Chinese","HANCESTRO:0021",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Functional analysis of DES-p.L398P and RBM20-p.R636C.","Functional analysis of DES-p.L398P and RBM20-p.R636C.",2019,0.75,NA,"PMID","30262925","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.","Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.",2018,0.75,NA,"PMID","29895960","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Applying High-Resolution Variant Classification to Cardiac Arrhythmogenic Gene Testing in a Demographically Diverse Cohort of Sudden Unexplained Deaths.","Applying High-Resolution Variant Classification to Cardiac Arrhythmogenic Gene Testing in a Demographically Diverse Cohort of Sudden Unexplained Deaths.",2017,0.75,NA,"PMID","29247119","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.","Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies.",2021,0.75,NA,"PMID","33500567","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.",2013,0.75,NA,"PMID","23861363","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Familial dilated cardiomyopathy with RBM20 mutation in an Indian patient: a case report.","Familial dilated cardiomyopathy with RBM20 mutation in an Indian patient: a case report.",2021,0.75,NA,"PMID","34021826","Indian","HANCESTRO:0487",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.",2009,0.75,NA,"PMID","19712804","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder.","Rapid Whole-Genomic Sequencing and a Targeted Neonatal Gene Panel in Infants With a Suspected Genetic Disorder.",2023,0.75,NA,"PMID","37432431","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.",2019,0.75,NA,"PMID","31514951","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy.","Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy.",2017,0.75,NA,"PMID","28416588","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Atlas of the clinical genetics of human dilated cardiomyopathy.","Atlas of the clinical genetics of human dilated cardiomyopathy.",2015,0.75,NA,"PMID","25163546","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study.","Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes Study.",2021,0.75,NA,"PMID","33906374","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Alternative Splicing Regulator RBM20 and Cardiomyopathy.","Alternative Splicing Regulator RBM20 and Cardiomyopathy.",2018,0.75,NA,"PMID","30547036","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.",2009,0.75,NA,"PMID","19712804","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","RBM20 mutation and ventricular arrhythmias in a young patient with dilated cardiomyopathy: a case report.","RBM20 mutation and ventricular arrhythmias in a young patient with dilated cardiomyopathy: a case report.",2021,0.75,NA,"PMID","34322310","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.","Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.",2020,0.75,NA,"PMID","32160020","American","HANCESTRO:0463",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","The Combined Human Genotype of Truncating TTN and RBM20 Mutations Is Associated with Severe and Early Onset of Dilated Cardiomyopathy.","The Combined Human Genotype of Truncating TTN and RBM20 Mutations Is Associated with Severe and Early Onset of Dilated Cardiomyopathy.",2021,0.75,NA,"PMID","34201072","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","New Insights in RBM20 Cardiomyopathy.","New Insights in RBM20 Cardiomyopathy.",2020,0.75,NA,"PMID","32789749","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Whole-exome sequencing reveals two de novo variants in the RBM20 gene in two Chinese patients with left ventricular non-compaction cardiomyopathy.","Whole-exome sequencing reveals two de novo variants in the RBM20 gene in two Chinese patients with left ventricular non-compaction cardiomyopathy.",2020,0.75,NA,"PMID","32851336","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.","Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.",2009,0.75,NA,"PMID","19450457","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Distinct mutations in the secreted extracellular matrix protein, fibulin-3 (F3), have been associated with a number of ocular diseases ranging from primary open angle glaucoma to cuticular age-related macular degeneration to a rare macular dystrophy, Malattia Leventinese (ML).","Distinct mutations in the secreted extracellular matrix protein, <span class='gene' en_id='2202'>fibulin-3</span> (<span class='gene' en_id='2202'>F3</span>), have been associated with a number of ocular diseases ranging from primary <span class='disease' en_id='C0017612'>open angle glaucoma</span> to cuticular age-related macular degeneration to a rare macular dystrophy, Malattia Leventinese (ML).",2021,0.75,NA,"PMID","33542268","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.75,NA,"PMID","11003624","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.75,NA,"PMID","26467199","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.75,NA,"PMID","12181437","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.75,NA,"PMID","11906189","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.75,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.",1999,0.75,NA,"PMID","10412811","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.75,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.75,NA,"PMID","10968441","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.75,NA,"PMID","23875061","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.",2006,0.75,NA,"PMID","16610035","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.75,NA,"PMID","20975617","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.",2011,0.75,NA,"PMID","21342357","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.",2011,0.75,NA,"PMID","21272068","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1A1 haplotype mutation among Asians in Singapore.","UGT1A1 haplotype mutation among Asians in Singapore.",2009,0.75,NA,"PMID","19325249","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.",2016,0.75,NA,"PMID","26727668","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.75,NA,"PMID","19830808","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.",2016,0.75,NA,"PMID","26727668","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.75,NA,"PMID","11425418","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.75,NA,"PMID","9375768","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.",1995,0.75,NA,"PMID","8528206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.75,NA,"PMID","12402338","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.75,NA,"PMID","11370628","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.75,NA,"PMID","9630669","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.",2015,0.75,NA,"PMID","26716871","Indian","HANCESTRO:0487",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscular Dystrophy, Limb-Girdle, Type 1D","[disease]","C3501858","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.",2012,0.75,NA,"PMID","22334415","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.",2020,0.75,NA,"PMID","32840935","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction.","Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction.",2017,0.75,NA,"PMID","28798025","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.","Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.",2016,0.75,NA,"PMID","26604136","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.",2012,0.75,NA,"PMID","22004663","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.","The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.",2014,0.75,NA,"PMID","24503780","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations.","Phenotype and progression among patients with dilated cardiomyopathy and RBM20 mutations.",2021,0.75,NA,"PMID","34174465","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.","Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.",2015,0.75,NA,"PMID","25979592","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.","Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.",2019,0.75,NA,"PMID","29961767","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.",2015,0.75,NA,"PMID","26084686","Finnish","HANCESTRO:0321",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.","A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.",2016,0.75,NA,"PMID","27496873","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.",2015,0.75,NA,"PMID","26084686","Finnish","HANCESTRO:0321",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.",2012,0.75,NA,"PMID","22004663","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.","Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.",2020,0.75,NA,"PMID","31317183","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Loss of Cardiac Splicing Regulator RBM20 Is Associated With Early-Onset Atrial Fibrillation.","Loss of Cardiac Splicing Regulator RBM20 Is Associated With Early-Onset Atrial Fibrillation.",2024,0.75,NA,"PMID","38510713","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic variant burden and adverse outcomes in pediatric cardiomyopathy.","Genetic variant burden and adverse outcomes in pediatric cardiomyopathy.",2021,0.75,NA,"PMID","32746448","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Proteome-wide quantitative RNA-interactome capture identifies phosphorylation sites with regulatory potential in RBM20.","Proteome-wide quantitative RNA-interactome capture identifies phosphorylation sites with regulatory potential in RBM20.",2022,0.75,NA,"PMID","35427468","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.",2018,0.75,NA,"PMID","29447731","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.","Cardiomyopathy-associated mutations in the RS domain affect nuclear localization of RBM20.",2020,0.75,NA,"PMID","32840935","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,0.75,NA,"PMID","22466703","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","HPO-driven virtual gene panel: a new efficient approach in molecular autopsy of sudden unexplained death.","HPO-driven virtual gene panel: a new efficient approach in molecular autopsy of sudden unexplained death.",2021,0.75,NA,"PMID","33789662","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.","Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy.",2017,0.75,NA,"PMID","29029073","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RNA sequencing reveals abnormal LDB3 splicing in sudden cardiac death.","RNA sequencing reveals abnormal LDB3 splicing in sudden cardiac death.",2019,0.75,NA,"PMID","31419596","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Structural basis of UCUU RNA motif recognition by splicing factor RBM20.","Structural basis of UCUU RNA motif recognition by splicing factor RBM20.",2020,0.75,NA,"PMID","32187365","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.",2012,0.75,NA,"PMID","22004663","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Cutis Laxa","[disease]","C0010495","Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the integument (01574)","CLINVAR","GeneticVariation",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.75,NA,"PMID","28520360","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Evaluation of mutation effects on UGT1A1 activity toward 17beta-estradiol using liquid chromatography-tandem mass spectrometry.","Evaluation of mutation effects on UGT1A1 activity toward 17beta-estradiol using liquid chromatography-tandem mass spectrometry.",2006,0.75,NA,"PMID","16504606","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.",1999,0.75,NA,"PMID","9929972","Japanese","HANCESTRO:0019",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.75,NA,"PMID","19830808","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.75,NA,"PMID","9435989","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.75,NA,"PMID","9630669","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article.","Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article.",2015,0.75,NA,"PMID","26039129","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.75,NA,"PMID","26467199","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.75,NA,"PMID","11003624","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.",1993,0.75,NA,"PMID","8276413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.75,NA,"PMID","1692835","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].",2016,0.75,NA,"PMID","27264814","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.75,NA,"PMID","9621515","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.75,NA,"PMID","10190918","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.",2013,0.75,NA,"PMID","24390994","Han Chinese,Chinese,Tibetan","HANCESTRO:0027,HANCESTRO:0021,HANCESTRO:0582",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.75,NA,"PMID","9435989","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.75,NA,"PMID","11906189","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.",2003,0.75,NA,"PMID","14616765","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.75,NA,"PMID","9639672","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.",1999,0.75,NA,"PMID","10472535","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.75,NA,"PMID","25200497","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.",2022,0.75,NA,"PMID","35490425","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","We describe the phenotype of juvenile onset open-angle glaucoma in a patient with a rare variant in EFEMP1 gene, who was also detected to have Stickler syndrome(STL).","We describe the phenotype of juvenile onset <span class='disease' en_id='C0017612'>open-angle glaucoma</span> in a patient with a rare variant in <span class='gene' en_id='2202'>EFEMP1</span> gene, who was also detected to have Stickler syndrome(STL).",2023,0.75,NA,"PMID","35946471","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","A New Ocular Phenotype Combining Juvenile Glaucoma and Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese) due to a Novel EFEMP1 Pathogenic Variant.","A New Ocular Phenotype Combining Juvenile Glaucoma and Doyne Honeycomb Retinal Dystrophy (Malattia Leventinese) due to a Novel EFEMP1 Pathogenic Variant.",2024,0.75,NA,"PMID","39264138","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Atrial Fibrillation","[disease]","C0004238","Pathological Conditions, Signs and Symptoms (C23) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.","Biobank-driven genomic discovery yields new insight into atrial fibrillation biology.",2018,0.75,NA,"PMID","30061737","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Atrial Fibrillation","[disease]","C0004238","Pathological Conditions, Signs and Symptoms (C23) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Multi-ethnic genome-wide association study for atrial fibrillation.","Multi-ethnic genome-wide association study for atrial fibrillation.",2018,0.75,NA,"PMID","29892015","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Functional analysis of DES-p.L398P and RBM20-p.R636C.","Functional analysis of DES-p.L398P and RBM20-p.R636C.",2019,0.75,NA,"PMID","30262925","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.",2010,0.75,NA,"PMID","20590677","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.","Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study.",2020,0.75,NA,"PMID","31317183","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.","Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria.",2021,0.75,NA,"PMID","33232181","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in RBM20.","Whole exome sequencing in a large pedigree with DCM identifies a novel mutation in RBM20.",2020,0.75,NA,"PMID","31583969","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians.","Nonsense mutations in BAG3 are associated with early-onset dilated cardiomyopathy in French Canadians.",2014,0.75,NA,"PMID","25448463","Canadian,French","HANCESTRO:0354,HANCESTRO:0363",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.",2009,0.75,NA,"PMID","19712804","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Structural basis of UCUU RNA motif recognition by splicing factor RBM20.","Structural basis of UCUU RNA motif recognition by splicing factor RBM20.",2020,0.75,NA,"PMID","32187365","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mislocalization of pathogenic RBM20 variants in dilated cardiomyopathy is caused by loss-of-interaction with Transportin-3.","Mislocalization of pathogenic RBM20 variants in dilated cardiomyopathy is caused by loss-of-interaction with Transportin-3.",2023,0.75,NA,"PMID","37463913","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy.","Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy.",2022,0.75,NA,"PMID","35288587","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A study of the pathogenicity of variants in familial heart disease. The value of cosegregation.","A study of the pathogenicity of variants in familial heart disease. The value of cosegregation.",2019,0.75,NA,"PMID","30972196","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RBM20-Associated Ventricular Arrhythmias in a Patient with Structurally Normal Heart.","RBM20-Associated Ventricular Arrhythmias in a Patient with Structurally Normal Heart.",2021,0.75,NA,"PMID","33450993","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,0.75,NA,"PMID","22466703","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","I536T variant of RBM20 affects splicing of cardiac structural proteins that are causative for developing dilated cardiomyopathy.","I536T variant of RBM20 affects splicing of cardiac structural proteins that are causative for developing dilated cardiomyopathy.",2022,0.75,NA,"PMID","36198914","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.","A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy.",2019,0.75,NA,"PMID","29892087","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy.","Prevalence of Pathogenic Gene Mutations and Prognosis Do Not Differ in Isolated Left Ventricular Dysfunction Compared With Dilated Cardiomyopathy.",2018,0.75,NA,"PMID","29540472","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Implications of Genetic Testing in Dilated Cardiomyopathy.","Implications of Genetic Testing in Dilated Cardiomyopathy.",2020,0.75,NA,"PMID","32880476","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy.","Clinical impact of re-evaluating genes and variants implicated in dilated cardiomyopathy.",2021,0.75,NA,"PMID","34194005","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Phenotypic Heterogeneity within Members of a Family Carrying the Same RBM20 Mutation R634W.","Phenotypic Heterogeneity within Members of a Family Carrying the Same RBM20 Mutation R634W.",2018,0.75,NA,"PMID","30557877","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.",2013,0.75,NA,"PMID","23861363","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Importance of genetic testing in unexplained cardiac arrest.","Importance of genetic testing in unexplained cardiac arrest.",2022,0.75,NA,"PMID","35352813","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction.","Novel Genetic Triggers and Genotype-Phenotype Correlations in Patients With Left Ventricular Noncompaction.",2017,0.75,NA,"PMID","28798025","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting.","Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting.",2016,0.75,NA,"PMID","27650965","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.","RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.",2018,0.75,NA,"PMID","29650543","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Dilated cardiomyopathy caused by a pathogenic nucleotide variant in RBM20 in an Iranian family.","Dilated cardiomyopathy caused by a pathogenic nucleotide variant in RBM20 in an Iranian family.",2022,0.75,NA,"PMID","35527250","Iranian","HANCESTRO:0438",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.","Modeling structural and functional deficiencies of RBM20 familial dilated cardiomyopathy using human induced pluripotent stem cells.",2016,0.75,NA,"PMID","26604136","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.","A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.",2016,0.75,NA,"PMID","27496873","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.","Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.",2019,0.75,NA,"PMID","30847666","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.","Genetic Risk of Arrhythmic Phenotypes in Patients With Dilated Cardiomyopathy.",2019,0.75,NA,"PMID","31514951","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,0.75,NA,"PMID","22466703","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","A fast and cost-effective molecular diagnostic tool for genetic diseases involved in sudden cardiac death.","A fast and cost-effective molecular diagnostic tool for genetic diseases involved in sudden cardiac death.",2016,0.75,NA,"PMID","26688388","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.","Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.",2019,0.75,NA,"PMID","29961767","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy.","Genetic analysis using targeted next-generation sequencing of sporadic Chinese patients with idiopathic dilated cardiomyopathy.",2021,0.75,NA,"PMID","33941202","Chinese","HANCESTRO:0021",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscular Dystrophy, Limb-Girdle, Type 1D","[disease]","C3501858","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.75,NA,"PMID","22366786","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.75,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.75,NA,"PMID","20975617","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.75,NA,"PMID","9639672","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].",2016,0.75,NA,"PMID","27264814","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.75,NA,"PMID","12181437","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin <span class='gene' en_id='54575'>UDP-glucuronosyltransferase 1</span> in <span class='disease' en_id='C0017551'>Gilbert's syndrome</span>.",1995,0.75,NA,"PMID","7565971","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.75,NA,"PMID","11370628","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.75,NA,"PMID","25200497","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.75,NA,"PMID","16114182","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.",2012,0.75,NA,"PMID","22325916","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.75,NA,"PMID","9497253","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.75,NA,"PMID","11061796","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.75,NA,"PMID","17496722","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.75,NA,"PMID","12850492","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Stop codon variant in EFEMP1 is associated with primary open-angle glaucoma due to impaired regulation of aqueous humor outflow.","Stop codon variant in EFEMP1 is associated with primary open-angle glaucoma due to impaired regulation of aqueous humor outflow.",2024,0.75,NA,"PMID","38467175","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Hypertensive disease","[disease]","C0020538","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","The hypertension was probably mediated by ENaC overactivity because 1) Nedd4-2 null mice had higher expression levels of all three ENaC subunits in kidney, but not of other Na+ transporters; 2) the downregulation of ENaC function in colon was impaired; and 3) NaCl-sensitive hypertension was substantially reduced in the presence of amiloride, a specific inhibitor of ENaC. Nedd4-2 null mice on a chronic high-salt diet showed cardiac hypertrophy and markedly depressed cardiac function.","The <span class='disease' en_id='C0020538'>hypertension</span> was probably mediated by ENaC overactivity because 1) <span class='gene' en_id='23327'>Nedd4-2</span> null mice had higher expression levels of all three ENaC subunits in kidney, but not of other Na+ transporters; 2) the downregulation of ENaC function in colon was impaired; and 3) <span class='chemical' en_id='CHEMBL1200574'>NaCl</span>-sensitive <span class='disease' en_id='C0020538'>hypertension</span> was substantially reduced in the presence of <span class='chemical' en_id='CHEMBL945'>amiloride</span>, a specific inhibitor of ENaC. <span class='gene' en_id='23327'>Nedd4-2</span> null mice on a chronic high-salt diet showed cardiac hypertrophy and markedly depressed cardiac function.",2008,0.75,NA,"PMID","18524855","","",NA,"Negative"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.75,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.","Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.",2012,0.75,NA,"PMID","22004663","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.",2010,0.75,NA,"PMID","20590677","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.","The penetrance of rare variants in cardiomyopathy-associated genes: A cross-sectional approach to estimating penetrance for secondary findings.",2023,0.75,NA,"PMID","37652022","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.",2009,0.75,NA,"PMID","19712804","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy.","Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy.",2019,0.75,NA,"PMID","30871348","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy.","Clinical Significance of Variants in the TTN Gene in a Large Cohort of Patients With Sporadic Dilated Cardiomyopathy.",2021,0.75,NA,"PMID","33996946","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Alternative Splicing Regulator RBM20 and Cardiomyopathy.","Alternative Splicing Regulator RBM20 and Cardiomyopathy.",2018,0.75,NA,"PMID","30547036","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.","Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy.",2018,0.75,NA,"PMID","29447731","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.","Phosphorylation of the RSRSP stretch is critical for splicing regulation by RNA-Binding Motif Protein 20 (RBM20) through nuclear localization.",2018,0.75,NA,"PMID","29895960","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.",2013,0.75,NA,"PMID","23861363","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.","Rare variant mutations identified in pediatric patients with dilated cardiomyopathy.",2011,0.75,NA,"PMID","21483645","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.","A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanism.",2016,0.75,NA,"PMID","27496873","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy.","Pathogenic RBM20-Variants Are Associated With a Severe Disease Expression in Male Patients With Dilated Cardiomyopathy.",2019,0.75,NA,"PMID","30871348","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.","RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling.",2018,0.75,NA,"PMID","29650543","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy.","RBM20 Is a Candidate Gene for Hypertrophic Cardiomyopathy.",2021,0.75,NA,"PMID","34333030","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.","Variant Interpretation for Dilated Cardiomyopathy: Refinement of the American College of Medical Genetics and Genomics/ClinGen Guidelines for the DCM Precision Medicine Study.",2020,0.75,NA,"PMID","32160020","American","HANCESTRO:0463",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy.","Deep phenotyping of two preclinical mouse models and a cohort of RBM20 mutation carriers reveals no sex-dependent disease severity in RBM20 cardiomyopathy.",2022,0.75,NA,"PMID","36367695","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.","Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.",2010,0.75,NA,"PMID","20590677","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.","Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.",2015,0.75,NA,"PMID","25979592","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.",2019,0.75,NA,"PMID","30871351","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.","Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy.",2020,0.75,NA,"PMID","31931689","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.","Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.",2019,0.75,NA,"PMID","30871351","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Whole-exome sequencing reveals two de novo variants in the RBM20 gene in two Chinese patients with left ventricular non-compaction cardiomyopathy.","Whole-exome sequencing reveals two de novo variants in the RBM20 gene in two Chinese patients with left ventricular non-compaction cardiomyopathy.",2020,0.75,NA,"PMID","32851336","Chinese","HANCESTRO:0021",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","The role of genetic testing in diagnosis and care of inherited cardiac conditions in a specialised multidisciplinary clinic.","The role of genetic testing in diagnosis and care of inherited cardiac conditions in a specialised multidisciplinary clinic.",2022,0.75,NA,"PMID","36578016","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Pathogenic variant of RBM20 in a multiplex family with hypertrophic cardiomyopathy.","Pathogenic variant of RBM20 in a multiplex family with hypertrophic cardiomyopathy.",2022,0.75,NA,"PMID","35181673","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Dilated, 1DD","[disease]","C2750995","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.","RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing.",2012,0.75,NA,"PMID","22466703","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Hypertensive disease","[disease]","C0020538","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Taken together, these results demonstrate that loss of NEDD4-2 in adult renal tubules causes a new form of mild, salt-sensitive hypertension without hyperkalemia that is characterized by upregulation of NCC, elevation of β/γENaC, but not αENaC, and a normal Na+/K+ balance maintained by downregulation of ENaC activity and upregulation of ROMK.","Taken together, these results demonstrate that loss of <span class='gene' en_id='23327'>NEDD4-2</span> in adult renal tubules causes a new form of mild, salt-sensitive <span class='disease' en_id='C0020538'>hypertension</span> without hyperkalemia that is characterized by upregulation of NCC, elevation of β/γENaC, but <span class='negation_marker' en_id=''>not</span> αENaC, and a normal Na+/K+ balance maintained by downregulation of ENaC activity and upregulation of ROMK.",2013,0.75,NA,"PMID","23348737","","",NA,"Negative"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.","<span class='gene' en_id='2202'>EFEMP1</span> rare variants cause familial juvenile-onset <span class='disease' en_id='C0017612'>open-angle glaucoma</span>.",2022,0.75,NA,"PMID","34923728","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.","Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.",2015,0.75,NA,"PMID","26162006","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Analysis of variants in Chinese individuals with primary open-angle glaucoma using molecular inversion probe (MIP)-based panel sequencing.","Analysis of variants in Chinese individuals with primary open-angle glaucoma using molecular inversion probe (MIP)-based panel sequencing.",2020,0.75,NA,"PMID","32476818","Chinese","HANCESTRO:0021",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,0.75,NA,"PMID","10369267","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Novel mutation in EFEMP1 identified from two Chinese POAG families differentially activated endoplasmic reticulum stress markers and induced glaucoma in mouse.","Novel mutation in EFEMP1 identified from two Chinese POAG families differentially activated endoplasmic reticulum stress markers and induced glaucoma in mouse.",2024,0.75,NA,"PMID","38083999","Chinese","HANCESTRO:0021",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma, Open-Angle","[disease]","C0017612","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINGEN","GeneticVariation","Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.","Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.",2020,0.75,NA,"PMID","31792352","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.",2021,0.75,NA,"PMID","32860008","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.",2013,0.75,NA,"PMID","23290513","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin <span class='gene' en_id='54575'>UDP-glucuronosyltransferase 1</span> in <span class='disease' en_id='C0017551'>Gilbert's syndrome</span>.",1995,0.75,NA,"PMID","7565971","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.",2013,0.75,NA,"PMID","23014115","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.",1995,0.75,NA,"PMID","8528206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.75,NA,"PMID","8514037","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.75,NA,"PMID","18004206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes.","Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes.",2006,0.75,NA,"PMID","16269258","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.75,NA,"PMID","9342374","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.75,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.75,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.75,NA,"PMID","15857854","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Blast Phase","[disease]","C0005699","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","","","RGD_HUMAN","CausalOrContributing","AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib.","AID expression is correlated with Bcr-Abl expression in CML-LBC and can be down-regulated by As2O3 and/or imatinib.",2011,0.75,NA,"PMID","21570118","","",NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","SPERMATOGENIC FAILURE 37","[disease]","C5193091","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.","Malattia leventinese/Doyne honeycomb retinal dystrophy in a chinese family with mutation of the EFEMP1 gene.",2014,0.7,NA,"PMID","25111685","Chinese","HANCESTRO:0021",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","An Arg345Trp (R345W) mutation in F3 was identified as the cause of a rare retinal dystrophy, Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy (ML/DHRD).","An Arg345Trp (R345W) mutation in <span class='gene' en_id='2202'>F3</span> was identified as the cause of a rare <span class='disease' en_id='C0854723'>retinal dystrophy</span>, Malattia Leventinese/Doyne Honeycomb Retinal Dystrophy (ML/DHRD).",2016,0.7,NA,"PMID","26427406","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Malattia Leventinese: EFEMP1 R345W Variant Is a Hot Spot Mutation, Not a Founder Mutation.","Malattia Leventinese: EFEMP1 R345W Variant Is a Hot Spot Mutation, Not a Founder Mutation.",2020,0.7,NA,"PMID","33019987","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family.","Doyne honeycomb retinal dystrophy/malattia leventinese induced by EFEMP1 mutation in a Chinese family.",2018,0.7,NA,"PMID","30541486","Chinese","HANCESTRO:0021",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","UNIPROT","CausalMutation","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.",2019,0.7,NA,"PMID","31130282","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","GENCC","CausalMutation","A multicenter clinical exome study in unselected cohorts from a consanguineous population of Saudi Arabia demonstrated a high diagnostic yield.","A multicenter clinical exome study in unselected cohorts from a consanguineous population of Saudi Arabia demonstrated a high diagnostic yield.",2017,0.7,NA,"PMID","28454995","Saudi","HANCESTRO:0449",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","GENCC","CausalMutation","Prevalence and architecture of de novo mutations in developmental disorders.","Prevalence and architecture of de novo mutations in developmental disorders.",2017,0.7,NA,"PMID","28135719","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Hypertensive disease","[disease]","C0020538","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Aortic Aneurysm, Thoracic","[disease]","C0162872","Cardiovascular Diseases (C14)","Anatomical Abnormality (T190)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.",2019,0.7,NA,"PMID","31130282","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.","Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.",2019,0.7,NA,"PMID","31155282","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","GENCC","CausalMutation","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.",2019,0.7,NA,"PMID","31607425","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Mapping wild-type and R345W fibulin-3 intracellular interactomes.","Mapping wild-type and R345W fibulin-3 intracellular interactomes.",2016,0.7,NA,"PMID","27777122","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Squamous cell carcinoma of esophagus","[disease]","C0279626","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","LOXL2 was found to be overexpressed in esophageal squamous cell carcinoma (ESCC) in our previous research.","<span class='gene' en_id='4017'>LOXL2</span> was found to be overexpressed in <span class='disease' en_id='C0279626'>esophageal squamous cell carcinoma</span> (<span class='disease' en_id='C0279626'>ESCC</span>) in our previous research.",2014,0.7,NA,"PMID","24716982","","",NA,"Positive"
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Seizures","[phenotype]","C0036572","Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23)","Sign or Symptom (T184)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Novel RETREG1 (FAM134B) founder allele is linked to HSAN2B and renal disease in a Turkish family.","Novel RETREG1 (FAM134B) founder allele is linked to HSAN2B and renal disease in a Turkish family.",2022,0.7,NA,"PMID","35332675","Turkish","HANCESTRO:0451",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Mutation in FAM134B causing severe hereditary sensory neuropathy.","Mutation in FAM134B causing severe hereditary sensory neuropathy.",2012,0.7,NA,"PMID","21115472","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.7,NA,"PMID","19838196","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Classification of suicidal behavior: a review and step toward integration.","Classification of suicidal behavior: a review and step toward integration.",1988,0.7,NA,"PMID","3064365","","",NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","SPERMATOGENIC FAILURE 37","[disease]","C5193091","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","UNIPROT","CausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.7,NA,"PMID","30929735","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Cerebellar Ataxia","[disease]","C0007758","Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","CausalMutation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","SPERMATOGENIC FAILURE 37","[disease]","C5193091","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.","The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice.",2007,0.7,NA,"PMID","17666404","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.","A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy.",1999,0.7,NA,"PMID","10369267","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.","A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.",1994,0.7,NA,"PMID","8052619","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.",2019,0.7,NA,"PMID","31130285","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","CausalMutation","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.",2019,0.7,NA,"PMID","31130282","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","CausalMutation","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.",2019,0.7,NA,"PMID","31130285","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.","TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway.",2002,0.7,NA,"PMID","11850823","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","GeneticVariation","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.",2019,0.7,NA,"PMID","31130282","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.","Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.",2019,0.7,NA,"PMID","31155282","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","CLINVAR","GeneticVariation","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.",2019,0.7,NA,"PMID","31607425","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","UNIPROT","CausalMutation","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.",2019,0.7,NA,"PMID","31607425","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","CLINVAR","CausalMutation","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.",2019,0.7,NA,"PMID","31607425","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","GENCC","CausalMutation","Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.","Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples.",2017,0.7,NA,"PMID","28191890","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Macular dystrophy","[disease]","C0730292","Eye Diseases (C11)","Disease or Syndrome (T047)","","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Hypertrophic Cardiomyopathy","[disease]","C0007194","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","GENCC","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Hypertrophic Cardiomyopathy","[disease]","C0007194","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","GeneticVariation","RBM20 variants are associated with increased risk for SCA in HCM.","<span class='gene' en_id='282996'>RBM20</span> variants are associated with increased risk for SCA in <span class='disease' en_id='C0007194,C0340425,C4551472'>HCM</span>.",2021,0.7,NA,"PMID","34333030","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Hereditary Sensory and Autonomic Neuropathy 2B Caused by a Novel RETREG1 Mutation (c.765dupT) and Paternal Uniparental Isodisomy of Chromosome 5.","Hereditary Sensory and Autonomic Neuropathy 2B Caused by a Novel RETREG1 Mutation (c.765dupT) and Paternal Uniparental Isodisomy of Chromosome 5.",2019,0.7,NA,"PMID","31737055","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.",2014,0.7,NA,"PMID","24327336","Turkish","HANCESTRO:0451",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Phenotypic features of RETREG1-related hereditary sensory autonomic neuropathy.","Phenotypic features of <span class='gene' en_id='54463'>RETREG1</span>-related <span class='disease' en_id='C0027889'>hereditary sensory autonomic neuropathy</span>.",2023,0.7,NA,"PMID","37448294","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Late-onset hereditary sensory and autonomic neuropathy type 2B caused by novel compound heterozygous mutations in FAM134B presenting as chronic recurrent ulcers on the soles.","Late-onset hereditary sensory and autonomic neuropathy type 2B caused by novel compound heterozygous mutations in FAM134B presenting as chronic recurrent ulcers on the soles.",2021,0.7,NA,"PMID","33943063","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.7,NA,"PMID","19838196","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Hypertrophic Cardiomyopathy","[disease]","C0007194","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","SPERMATOGENIC FAILURE 37","[disease]","C5193091","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation","Noonan Syndrome","Noonan Syndrome",1993,0.7,NA,"PMID","20301303","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","GENCC","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND BEHAVIORAL ABNORMALITIES","[disease]","C5231462","","Disease or Syndrome (T047)","syndrome (225) | genetic disease (630)","","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.","Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.",2019,0.7,NA,"PMID","31155282","","",NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","SPERMATOGENIC FAILURE 37","[disease]","C5193091","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.7,NA,"PMID","30929735","","",NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","SPERMATOGENIC FAILURE 37","[disease]","C5193091","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.7,NA,"PMID","30929735","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Dominant radial drusen and Arg345Trp EFEMP1 mutation.","Dominant radial drusen and Arg345Trp EFEMP1 mutation.",2001,0.7,NA,"PMID","11384588","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization.","Clinically-identified C-terminal mutations in fibulin-3 are prone to misfolding and destabilization.",2021,0.7,NA,"PMID","33542268","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Retinal microstructure in patients with EFEMP1 retinal dystrophy evaluated by Fourier domain OCT.","Retinal microstructure in patients with <span class='gene' en_id='2202'>EFEMP1</span> <span class='disease' en_id='C0854723'>retinal dystrophy</span> evaluated by Fourier domain OCT.",2009,0.7,NA,"PMID","18791549","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","[disease]","C1961099","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","","Abnormality of the immune system (02715) | Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","ORPHANET","FusionGene",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Pulmonary Emphysema","[disease]","C0034067","Respiratory Tract Diseases (C08) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","Abnormality of the respiratory system (02086)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory and Autonomic Neuropathies","[disease]","C0027889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINGEN","CausalMutation","Regulation of endoplasmic reticulum turnover by selective autophagy.","Regulation of endoplasmic reticulum turnover by selective autophagy.",2015,0.7,NA,"PMID","26040720","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Hypertrophic Cardiomyopathy","[disease]","C0007194","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINGEN","GeneticVariation","Therefore, RBM20 p.Arg636His could be the causative variant for this familial HCM, and RBM20 might be a novel causative gene for HCM.","Therefore, <span class='gene' en_id='282996'>RBM20</span> p.Arg636His could be the causative variant for this familial <span class='disease' en_id='C0007194,C0340425,C4551472'>HCM</span>, and <span class='gene' en_id='282996'>RBM20</span> might be a novel causative gene for <span class='disease' en_id='C0007194,C0340425,C4551472'>HCM</span>.",2022,0.7,NA,"PMID","35181673","","",NA,"Positive"
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Myofibrillar Myopathy","[disease]","C2678065","Musculoskeletal Diseases (C05) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127)","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","GeneticVariation","Noonan Syndrome","Noonan Syndrome",1993,0.7,NA,"PMID","20301303","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","GENCC","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","ZIMMERMANN-LABAND SYNDROME 3","[disease]","C5231447","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin 3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy.","Responsiveness of choroidal neovascular membranes in patients with R345W mutation in fibulin 3 (Doyne honeycomb retinal dystrophy) to anti-vascular endothelial growth factor therapy.",2011,0.7,NA,"PMID","22159686","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","[Optical coherence tomography in Malattia Leventinese].","[Optical coherence tomography in Malattia Leventinese].",2005,0.7,NA,"PMID","15785976","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.",2011,0.7,NA,"PMID","22031286","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration.","Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration.",2015,0.7,NA,"PMID","25077532","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy.","Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy.",2022,0.7,NA,"PMID","36460718","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal Dystrophies","[disease]","C0854723","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation","First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.","First reported case of Doyne honeycomb retinal dystrophy (Malattia Leventinese/autosomal dominant drusen) in Scandinavia.",2021,0.7,NA,"PMID","33689237","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","NOONAN SYNDROME 12","[disease]","C5231432","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","UNIPROT","CausalMutation","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.",2019,0.7,NA,"PMID","31130285","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Menkes Kinky Hair Syndrome","[disease]","C0022716","Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.7,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).",2021,0.65,NA,"PMID","34131312","American","HANCESTRO:0463",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Comprehensive evaluation of the child with intellectual disability or global developmental delays.","Comprehensive evaluation of the child with intellectual disability or global developmental delays.",2014,0.65,NA,"PMID","25157020","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary sensory and autonomic neuropathy type II","[disease]","C5574675","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Hereditary Sensory and Autonomic Neuropathy Type II","Hereditary Sensory and Autonomic Neuropathy Type II",1993,0.65,NA,"PMID","21089229","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Autism Spectrum Disorders","[disease]","C1510586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation.","American College of Medical Genetics guideline on the cytogenetic evaluation of the individual with developmental delay or mental retardation.",2005,0.65,NA,"PMID","16301868","American","HANCESTRO:0463",NA,NA
"CRIM1",51232,"ENSG00000150938","protein-coding",0.593,0.739,1,"Q9NZV1","","","MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA","[disease]","C1865286","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","The Oculome Panel Test: Next-Generation Sequencing to Diagnose a Diverse Range of Genetic Developmental Eye Disorders.","The Oculome Panel Test: Next-Generation Sequencing to Diagnose a Diverse Range of Genetic Developmental Eye Disorders.",2019,0.65,NA,"PMID","30653986","","",NA,NA
"CRIM1",51232,"ENSG00000150938","protein-coding",0.593,0.739,1,"Q9NZV1","","","MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA","[disease]","C1865286","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.","High-resolution array-CGH analysis on 46,XX patients affected by early onset primary ovarian insufficiency discloses new genes involved in ovarian function.",2019,0.65,NA,"PMID","30689869","","",NA,NA
"CRIM1",51232,"ENSG00000150938","protein-coding",0.593,0.739,1,"Q9NZV1","","","MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA","[disease]","C1865286","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Taken together, these findings identify CRIM1 as the causative gene for MACOM syndrome and emphasize the importance of CRIM1 in eye development.","Taken together, these findings identify <span class='gene' en_id='51232'>CRIM1</span> as the causative gene for <span class='disease' en_id='C1865286'>MACOM syndrome</span> and emphasize the importance of <span class='gene' en_id='51232'>CRIM1</span> in eye development.",2015,0.65,NA,"PMID","25561690","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial dilated cardiomyopathy","[disease]","C0340427","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial dilated cardiomyopathy","[disease]","C0340427","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A study of the pathogenicity of variants in familial heart disease. The value of cosegregation.","A study of the pathogenicity of variants in familial heart disease. The value of cosegregation.",2019,0.65,NA,"PMID","30972196","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Marfan Syndrome","[disease]","C0024796","Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","Cardiomyopathy, familial dilated.","Cardiomyopathy, familial dilated.",2006,0.65,NA,"PMID","16839424","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Cardiomyopathy, Dilated","[disease]","C0007193","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation","This variant, however, was considered nonexplanatory for the proband's dilated cardiomyopathy, which could be a sequela of the child's condition and/or related to other genetic variants, which include de novo mutations in the genes NEDD4L and GSK3A and a maternally inherited SCN5A variant.","This variant, however, was considered nonexplanatory for the proband's <span class='disease' en_id='C0007193'>dilated cardiomyopathy</span>, which could be a sequela of the child's condition and/or related to other genetic variants, which include de novo mutations in the genes <span class='gene' en_id='23327'>NEDD4L</span> and GSK3A and a maternally inherited SCN5A variant.",2017,0.65,NA,"PMID","28701297","","",NA,"Positive"
"KLRC4",8302,"ENSG00000183542","protein-coding",0.606,0.783,0.10803,"O43908","","","Behcet Syndrome","[disease]","C0004943","Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Stomatognathic Diseases (C07) | Eye Diseases (C11) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","ORPHANET","SusceptibilityMutation","This study reinforces the notion that CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 are bona fide susceptibility genes for BD, in addition to the MHC, IL10, and IL23R-IL12RB2 loci.","This study reinforces the notion that CCR1, <span class='gene' en_id='8302'>KLRC4</span>, IL12A-AS1, STAT4, and ERAP1 are bona fide susceptibility genes for <span class='disease' en_id='C0004943'>BD</span>, in addition to the MHC, IL10, and IL23R-IL12RB2 loci.",2015,0.65,NA,"PMID","26097239","","",NA,"Positive"
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Although the de novo variants in JMJD1C are likely to be relevant to the developmental phenotypes observed in these patients, we conclude that further data supporting the association of JMJD1C variants with intellectual disability is still needed.","Although the de novo variants in <span class='gene' en_id='221037'>JMJD1C</span> are likely to be relevant to the developmental phenotypes observed in these patients, we conclude that further data supporting the association of <span class='gene' en_id='221037'>JMJD1C</span> variants with <span class='disease' en_id='C3714756'>intellectual disability</span> is still needed.",2020,0.65,NA,"PMID","31954878","","",NA,"Positive"
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.","Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.",2011,0.65,NA,"PMID","21956720","American","HANCESTRO:0463",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Our findings indicate that mutations in JMJD1C contribute to the development of Rett syndrome and intellectual disability.","Our findings indicate that mutations in <span class='gene' en_id='221037'>JMJD1C</span> contribute to the development of Rett syndrome and <span class='disease' en_id='C3714756'>intellectual disability</span>.",2016,0.65,NA,"PMID","26181491","","",NA,"Positive"
"PRMT5",10419,"ENSG00000100462","protein-coding",0.486,0.87,1,"O14744","DTO_05007378","Epigenetic regulator","Triple Negative Breast Neoplasms","[disease]","C3539878","Skin and Connective Tissue Diseases (C17) | Neoplasms (C04)","Neoplastic Process (T191)","","","RGD_HUMAN","CausalOrContributing","Protein arginine methyltransferase 5: A novel therapeutic target for triple-negative breast cancers.","<span class='gene' en_id='10419'>Protein arginine methyltransferase 5</span>: A novel therapeutic target for <span class='disease' en_id='C3539878'>triple-negative breast cancers</span>.",2019,0.65,NA,"PMID","30957988","","",NA,"Positive"
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Zimmerman Laband syndrome","[disease]","C0796013","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Stomatognathic Diseases (C07)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","We report de novo missense variants in KCNN3 in three individuals with typical clinical features of ZLS.","We report de novo missense variants in <span class='gene' en_id='3782'>KCNN3</span> in three individuals with typical clinical features of <span class='disease' en_id='C0796013'>ZLS</span>.",2019,0.65,NA,"PMID","31155282","","",NA,"Positive"
"CRIM1",51232,"ENSG00000150938","protein-coding",0.593,0.739,1,"Q9NZV1","","","MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA","[disease]","C1865286","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","Taken together, these findings identify CRIM1 as the causative gene for MACOM syndrome and emphasize the importance of CRIM1 in eye development.","Taken together, these findings identify <span class='gene' en_id='51232'>CRIM1</span> as the causative gene for <span class='disease' en_id='C1865286'>MACOM syndrome</span> and emphasize the importance of <span class='gene' en_id='51232'>CRIM1</span> in eye development.",2015,0.65,NA,"PMID","25561690","","",NA,"Positive"
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Autism Spectrum Disorders","[disease]","C1510586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.","Genetic/familial high-risk assessment: breast and ovarian, version 1.2014.",2014,0.65,NA,"PMID","25190698","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial dilated cardiomyopathy","[disease]","C0340427","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of nuclear retention domains in the RBM20 protein.","Identification of nuclear retention domains in the RBM20 protein.",2013,0.65,NA,"PMID","23886709","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory Autonomic Neuropathy, Type 2","[disease]","C0020072","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation","Hereditary Sensory and Autonomic Neuropathy Type II","Hereditary Sensory and Autonomic Neuropathy Type II",1993,0.65,NA,"PMID","21089229","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory Autonomic Neuropathy, Type 2","[disease]","C0020072","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Here we show that loss-of-function mutations in FAM134B, encoding a newly identified cis-Golgi protein, cause HSAN II.","Here we show that loss-of-function mutations in <span class='gene' en_id='54463'>FAM134B</span>, encoding a newly identified cis-Golgi protein, cause <span class='disease' en_id='C0020072,C0270914,C5574675'>HSAN II</span>.",2009,0.65,NA,"PMID","19838196","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Carcinoma","[disease]","C0007097","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.","cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.",2002,0.65,NA,"PMID","12376462","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Epilepsy","[disease]","C0014544","Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Autism Spectrum Disorders","[disease]","C1510586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes.","Genome sequencing identifies multiple deleterious variants in autism patients with more severe phenotypes.",2019,0.65,NA,"PMID","30504930","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial dilated cardiomyopathy","[disease]","C0340427","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.",2009,0.65,NA,"PMID","19712804","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Increased bilirubin level (finding)","[phenotype]","C0311468","","Finding (T033)","","Abnormality of metabolism/homeostasis (01939)","CLINVAR","CausalMutation","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.",2008,0.65,NA,"PMID","18414213","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Mammary Neoplasms","[disease]","C1458155","Skin and Connective Tissue Diseases (C17) | Neoplasms (C04)","Neoplastic Process (T191)","","Abnormality of the breast (00769) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.","MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.",2013,0.65,NA,"PMID","24014025","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Pulmonary Hypertension","[phenotype]","C0020542","Respiratory Tract Diseases (C08) | Cardiovascular Diseases (C14)","Pathologic Function (T046)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Upregulated copper transporters in hypoxia-induced pulmonary hypertension.","Upregulated copper transporters in hypoxia-induced pulmonary hypertension.",2014,0.65,NA,"PMID","24614111","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Cutis Laxa","[disease]","C0010495","Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the integument (01574)","CLINVAR","CausalMutation",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Cutis Laxa","[disease]","C0010495","Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the integument (01574)","GENCC","GeneticVariation",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"MAGI1",9223,"ENSG00000151276","protein-coding",0.586,0.913,0.85449,"Q96QZ7","","","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","Results presented herein provide further evidence for a role of MAGI1 and MAGI2 in BPAD and SZ etiology.","Results presented herein provide further evidence for a role of <span class='gene' en_id='9223'>MAGI1</span> and MAGI2 in <span class='disease' en_id='C0005586'>BPAD</span> and SZ etiology.",2012,0.65,NA,"PMID","22381734","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Increased bilirubin level (finding)","[phenotype]","C0311468","","Finding (T033)","","Abnormality of metabolism/homeostasis (01939)","CLINVAR","GeneticVariation",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"CRIM1",51232,"ENSG00000150938","protein-coding",0.593,0.739,1,"Q9NZV1","","","MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA","[disease]","C1865286","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","A novel role for CRIM1 in the corneal response to UV and pterygium development.","A novel role for CRIM1 in the corneal response to UV and pterygium development.",2019,0.65,NA,"PMID","30365943","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial dilated cardiomyopathy","[disease]","C0340427","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.","Genetics and genotype-phenotype correlations in Finnish patients with dilated cardiomyopathy.",2015,0.65,NA,"PMID","26084686","Finnish","HANCESTRO:0321",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Increased bilirubin level (finding)","[phenotype]","C0311468","","Finding (T033)","","Abnormality of metabolism/homeostasis (01939)","CLINVAR","GeneticVariation","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.",2008,0.65,NA,"PMID","18414213","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory Autonomic Neuropathy, Type 2","[disease]","C0020072","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"MAGI1",9223,"ENSG00000151276","protein-coding",0.586,0.913,0.85449,"Q96QZ7","","","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","The strongest signals were detected in the full set at MAGI1 (p=5.1×10(-7)), previously associated with bipolar disorder, and in the FH+ subset at STIM1 (p=3.9×10(-6) after imputation), a calcium channel signaling gene.","The strongest signals were detected in the full set at <span class='gene' en_id='9223'>MAGI1</span> (p=5.1×10(-7)), previously associated with <span class='disease' en_id='C0005586'>bipolar disorder</span>, and in the FH+ subset at STIM1 (p=3.9×10(-6) after imputation), a calcium channel signaling gene.",2014,0.65,NA,"PMID","24215895","","",NA,"Positive"
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Autistic Disorder","[disease]","C0004352","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","These observations suggest that TRIP8 and REEP3 are both positional candidate genes for autism.","These observations suggest that <span class='gene' en_id='221037'>TRIP8</span> and REEP3 are both positional candidate genes for <span class='disease' en_id='C0004352,C0524528'>autism</span>.",2007,0.65,NA,"PMID","17290275","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary sensory and autonomic neuropathy type II","[disease]","C5574675","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","Hereditary Sensory and Autonomic Neuropathy Type II","Hereditary Sensory and Autonomic Neuropathy Type II",1993,0.65,NA,"PMID","21089229","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary sensory and autonomic neuropathy type II","[disease]","C5574675","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Here we show that loss-of-function mutations in FAM134B, encoding a newly identified cis-Golgi protein, cause HSAN II.","Here we show that loss-of-function mutations in <span class='gene' en_id='54463'>FAM134B</span>, encoding a newly identified cis-Golgi protein, cause <span class='disease' en_id='C0020072,C0270914,C5574675'>HSAN II</span>.",2009,0.65,NA,"PMID","19838196","","",NA,"Positive"
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary sensory and autonomic neuropathy type II","[disease]","C5574675","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.",2014,0.65,NA,"PMID","24327336","Turkish","HANCESTRO:0451",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Mammary Neoplasms","[disease]","C1458155","Skin and Connective Tissue Diseases (C17) | Neoplasms (C04)","Neoplastic Process (T191)","","Abnormality of the breast (00769) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Results support the role of LOXL2 in selectively promoting a metastatic phenotype in breast tumor cells.","Results support the role of <span class='gene' en_id='4017'>LOXL2</span> in selectively promoting a metastatic phenotype in <span class='disease' en_id='C1458155'>breast tumor</span> cells.",2009,0.65,NA,"PMID","19330836","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial dilated cardiomyopathy","[disease]","C0340427","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Whole exome sequencing identifies a causal RBM20 mutation in a large pedigree with familial dilated cardiomyopathy.","Whole exome sequencing identifies a causal <span class='gene' en_id='282996'>RBM20</span> mutation in a large pedigree with <span class='disease' en_id='C0340427'>familial dilated cardiomyopathy</span>.",2013,0.65,NA,"PMID","23861363","","",NA,"Positive"
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Zimmerman Laband syndrome","[disease]","C0796013","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Stomatognathic Diseases (C07)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","We report de novo missense variants in KCNN3 in three individuals with typical clinical features of ZLS.","We report de novo missense variants in <span class='gene' en_id='3782'>KCNN3</span> in three individuals with typical clinical features of <span class='disease' en_id='C0796013'>ZLS</span>.",2019,0.65,NA,"PMID","31155282","","",NA,"Positive"
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).","Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).",2021,0.65,NA,"PMID","34211152","American","HANCESTRO:0463",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Testicular Germ Cell Tumor","[disease]","C1336708","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","In the combined analysis, risk of TGCT was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in MAD1L1 (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.","In the combined analysis, risk of <span class='disease' en_id='C1336708'>TGCT</span> was significantly associated with markers at four previously unreported loci: 4q22.2 in HPGDS (per-allele odds ratio (OR) = 1.19, 95% confidence interval (CI) = 1.12-1.26; P = 1.11 × 10(-8)), 7p22.3 in <span class='gene' en_id='8379'>MAD1L1</span> (OR = 1.21, 95% CI = 1.14-1.29; P = 5.59 × 10(-9)), 16q22.3 in RFWD3 (OR = 1.26, 95% CI = 1.18-1.34; P = 5.15 × 10(-12)) and 17q22 (rs9905704: OR = 1.27, 95% CI = 1.18-1.33; P = 4.32 × 10(-13) and rs7221274: OR = 1.20, 95% CI = 1.12-1.28; P = 4.04 × 10(-9)), a locus that includes TEX14, RAD51C and PPM1E.",2013,0.65,NA,"PMID","23666239","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Cutis Laxa","[disease]","C0010495","Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the integument (01574)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.65,NA,NA,NA,NA,NA,NA,NA
"THSD7A",221981,"ENSG00000005108","protein-coding",0.555,0.826,0.011926,"Q9UPZ6","DTO_05007621","Extracellular structure","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Genome-wide association study identifies 30 loci associated with bipolar disorder.","Genome-wide association study identifies 30 loci associated with bipolar disorder.",2019,0.65,NA,"PMID","31043756","","",NA,NA
"FAM83D",81610,"ENSG00000101447","protein-coding",0.658,0.478,3.3088e-11,"Q9H4H8","","","Liver carcinoma","[disease]","C2239176","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the digestive system (25031) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.","Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.",2017,0.6,NA,"PMID","28284560","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.","Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.",2023,0.6,NA,"PMID","37540500","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Neurodevelopmental Disorders","[disease]","C1535926","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Myeloid neoplasm (morphologic abnormality)","[disease]","C2939461","Hemic and Lymphatic Diseases (C15) | Neoplasms (C04)","Neoplastic Process (T191)","","","RGD_HUMAN","CausalOrContributing","Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.","Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome.",2013,0.6,NA,"PMID","22875613","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.6,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Lysyl oxidase is required for vascular and diaphragmatic development in mice.","Lysyl oxidase is required for vascular and diaphragmatic development in mice.",2003,0.6,NA,"PMID","12473682","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.6,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.6,NA,"PMID","26838787","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Ehlers-Danlos Syndrome","[disease]","C0013720","Skin and Connective Tissue Diseases (C17) | Hemic and Lymphatic Diseases (C15) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Colorectal Carcinoma","[disease]","C0009402","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","UNIPROT","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Motor and Sensory-Neuropathy Type II","[disease]","C0270914","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Connective Tissue Diseases","[disease]","C0009782","Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","We report the case of a 9-year-old boy with a discernible connective tissue disorder characterized by cutis laxa (CL) and multiple herniations and caused by biallelic loss-of-function variants in EFEMP1.","We report the case of a 9-year-old boy with a discernible <span class='disease' en_id='C0009782'>connective tissue disorder</span> characterized by cutis laxa (CL) and multiple herniations and caused by biallelic loss-of-function variants in <span class='gene' en_id='2202'>EFEMP1</span>.",2021,0.6,NA,"PMID","33807164","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Connective Tissue Diseases","[disease]","C0009782","Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.","Compromised mutant EFEMP1 secretion associated with macular dystrophy remedied by proteostasis network alteration.",2011,0.6,NA,"PMID","22031286","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Cleft Palate","[disease]","C0008925","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Stomatognathic Diseases (C07)","Congenital Abnormality (T019)","physical disorder (0080015) | syndrome (225)","","RGD_HUMAN","CausalOrContributing","Here we show that missense mutations in NEDD4L mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, cleft palate and neurodevelopmental delay.","Here we show that missense mutations in <span class='gene' en_id='23327'>NEDD4L</span> mapping to the HECT domain of the encoded E3 ubiquitin ligase lead to PNH associated with toe syndactyly, <span class='disease' en_id='C0008925,C1837218'>cleft palate</span> and neurodevelopmental delay.",2016,0.6,NA,"PMID","27694961","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.6,NA,"PMID","9497253","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.6,NA,"PMID","9630669","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.",2015,0.6,NA,"PMID","26697581","Iranian","HANCESTRO:0438",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Molecular analysis of patients of Sardinian descent with Crigler-Najjar syndrome type I.","Molecular analysis of patients of Sardinian descent with Crigler-Najjar syndrome type I.",1997,0.6,NA,"PMID","9039987","Sardinian","HANCESTRO:0309",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Paternal isodisomy for chromosome 2 as the cause of Crigler-Najjar type I syndrome.","Paternal isodisomy for chromosome 2 as the cause of Crigler-Najjar type I syndrome.",2005,0.6,NA,"PMID","15586176","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2000,0.6,NA,"PMID","11182932","","",NA,NA
"PRMT5",10419,"ENSG00000100462","protein-coding",0.486,0.87,1,"O14744","DTO_05007378","Epigenetic regulator","Diffuse Large B-Cell Lymphoma","[disease]","C0079744","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Co-targeting PRMT5 and AKT by their specific inhibitors is lethal to DLBCL cell lines and primary cancer cells.","Co-targeting <span class='gene' en_id='10419'>PRMT5</span> and AKT by their specific inhibitors is lethal to <span class='disease' en_id='C0079744'>DLBCL</span> cell lines and primary cancer cells.",2019,0.6,NA,"PMID","31123343","","",NA,"Positive"
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Cardiovascular Diseases","[disease]","C0007222","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINPGX","Pharmacogenomics","Genotype AG is associated with increased risk of Cardiovascular Diseases in people with Hypertension.","Genotype AG is associated with increased risk of Cardiovascular Diseases in people with Hypertension.",2013,0.6,NA,"PMID","23353631","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","To investigate a possible involvement of expanded triplet repeats of genome in the genomes of patients with endogenous psychoses, we examined a CAG repeat polymorphism in the coding region of the KCNN3 gene in schizophrenia, schizoaffective disorder, bipolar disorder and controls of the Japanese population.","To investigate a possible involvement of expanded triplet repeats of genome in the genomes of patients with endogenous psychoses, we examined a CAG repeat polymorphism in the coding region of the <span class='gene' en_id='3782'>KCNN3</span> gene in schizophrenia, schizoaffective disorder, <span class='disease' en_id='C0005586'>bipolar disorder</span> and controls of the Japanese population.",2001,0.6,NA,"PMID","11311923","Japanese","HANCESTRO:0019",NA,"Positive"
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Autosomal dominant cerebellar ataxia","[disease]","C4087347","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION","[disease]","C5774284","","Disease or Syndrome (T047)","syndrome (225)","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"MICA",100507436,"ENSG00000204520","protein-coding",0.405,0.913,0.0031713,"Q29983","","","Oral Submucous Fibrosis","[disease]","C0029172","Stomatognathic Diseases (C07)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Oral submucous fibrosis: review on aetiology and pathogenesis.","Oral submucous fibrosis: review on aetiology and pathogenesis.",2006,0.6,NA,"PMID","16311067","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION","[disease]","C5774284","","Disease or Syndrome (T047)","syndrome (225)","","CLINVAR","CausalMutation","Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.","Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.",2022,0.6,NA,"PMID","36322655","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genome Sequencing as a Diagnostic Test in Children With Unexplained Medical Complexity.","Genome Sequencing as a Diagnostic Test in Children With Unexplained Medical Complexity.",2020,0.6,NA,"PMID","32960281","","",NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.",2017,0.6,NA,"PMID","27967308","","",NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.",2017,0.6,NA,"PMID","27967308","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Marfan Syndrome","[disease]","C0024796","Skin and Connective Tissue Diseases (C17) | Musculoskeletal Diseases (C05) | Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","A new type of defect in the gene for bilirubin uridine 5'-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.","A new type of defect in the gene for bilirubin uridine 5'-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.",1994,0.6,NA,"PMID","7936809","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.6,NA,"PMID","23875061","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.","Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.",2002,0.6,NA,"PMID","11968090","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.6,NA,"PMID","25200497","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.","Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.",1992,0.6,NA,"PMID","1634606","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.6,NA,"PMID","19830808","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Lung Neoplasms","[disease]","C0024121","Respiratory Tract Diseases (C08) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Neoplasm (02664) | Abnormality of the respiratory system (02086)","RGD_HUMAN","CausalOrContributing","Promoter hypermethylation of RAMP2, epidermal growth factor-containing fibulin-like extracellular matrix protein 1, and deleted in U Twenty Twenty cells was detected in 36% to 77% of 22 lung cancer cell lines and in 38% to 50% of 32 primary lung tumors, whereas hypermethylathion of these genes was rarely found in the matched normal samples.","Promoter hypermethylation of RAMP2, <span class='gene' en_id='2202'>epidermal growth factor-containing fibulin-like extracellular matrix protein 1</span>, and deleted in U Twenty Twenty cells was detected in 36% to 77% of 22 lung cancer cell lines and in 38% to 50% of 32 primary <span class='disease' en_id='C0024121'>lung tumors</span>, whereas hypermethylathion of these genes was rarely found in the matched normal samples.",2007,0.6,NA,"PMID","17671114","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Unipolar Depression","[disease]","C0041696","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","PSYGENET","Biomarker","Our results suggest that genetic variations in the BCR gene could confer susceptibility to bipolar disorder and major depressive disorder.","Our results suggest that genetic variations in the <span class='gene' en_id='613'>BCR</span> gene could confer susceptibility to bipolar disorder and <span class='disease' en_id='C0041696'>major depressive disorder</span>.",2005,0.6,NA,"PMID","15866548","","",NA,"Positive"
"SLC6A12",6539,"ENSG00000111181","protein-coding",0.688,0.522,8.1403e-10,"P48065","DTO_05007405","Transporter","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","Transcriptional dysregulation of ?-aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia.","Transcriptional dysregulation of <span class='gene' en_id='6539'>?-aminobutyric acid transporter</span> in parvalbumin-containing inhibitory neurons in the prefrontal cortex in <span class='disease' en_id='C0036341'>schizophrenia</span>.",2014,0.6,NA,"PMID","25312391","","",NA,"Positive"
"SLC6A12",6539,"ENSG00000111181","protein-coding",0.688,0.522,8.1403e-10,"P48065","DTO_05007405","Transporter","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","We investigated the association of single nucleotide polymorphisms of solute carrier family 6 member 11 (SLC6A11) (rs2304725, rs2272400, and rs2245532), SLC6A12 (rs216250 and rs557881) and SLC6A13 (rs2289954) with schizophrenia and its clinical symptoms.","We investigated the association of single nucleotide polymorphisms of solute carrier family 6 member 11 (SLC6A11) (rs2304725, rs2272400, and rs2245532), <span class='gene' en_id='6539'>SLC6A12</span> (rs216250 and rs557881) and SLC6A13 (rs2289954) with <span class='disease' en_id='C0036341'>schizophrenia</span> and its clinical symptoms.",2011,0.6,NA,"PMID","21367462","","",NA,"Positive"
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Osteosarcoma","[disease]","C0029463","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Interactive effect of bisphenol A (BPA) exposure with -22G/C polymorphism in LOX gene on the risk of osteosarcoma.","Interactive effect of bisphenol A (BPA) exposure with -22G/C polymorphism in LOX gene on the risk of osteosarcoma.",2013,0.6,NA,"PMID","23886186","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Connective Tissue Diseases","[disease]","C0009782","Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Connective Tissue Diseases","[disease]","C0009782","Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.",2022,0.6,NA,"PMID","34923728","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","A multiallelic CAG repeat polymorphism within the KCNN3 has been associated with schizophrenia and bipolar disorder.","A multiallelic CAG repeat polymorphism within the <span class='gene' en_id='3782'>KCNN3</span> has been associated with schizophrenia and <span class='disease' en_id='C0005586'>bipolar disorder</span>.",2004,0.6,NA,"PMID","15389773","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","We previously reported a significant association between genetic variations in the breakpoint cluster region (BCR) gene and bipolar disorder.","We previously reported a significant association between genetic variations in the <span class='gene' en_id='613'>breakpoint cluster region</span> (<span class='gene' en_id='613'>BCR</span>) gene and <span class='disease' en_id='C0005586'>bipolar disorder</span>.",2008,0.6,NA,"PMID","17822820","","",NA,"Positive"
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION","[disease]","C5774284","","Disease or Syndrome (T047)","syndrome (225)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Immunohistochemical localization of lysyl oxidase with monoclonal antibodies.","Immunohistochemical localization of lysyl oxidase with monoclonal antibodies.",1990,0.6,NA,"PMID","1975633","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.6,NA,"PMID","26838787","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.","Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.",2002,0.6,NA,"PMID","12417550","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients.","Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients.",2019,0.6,NA,"PMID","30675029","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.6,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.6,NA,"PMID","26838787","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings.","Uridine-responsive epileptic encephalopathy due to inherited variants in CAD: A Tale of Two Siblings.",2021,0.6,NA,"PMID","33497533","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Biallelic CAD variants underlie CAD deficiency (or early infantile epileptic encephalopathy-50, [EIEE-50]), an error of pyrimidine de novo biosynthesis amenable to treatment via the uridine salvage pathway.","Biallelic <span class='gene' en_id='124872,790'>CAD</span> variants underlie CAD deficiency (or <span class='disease' en_id='C0393706,C4552072,C5779964,C5781758'>early infantile epileptic encephalopathy</span>-50, [EIEE-50]), an error of pyrimidine de novo biosynthesis amenable to treatment via the uridine salvage pathway.",2020,0.6,NA,"PMID","32820246","","",NA,"Positive"
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Syndactyly","[disease]","C0039075","Musculoskeletal Diseases (C05) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Congenital Abnormality (T019)","disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127) | Abnormality of limbs (40064)","RGD_HUMAN","CausalOrContributing","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.",2016,0.6,NA,"PMID","27694961","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Scoliosis, unspecified","[disease]","C0036439","Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the musculoskeletal system (33127)","CLINVAR","CausalMutation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Hereditary ataxia (disorder)","[disease]","C0004138","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"PRMT5",10419,"ENSG00000100462","protein-coding",0.486,0.87,1,"O14744","DTO_05007378","Epigenetic regulator","Medulloblastoma","[disease]","C0025149","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Neoplasm (02664) | Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Our results reveal the regulation of MYC oncoprotein by PRMT5 and suggest that targeting PRMT5 could be a potential therapeutic strategy for MYC-driven medulloblastoma.","Our results reveal the regulation of MYC oncoprotein by <span class='gene' en_id='10419'>PRMT5</span> and suggest that targeting <span class='gene' en_id='10419'>PRMT5</span> could be a potential therapeutic strategy for MYC-driven <span class='disease' en_id='C0025149'>medulloblastoma</span>.",2019,0.6,NA,"PMID","31694585","","",NA,"Positive"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Tachycardia, Ventricular","[disease]","C0042514","Cardiovascular Diseases (C14) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.6,NA,"PMID","20975617","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.",1992,0.6,NA,"PMID","1634050","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.",1994,0.6,NA,"PMID","7906695","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.6,NA,"PMID","9497253","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.",1993,0.6,NA,"PMID","8276413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.",2012,0.6,NA,"PMID","22325916","","",NA,NA
"MAGI1",9223,"ENSG00000151276","protein-coding",0.586,0.913,0.85449,"Q96QZ7","","","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","Results presented herein provide further evidence for a role of MAGI1 and MAGI2 in BPAD and SZ etiology.","Results presented herein provide further evidence for a role of <span class='gene' en_id='9223'>MAGI1</span> and MAGI2 in BPAD and <span class='disease' en_id='C0036341'>SZ</span> etiology.",2012,0.6,NA,"PMID","22381734","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","Various other protein products of genes associated with bipolar disorder either bind to or are affected by phosphatidyl-inositol phosphate products of this pathway (ADBRK2, HIP1R, KCNQ2, RGS4, WFS1), are associated with its constituent elements (BCR, DUSP6, FAT, GNAZ) or are downstream targets of this signalling cascade (DPYSL2, DRD3, GAD1, G6PD, GCH1, KCNQ2, NOS3, SLC6A3, SLC6A4, SST, TH, TIMELESS).","Various other protein products of genes associated with <span class='disease' en_id='C0005586'>bipolar disorder</span> either bind to or are affected by phosphatidyl-inositol phosphate products of this pathway (ADBRK2, HIP1R, KCNQ2, RGS4, WFS1), are associated with its constituent elements (<span class='gene' en_id='613'>BCR</span>, DUSP6, FAT, GNAZ) or are downstream targets of this signalling cascade (DPYSL2, DRD3, GAD1, G6PD, GCH1, KCNQ2, NOS3, SLC6A3, SLC6A4, SST, TH, TIMELESS).",2007,0.6,NA,"PMID","17239488","","",NA,"Positive"
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy.","Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy.",2020,0.6,NA,"PMID","32461667","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.6,NA,"PMID","26838787","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.6,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.6,NA,"PMID","26838787","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION","[disease]","C5774284","","Disease or Syndrome (T047)","syndrome (225)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Left ventricular noncompaction cardiomyopathy","[disease]","C4021133","Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","OVARIAN DYSGENESIS 9","[disease]","C5562046","","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","A SPIDR homozygous nonsense pathogenic variant in isolated primary ovarian insufficiency with chromosomal instability.","A SPIDR homozygous nonsense pathogenic variant in isolated primary ovarian insufficiency with chromosomal instability.",2022,0.6,NA,"PMID","34697795","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Ehlers-Danlos Syndrome","[disease]","C0013720","Skin and Connective Tissue Diseases (C17) | Hemic and Lymphatic Diseases (C15) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Left ventricular noncompaction cardiomyopathy","[disease]","C4021133","Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","Abnormality of the cardiovascular system (01626)","CLINVAR","CausalMutation","Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.","Reduced Systolic Function and Not Genetic Variants Determine Outcome in Pediatric and Adult Left Ventricular Noncompaction Cardiomyopathy.",2021,0.6,NA,"PMID","34540771","","",NA,NA
"PRMT5",10419,"ENSG00000100462","protein-coding",0.486,0.87,1,"O14744","DTO_05007378","Epigenetic regulator","Multiple Myeloma","[disease]","C0026764","Immune System Diseases (C20) | Cardiovascular Diseases (C14) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Neoplasm (02664) | Abnormality of blood and blood-forming tissues (01871)","RGD_HUMAN","CausalOrContributing","Either genetic knockdown or pharmacological inhibition of PRMT5 with the inhibitor EPZ015666 significantly inhibited growth of both cell lines and patient MM cells.","Either genetic knockdown or pharmacological inhibition of <span class='gene' en_id='10419'>PRMT5</span> with the inhibitor <span class='chemical' en_id='CHEMBL3414626'>EPZ015666</span> significantly inhibited growth of both cell lines and patient <span class='disease' en_id='C0026764'>MM</span> cells.",2018,0.6,NA,"PMID","29158558","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.","A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.",1993,0.6,NA,"PMID","8226884","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.","Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.",1993,0.6,NA,"PMID","8102509","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.6,NA,"PMID","1692835","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Liver Cirrhosis","[disease]","C0023890","Pathological Conditions, Signs and Symptoms (C23) | Digestive System Diseases (C06)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the digestive system (25031)","RGD_HUMAN","CausalOrContributing","Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis.","Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis.",2016,0.6,NA,"PMID","26396155","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Connective Tissue Diseases","[disease]","C0009782","Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","We conclude that loss of EFEMP1 function in this individual is the cause of a connective tissue disorder with a novel combination of phenotypic features, and can perhaps explain similar, previously reported cases in the literature.","We conclude that loss of <span class='gene' en_id='2202'>EFEMP1</span> function in this individual is the cause of a <span class='disease' en_id='C0009782'>connective tissue disorder</span> with a novel combination of phenotypic features, and can perhaps explain similar, previously reported cases in the literature.",2020,0.6,NA,"PMID","31792352","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","The positional candidate approach showed an association between bipolar disorder and TRPM2 (21q22.3), GPR50 (Xq28), Citron (12q24), CHMP1.5 (18p11.2), GCHI (14q22-24), MLC1 (22q13), GABRA5 (15q11-q13), BCR (22q11), CUX2, FLJ32356 (12q23-q24), and NAPG (18p11).","The positional candidate approach showed an association between <span class='disease' en_id='C0005586'>bipolar disorder</span> and TRPM2 (21q22.3), GPR50 (Xq28), Citron (12q24), CHMP1.5 (18p11.2), GCHI (14q22-24), MLC1 (22q13), GABRA5 (15q11-q13), <span class='gene' en_id='613'>BCR</span> (22q11), CUX2, FLJ32356 (12q23-q24), and NAPG (18p11).",2007,0.6,NA,"PMID","17239033","","",NA,"Positive"
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","GENCC","CausalMutation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINGEN","CausalMutation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.6,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.","Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings.",2024,0.6,NA,"PMID","39039281","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Familial thoracic aortic aneurysm and aortic dissection","[disease]","C4707243","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.","Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.",2002,0.6,NA,"PMID","12417550","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.","Beyond genetics: Deciphering the impact of missense variants in CAD deficiency.",2023,0.6,NA,"PMID","37540500","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Infantile Epileptic-Dyskinetic Encephalopathy","[disease]","C4552072","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Disruption of CAD Oligomerization by Pathogenic Variants.","Disruption of CAD Oligomerization by Pathogenic Variants.",2024,0.6,NA,"PMID","39447673","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Major Depressive Disorder","[disease]","C1269683","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","PSYGENET","Biomarker","Our results suggest that genetic variations in the BCR gene could confer susceptibility to bipolar disorder and major depressive disorder.","Our results suggest that genetic variations in the <span class='gene' en_id='613'>BCR</span> gene could confer susceptibility to bipolar disorder and <span class='disease' en_id='C1269683'>major depressive disorder</span>.",2005,0.6,NA,"PMID","15866548","","",NA,"Positive"
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 7 WITH INFLAMMATION AND TUMOR PREDISPOSITION","[disease]","C5774284","","Disease or Syndrome (T047)","syndrome (225)","","GENCC","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Colorectal Carcinoma","[disease]","C0009402","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","UNIPROT","GeneticVariation",NA,NA,NA,0.6,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Oral Submucous Fibrosis","[disease]","C0029172","Stomatognathic Diseases (C07)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Oral submucous fibrosis: review on aetiology and pathogenesis.","Oral submucous fibrosis: review on aetiology and pathogenesis.",2006,0.6,NA,"PMID","16311067","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.",2003,0.6,NA,"PMID","14616765","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.6,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.6,NA,"PMID","11906189","","",NA,NA
"SLC6A12",6539,"ENSG00000111181","protein-coding",0.688,0.522,8.1403e-10,"P48065","DTO_05007405","Transporter","Schizophrenia","[disease]","C0036341","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","We determined if mRNAs encoding presynaptic proteins enriched in inhibitory (vesicular gamma-aminobutyric acid transporter [VGAT] and complexin 1) and/or excitatory (vesicular glutamate transporter 1 [VGluT1] and complexin 2) terminals are altered in the dorsolateral prefrontal cortex of subjects with schizophrenia (n = 37 patients, n = 37 control subjects).","We determined if mRNAs encoding presynaptic proteins enriched in inhibitory (vesicular <span class='gene' en_id='6539'>gamma-aminobutyric acid transporter</span> [VGAT] and complexin 1) and/or excitatory (vesicular glutamate transporter 1 [VGluT1] and complexin 2) terminals are altered in the dorsolateral prefrontal cortex of subjects with <span class='disease' en_id='C0036341'>schizophrenia</span> (n = 37 patients, n = 37 control subjects).",2011,0.6,NA,"PMID","21145444","","",NA,NA
"COL26A1",136227,"ENSG00000160963","protein-coding",0.743,0.478,2.3673e-11,"Q96A83","","","Asthma","[disease]","C0004096","Respiratory Tract Diseases (C08) | Immune System Diseases (C20)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the immune system (02715) | Abnormality of the respiratory system (02086)","CLINPGX","Pharmacogenomics","Allele A is associated with decreased risk of asthma when treated with aspirin as compared to allele G.","Allele A is associated with decreased risk of asthma when treated with aspirin as compared to allele G.",2011,0.6,NA,"PMID","21086123","","",NA,"Positive"
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","We investigated the contribution of the CAG repeat at the KCNN3 gene, localized to chromosome 1q21.3, to the genetic susceptibility for schizophrenia, schizoaffective and bipolar disorders.","We investigated the contribution of the CAG repeat at the <span class='gene' en_id='3782'>KCNN3</span> gene, localized to chromosome 1q21.3, to the genetic susceptibility for schizophrenia, schizoaffective and <span class='disease' en_id='C0005586'>bipolar disorders</span>.",2003,0.6,NA,"PMID","12960745","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","The results of these meta-analyses demonstrate that the risks for both schizophrenia and bipolar disorder are largely, if not entirely, independent of CAG-repeat length in exon 1 of KCNN3.","The results of these meta-analyses demonstrate that the risks for both schizophrenia and <span class='disease' en_id='C0005586'>bipolar disorder</span> are largely, if not entirely, independent of CAG-repeat length in exon 1 of <span class='gene' en_id='3782'>KCNN3</span>.",2003,0.6,NA,"PMID","12898569","","",NA,"Negative"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","Our results suggest that genetic variations in the BCR gene could confer susceptibility to bipolar disorder and major depressive disorder.","Our results suggest that genetic variations in the <span class='gene' en_id='613'>BCR</span> gene could confer susceptibility to <span class='disease' en_id='C0005586'>bipolar disorder</span> and major depressive disorder.",2005,0.6,NA,"PMID","15866548","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Arachnodactyly","[disease]","C0003706","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Musculoskeletal Diseases (C05)","Congenital Abnormality (T019)","","Abnormality of the musculoskeletal system (33127) | Abnormality of limbs (40064) | Growth abnormality (01507)","CLINVAR","CausalMutation",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.",1994,0.55,NA,"PMID","7906695","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia.","Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia.",2007,0.55,NA,"PMID","17229650","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.",2005,0.55,NA,"PMID","15712364","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?","Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?",2014,0.55,NA,"PMID","24071797","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.","Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.",2021,0.55,NA,"PMID","33497248","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.","NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.",2011,0.55,NA,"PMID","22138009","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?","Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of prostate cancer improve patient health outcomes?",2014,0.55,NA,"PMID","24071797","","",NA,NA
"NTM",50863,"ENSG00000182667","protein-coding",0.586,0.913,0.98694,"Q9P121","","","Primary open angle glaucoma","[disease]","C0339573","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2000,0.55,NA,"PMID","11182932","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.",2015,0.55,NA,"PMID","26697581","Iranian","HANCESTRO:0438",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Early detection of prostate cancer: AUA Guideline.","Early detection of prostate cancer: AUA Guideline.",2013,0.55,NA,"PMID","23659877","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.","NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.",2011,0.55,NA,"PMID","22138009","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.","Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.",2022,0.55,NA,"PMID","35924163","","",NA,NA
"SLC6A12",6539,"ENSG00000111181","protein-coding",0.688,0.522,8.1403e-10,"P48065","DTO_05007405","Transporter","Asthma","[disease]","C0004096","Respiratory Tract Diseases (C08) | Immune System Diseases (C20)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the immune system (02715) | Abnormality of the respiratory system (02086)","CLINPGX","Pharmacogenomics","Allele A is associated with increased likelihood of Asthma when treated with aspirin in people with Asthma as compared to allele T.","Allele A is associated with increased likelihood of Asthma when treated with aspirin in people with Asthma as compared to allele T.",2010,0.55,NA,"PMID","20597903","","",NA,"Positive"
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.55,NA,"PMID","19830808","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.",2013,0.55,NA,"PMID","23997956","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Genetics of Prostate Cancer (PDQ®): Health Professional Version","Genetics of Prostate Cancer (PDQ®): Health Professional Version",2002,0.55,NA,"PMID","26389227","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Early detection of prostate cancer: AUA Guideline.","Early detection of prostate cancer: AUA Guideline.",2013,0.55,NA,"PMID","23659877","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.","Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.",2020,0.55,NA,"PMID","31829902","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Prediabetes syndrome","[disease]","C0362046","Nutritional and Metabolic Diseases (C18) | Endocrine System Diseases (C19)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.","National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.",2008,0.55,NA,"PMID","19042984","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.",1992,0.55,NA,"PMID","1634050","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.55,NA,"PMID","23875061","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.",2005,0.55,NA,"PMID","15712364","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.","Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.",2022,0.55,NA,"PMID","35924163","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Lymphoma","[disease]","C0024299","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of blood and blood-forming tissues (01871) | Neoplasm (02664)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","Leukodystrophy (disorder)","[disease]","C0023520","Nervous System Diseases (C10) | Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation",NA,NA,NA,0.55,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Genetics of Prostate Cancer (PDQ®): Health Professional Version","Genetics of Prostate Cancer (PDQ®): Health Professional Version",2002,0.55,NA,"PMID","26389227","","",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.","Molecular Biomarkers in Localized Prostate Cancer: ASCO Guideline.",2020,0.55,NA,"PMID","31829902","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.","National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.",2008,0.55,NA,"PMID","19042984","","",NA,NA
"PTPRN2",5799,"ENSG00000155093","protein-coding",0.562,0.87,4.8153e-15,"Q92932","","","Malignant neoplasm of prostate","[disease]","C0376358","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","GeneticVariation","Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.","Initial Management of Noncastrate Advanced, Recurrent, or Metastatic Prostate Cancer: ASCO Guideline Update.",2021,0.55,NA,"PMID","33497248","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.","Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.",2000,0.55,NA,"PMID","11013440","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Two unrelated patients with rare Crigler-Najjar syndrome type I: two novel mutations and a patient with loss of heterozygosity of UGT1A1 gene.","Two unrelated patients with rare Crigler-Najjar syndrome type I: two novel mutations and a patient with loss of heterozygosity of UGT1A1 gene.",2014,0.55,NA,"PMID","24793765","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Severe early-onset obesity insulin resistance syndrome due to SH2B1 deficiency","[disease]","C5190989","Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation","Human SH2B1 mutations are associated with maladaptive behaviors and obesity.","Human SH2B1 mutations are associated with maladaptive behaviors and obesity.",2012,0.5,NA,"PMID","23160192","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma 1, Open Angle, H","[disease]","C1969811","Eye Diseases (C11)","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.","Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.",2015,0.5,NA,"PMID","26162006","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Blindness","[disease]","C0456909","Eye Diseases (C11) | Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","A loss-of-function cysteine mutant in fibulin-3 (EFEMP1) forms aberrant extracellular disulfide-linked homodimers and alters extracellular matrix composition.","A loss-of-function cysteine mutant in fibulin-3 (EFEMP1) forms aberrant extracellular disulfide-linked homodimers and alters extracellular matrix composition.",2022,0.5,NA,"PMID","35998264","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.","Myopathy-causing mutations in an HSP40 chaperone disrupt processing of specific client conformers.",2014,0.5,NA,"PMID","24920671","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","DNAJB6 myopathy in an Asian cohort and cytoplasmic/nuclear inclusions.","DNAJB6 myopathy in an Asian cohort and cytoplasmic/nuclear inclusions.",2013,0.5,NA,"PMID","23394708","Asian","HANCESTRO:0008",NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Severe early-onset obesity insulin resistance syndrome due to SH2B1 deficiency","[disease]","C5190989","Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Human SH2B1 mutations are associated with maladaptive behaviors and obesity.","Human SH2B1 mutations are associated with maladaptive behaviors and obesity.",2012,0.5,NA,"PMID","23160192","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","GENCC","CausalMutation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"MUCL3",135656,"ENSG00000168631","protein-coding",0.496,0.87,9.5384e-08,"Q3MIW9","","","Diffuse panbronchiolitis","[disease]","C0878555","Respiratory Tract Diseases (C08) | Infections (C01)","Disease or Syndrome (T047)","","","RGD_HUMAN","CausalOrContributing","Effect of diffuse panbronchiolitis critical region 1 polymorphisms on the risk of aspirin-exacerbated respiratory disease in Korean asthmatics.","Effect of diffuse panbronchiolitis critical region 1 polymorphisms on the risk of aspirin-exacerbated respiratory disease in Korean asthmatics.",2012,0.5,NA,"PMID","22152429","Korean","HANCESTRO:0022",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.5,NA,"PMID","26838787","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection.","Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection.",2019,0.5,NA,"PMID","31211624","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.",2021,0.5,NA,"PMID","32860008","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients.","Next-generation sequencing of 32 genes associated with hereditary aortopathies and related disorders of connective tissue in a cohort of 199 patients.",2019,0.5,NA,"PMID","30675029","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection.","Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection.",2018,0.5,NA,"PMID","30071989","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.","Complete loss of the DNAJB6 G/F domain and novel missense mutations cause distal-onset DNAJB6 myopathy.",2015,0.5,NA,"PMID","26205529","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.","Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.",2020,0.5,NA,"PMID","31792352","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3.","Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3.",2020,0.5,NA,"PMID","32006683","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Primary Biliary Cholangitis","[disease]","C0008312","Digestive System Diseases (C06) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the digestive system (25031)","RGD_HUMAN","CausalOrContributing","Upregulation of Lox and Loxl2 in hepatocytes of Wilson's disease and PBC patients may contribute to liver damage by various mechanisms.","Upregulation of <span class='gene' en_id='4015'>Lox</span> and Loxl2 in hepatocytes of Wilson's disease and <span class='disease' en_id='C0008312'>PBC</span> patients may contribute to liver damage by various mechanisms.",2005,0.5,NA,"PMID","16023247","","",NA,"Positive"
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Primary Biliary Cholangitis","[disease]","C0008312","Digestive System Diseases (C06) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the digestive system (25031)","RGD_HUMAN","CausalOrContributing","Upregulation of Lox and Loxl2 in hepatocytes of Wilson's disease and PBC patients may contribute to liver damage by various mechanisms.","Upregulation of Lox and <span class='gene' en_id='4017'>Loxl2</span> in hepatocytes of Wilson's disease and <span class='disease' en_id='C0008312'>PBC</span> patients may contribute to liver damage by various mechanisms.",2005,0.5,NA,"PMID","16023247","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Adenocarcinoma","[disease]","C0001418","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.","Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation.",2007,0.5,NA,"PMID","17671114","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Diarrhea","[phenotype]","C0011991","Pathological Conditions, Signs and Symptoms (C23)","Sign or Symptom (T184)","","Abnormality of the digestive system (25031)","CLINPGX","Pharmacogenomics","Genotype CC is associated with increased risk of Diarrhea when treated with cyclosporine and mycophenolate mofetil in people with Kidney Transplantation as compared to genotypes CG + GG.","Genotype CC is associated with increased risk of Diarrhea when treated with cyclosporine and mycophenolate mofetil in people with Kidney Transplantation as compared to genotypes CG + GG.",2010,0.5,NA,"PMID","20565459","","",NA,"Positive"
"VIPR2",7434,"ENSG00000106018","protein-coding",0.565,0.87,8.2204e-13,"P41587","DTO_02300001","G-protein coupled receptor","Bipolar Disorder","[disease]","C0005586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","PSYGENET","Biomarker","We examined 209 single-nucleotide polymorphisms (SNPs) covering 19 circadian genes (ADCYAP1, ARNTL, ARNTL2, BHLHB2, BHLHB3, CLOCK, CRY1, CRY2, CSNK1E, DBP, NPAS2, NR1D1, PER1, PER2, PER3, RORA, TIMELESS, VIP, and VIPR2) in a sample of 534 MD patients (335 with unipolar major mood depression (MDD) and 199 with bipolar disorder (BD)) and 440 community-based screened controls.","We examined 209 single-nucleotide polymorphisms (SNPs) covering 19 circadian genes (ADCYAP1, ARNTL, ARNTL2, BHLHB2, BHLHB3, CLOCK, CRY1, CRY2, CSNK1E, DBP, NPAS2, NR1D1, PER1, PER2, PER3, RORA, TIMELESS, VIP, and <span class='gene' en_id='7434'>VIPR2</span>) in a sample of 534 MD patients (335 with unipolar major mood depression (MDD) and 199 with <span class='disease' en_id='C0005586'>bipolar disorder</span> (<span class='disease' en_id='C0005586'>BD)</span>) and 440 community-based screened controls.",2010,0.5,NA,"PMID","20072116","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Familial Idiopathic","[disease]","C1449563","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","LMNA-Related Dilated Cardiomyopathy","LMNA-Related Dilated Cardiomyopathy",1993,0.5,NA,"PMID","20301717","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Familial Idiopathic","[disease]","C1449563","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation","LMNA-Related Dilated Cardiomyopathy","LMNA-Related Dilated Cardiomyopathy",1993,0.5,NA,"PMID","20301717","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","GENCC","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma 1, Open Angle, H","[disease]","C1969811","Eye Diseases (C11)","Disease or Syndrome (T047)","","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Functional importance of lysyl oxidase family propeptide regions.","Functional importance of lysyl oxidase family propeptide regions.",2018,0.5,NA,"PMID","29086201","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.5,NA,"PMID","27432961","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Loss-of-Function Variants in EFEMP1 Cause a Recognizable Connective Tissue Disorder Characterized by Cutis Laxa and Multiple Herniations.","Loss-of-Function Variants in EFEMP1 Cause a Recognizable Connective Tissue Disorder Characterized by Cutis Laxa and Multiple Herniations.",2021,0.5,NA,"PMID","33807164","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.","Biallelic variants in EFEMP1 in a man with a pronounced connective tissue phenotype.",2020,0.5,NA,"PMID","31792352","","",NA,NA
"NTM",50863,"ENSG00000182667","protein-coding",0.586,0.913,0.98694,"Q9P121","","","Unipolar Depression","[disease]","C0041696","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","PSYGENET","Biomarker","It has been reported that NTM might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and major depression.","It has been reported that <span class='gene' en_id='50863'>NTM</span> might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and <span class='disease' en_id='C0041696'>major depression</span>.",2011,0.5,NA,"PMID","21036197","","",NA,"Positive"
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Necrosis","[phenotype]","C0027540","Pathological Conditions, Signs and Symptoms (C23)","Pathologic Function (T046)","","","RGD_HUMAN","CausalOrContributing","Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation.","Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation.",2013,0.5,NA,"PMID","23211037","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Long QT Syndrome","[disease]","C0023976","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Hepatolenticular Degeneration","[disease]","C0019202","Digestive System Diseases (C06) | Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","RGD_HUMAN","CausalOrContributing","Upregulation of Lox and Loxl2 in hepatocytes of Wilson's disease and PBC patients may contribute to liver damage by various mechanisms.","Upregulation of <span class='gene' en_id='4015'>Lox</span> and Loxl2 in hepatocytes of <span class='disease' en_id='C0019202'>Wilson's disease</span> and PBC patients may contribute to liver damage by various mechanisms.",2005,0.5,NA,"PMID","16023247","","",NA,"Positive"
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Hepatolenticular Degeneration","[disease]","C0019202","Digestive System Diseases (C06) | Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","RGD_HUMAN","CausalOrContributing","Upregulation of Lox and Loxl2 in hepatocytes of Wilson's disease and PBC patients may contribute to liver damage by various mechanisms.","Upregulation of Lox and <span class='gene' en_id='4017'>Loxl2</span> in hepatocytes of <span class='disease' en_id='C0019202'>Wilson's disease</span> and PBC patients may contribute to liver damage by various mechanisms.",2005,0.5,NA,"PMID","16023247","","",NA,"Positive"
"ADARB2",105,"ENSG00000185736","protein-coding",0.62,0.87,0.0043883,"Q9NS39","DTO_05007624","Enzyme","Parkinson Disease","[disease]","C0030567","Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","We identified 13 common genes (ADARB2, CEACAM6, CNTNAP2, COL19A1, DEF4, DRAXIN, FCER2, HBG1, NCAPG2, PVRL2, SLC2A14, SNCA, and TCL1B) showing significant differential expression between G2019S-associated PD and asymptomatic carriers and also between idiopathic PD and controls but not between untreated and treated patients.","We identified 13 common genes (<span class='gene' en_id='105'>ADARB2</span>, CEACAM6, CNTNAP2, COL19A1, DEF4, DRAXIN, FCER2, HBG1, NCAPG2, PVRL2, SLC2A14, SNCA, and TCL1B) showing significant differential expression between G2019S-associated <span class='disease' en_id='C0030567'>PD</span> and asymptomatic carriers and also between idiopathic <span class='disease' en_id='C0030567'>PD</span> and controls but <span class='negation_marker' en_id=''>not</span> between untreated and treated patients.",2015,0.5,NA,"PMID","25475535","","",NA,"Negative"
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Arrhythmogenic Right Ventricular Dysplasia","[disease]","C0349788","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Severe early-onset obesity insulin resistance syndrome due to SH2B1 deficiency","[disease]","C5190989","Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","GENCC","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Severe early-onset obesity insulin resistance syndrome due to SH2B1 deficiency","[disease]","C5190989","Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.5,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.5,NA,"PMID","26838787","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Variants of Unknown Significance in Genes Associated with Heritable Thoracic Aortic Disease Can Be Low Penetrant ""Risk Variants"".","Variants of Unknown Significance in Genes Associated with Heritable Thoracic Aortic Disease Can Be Low Penetrant ""Risk Variants"".",2018,0.5,NA,"PMID","29961567","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.","Loss of function mutation in LOX causes thoracic aortic aneurysm and dissection in humans.",2016,0.5,NA,"PMID","27432961","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.","Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.",2021,0.5,NA,"PMID","34281165","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma 1, Open Angle, H","[disease]","C1969811","Eye Diseases (C11)","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.",2022,0.5,NA,"PMID","34923728","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Malignant neoplasm of ovary","[disease]","C1140680","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","GENCC","CausalOrContributing",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.","Mutations affecting the cytoplasmic functions of the co-chaperone DNAJB6 cause limb-girdle muscular dystrophy.",2012,0.5,NA,"PMID","22366786","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease.","Novel mutations in DNAJB6 gene cause a very severe early-onset limb-girdle muscular dystrophy 1D disease.",2015,0.5,NA,"PMID","26338452","","",NA,NA
"MAGI1",9223,"ENSG00000151276","protein-coding",0.586,0.913,0.85449,"Q96QZ7","","","MAJOR AFFECTIVE DISORDER 2","[disease]","C1839839","Mental Disorders (F03) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Mental or Behavioral Dysfunction (T048)","","","PSYGENET","Biomarker","Results presented herein provide further evidence for a role of MAGI1 and MAGI2 in BPAD and SZ etiology.","Results presented herein provide further evidence for a role of <span class='gene' en_id='9223'>MAGI1</span> and MAGI2 in <span class='disease' en_id='C1839839'>BPAD</span> and SZ etiology.",2012,0.5,NA,"PMID","22381734","","",NA,"Positive"
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A loss-of-function cysteine mutant in fibulin-3 (EFEMP1) forms aberrant extracellular disulfide-linked homodimers and alters extracellular matrix composition.","A loss-of-function cysteine mutant in fibulin-3 (EFEMP1) forms aberrant extracellular disulfide-linked homodimers and alters extracellular matrix composition.",2022,0.5,NA,"PMID","35998264","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Hepatitis C","[disease]","C0019196","Digestive System Diseases (C06) | Infections (C01)","Disease or Syndrome (T047)","disease by infectious agent (0050117) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.",2005,0.5,NA,"PMID","16023247","","",NA,NA
"MICA",100507436,"ENSG00000204520","protein-coding",0.405,0.913,0.0031713,"Q29983","","","Stevens-Johnson Syndrome","[disease]","C0038325","Immune System Diseases (C20) | Skin and Connective Tissue Diseases (C17) | Chemically-Induced Disorders (C25) | Stomatognathic Diseases (C07)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINPGX","Pharmacogenomics","Allele C is associated with increased risk of Stevens-Johnson Syndrome when treated with carbamazepine as compared to allele G.","Allele C is associated with increased risk of Stevens-Johnson Syndrome when treated with carbamazepine as compared to allele G.",2006,0.5,NA,"PMID","16538176","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma 1, Open Angle, H","[disease]","C1969811","Eye Diseases (C11)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma 1, Open Angle, H","[disease]","C1969811","Eye Diseases (C11)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma 1, Open Angle, H","[disease]","C1969811","Eye Diseases (C11)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.","Exome Sequencing Identifies a Missense Variant in EFEMP1 Co-Segregating in a Family with Autosomal Dominant Primary Open-Angle Glaucoma.",2015,0.5,NA,"PMID","26162006","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.","Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice.",2002,0.5,NA,"PMID","12417550","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.5,NA,"PMID","26838787","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Alternative promoter activation leads to the expression of a novel human lysyl oxidase variant that functions as an amine oxidase.","Alternative promoter activation leads to the expression of a novel human lysyl oxidase variant that functions as an amine oxidase.",2014,0.5,NA,"PMID","25017124","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.","Novel LOX Variants in Five Families with Aortic/Arterial Aneurysm and Dissection with Variable Connective Tissue Findings.",2021,0.5,NA,"PMID","34281165","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","AORTIC ANEURYSM, FAMILIAL THORACIC 10","[disease]","C4284414","","Disease or Syndrome (T047)","","","GENCC","CausalMutation","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.","LOX Mutations Predispose to Thoracic Aortic Aneurysms and Dissections.",2016,0.5,NA,"PMID","26838787","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3.","Recessive marfanoid syndrome with herniation associated with a homozygous mutation in Fibulin-3.",2020,0.5,NA,"PMID","32006683","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","UNIPROT","CausalMutation","Loss-of-Function Variants in EFEMP1 Cause a Recognizable Connective Tissue Disorder Characterized by Cutis Laxa and Multiple Herniations.","Loss-of-Function Variants in EFEMP1 Cause a Recognizable Connective Tissue Disorder Characterized by Cutis Laxa and Multiple Herniations.",2021,0.5,NA,"PMID","33807164","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE ID","[disease]","C5935602","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Marfanoid habitus, inguinal hernia, advanced bone age, and distinctive facial features: a new collagenopathy?","Marfanoid habitus, inguinal hernia, advanced bone age, and distinctive facial features: a new collagenopathy?",2012,0.5,NA,"PMID","22489068","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Muscle Weakness","[phenotype]","C0151786","Musculoskeletal Diseases (C05) | Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Sign or Symptom (T184)","","Abnormality of the musculoskeletal system (33127)","CLINVAR","GeneticVariation",NA,NA,NA,0.5,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Autosomal dominant limb girdle muscular dystrophy","[disease]","C5675009","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINGEN","CausalMutation","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.","Exome sequencing reveals DNAJB6 mutations in dominantly-inherited myopathy.",2012,0.5,NA,"PMID","22334415","","",NA,NA
"NTM",50863,"ENSG00000182667","protein-coding",0.586,0.913,0.98694,"Q9P121","","","Major Depressive Disorder","[disease]","C1269683","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","PSYGENET","Biomarker","It has been reported that NTM might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and major depression.","It has been reported that <span class='gene' en_id='50863'>NTM</span> might play a role in late-onset Alzheimer disease while NR3C2 may be associated with cognitive function and <span class='disease' en_id='C1269683'>major depression</span>.",2011,0.5,NA,"PMID","21036197","","",NA,"Positive"
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Oral submucosal fibrosis, including of tongue","[disease]","C0029171","","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Oral submucous fibrosis: review on aetiology and pathogenesis.","Oral submucous fibrosis: review on aetiology and pathogenesis.",2006,0.5,NA,"PMID","16311067","","",NA,NA
"FAM83D",81610,"ENSG00000101447","protein-coding",0.658,0.478,3.3088e-11,"Q9H4H8","","","Glioblastoma","[disease]","C0017636","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","The re-expression of β-catenin reversed FAM83D-silencing-induced antitumor effects in GBM cells.","The re-expression of β-catenin reversed <span class='gene' en_id='81610'>FAM83D</span>-silencing-induced antitumor effects in <span class='disease' en_id='C0017636,C1621958'>GBM</span> cells.",2022,0.5,NA,"PMID","35150198","","",NA,"Positive"
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Periventricular Heterotopia, X-Linked","[disease]","C1848213","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Advanced bone age","[phenotype]","C0545053","","Finding (T033)","","Abnormality of the musculoskeletal system (33127)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Tall stature","[phenotype]","C0241240","","Finding (T033)","","Growth abnormality (01507)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Lower eyelid ectropion","[disease]","C0521736","Eye Diseases (C11)","Disease or Syndrome (T047)","","Abnormality of head or neck (00152)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Precursor Lymphoid Neoplasm","[disease]","C1335469","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Nyctalopia","[disease]","C0028077","Eye Diseases (C11)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Chronic paranoid schizophrenia","[disease]","C0270398","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"HCP5",10866,"ENSG00000206337","ncRNA",0.432,0.87,NA,"","","","Thrombocytopenia","[disease]","C0040034","Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of blood and blood-forming tissues (01871)","CLINPGX","Pharmacogenomics","Allele G is associated with increased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.","Allele G is associated with increased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele A.",2021,0.45,NA,"PMID","31616045","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","DiGeorge Syndrome","[disease]","C0012236","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Endocrine System Diseases (C19) | Musculoskeletal Diseases (C05) | Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","ORPHANET","GermlineModifyingMutation","Histone Modifier Genes Alter Conotruncal Heart Phenotypes in 22q11.2 Deletion Syndrome.","Histone Modifier Genes Alter Conotruncal Heart Phenotypes in 22q11.2 Deletion Syndrome.",2015,0.45,NA,"PMID","26608785","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.45,NA,"PMID","11370628","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.45,NA,"PMID","7565971","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.45,NA,"PMID","1692835","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.45,NA,"PMID","19830808","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms.","Structure of human succinic semialdehyde dehydrogenase gene: identification of promoter region and alternatively processed isoforms.",2002,0.45,NA,"PMID","12208142","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.45,NA,"PMID","8514037","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.45,NA,"PMID","23875061","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.45,NA,"PMID","11370628","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.",1995,0.45,NA,"PMID","8528206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.45,NA,"PMID","9621515","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.45,NA,"PMID","19830808","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.45,NA,"PMID","26467199","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.",2011,0.45,NA,"PMID","21342357","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.","Gilbert and Crigler Najjar syndromes: an update of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene mutation database.",2013,0.45,NA,"PMID","23403257","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.45,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.45,NA,"PMID","25200497","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.",1999,0.45,NA,"PMID","10412811","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.45,NA,"PMID","10190918","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.45,NA,"PMID","9653159","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.45,NA,"PMID","11061796","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.45,NA,"PMID","11906189","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.",2011,0.45,NA,"PMID","21272068","Chinese","HANCESTRO:0021",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma of childhood","[disease]","C2981140","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Dural ectasia","[phenotype]","C1851712","","Finding (T033)","","Abnormality of the nervous system (00707)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Prostatic Neoplasms","[disease]","C0033578","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Neurodevelopmental Disorders","[disease]","C1535926","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","GENCC","GeneticVariation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Periventricular Heterotopia, X-Linked","[disease]","C1848213","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.","Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia.",2016,0.45,NA,"PMID","27694961","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Congenital hernia of foramen of Bochdalek","[disease]","C0265700","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Pathological Conditions, Signs and Symptoms (C23)","Congenital Abnormality (T019)","","","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Bulla of lung","[disease]","C0241982","Respiratory Tract Diseases (C08) | Pathological Conditions, Signs and Symptoms (C23)","Anatomical Abnormality (T190)","","","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"MUCL3",135656,"ENSG00000168631","protein-coding",0.496,0.87,9.5384e-08,"Q3MIW9","","","Thrombocytopenia","[disease]","C0040034","Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of blood and blood-forming tissues (01871)","CLINPGX","Pharmacogenomics","Allele A is associated with increased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.","Allele A is associated with increased severity of Thrombocytopenia when treated with carboplatin and gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to allele G.",2021,0.45,NA,"PMID","31616045","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.45,NA,"PMID","28520360","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.45,NA,"PMID","9497253","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.45,NA,"PMID","9435989","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.45,NA,"PMID","9435989","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.",2015,0.45,NA,"PMID","26716871","Indian","HANCESTRO:0487",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.",2016,0.45,NA,"PMID","26727668","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.45,NA,"PMID","16114182","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1A1 haplotype mutation among Asians in Singapore.","UGT1A1 haplotype mutation among Asians in Singapore.",2009,0.45,NA,"PMID","19325249","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.45,NA,"PMID","18004206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.45,NA,"PMID","12859413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Evaluation of mutation effects on UGT1A1 activity toward 17beta-estradiol using liquid chromatography-tandem mass spectrometry.","Evaluation of mutation effects on UGT1A1 activity toward 17beta-estradiol using liquid chromatography-tandem mass spectrometry.",2006,0.45,NA,"PMID","16504606","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.45,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.45,NA,"PMID","26467199","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Long narrow head","[disease]","C0221358","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Musculoskeletal Diseases (C05)","Congenital Abnormality (T019)","","Abnormality of head or neck (00152) | Abnormality of the musculoskeletal system (33127)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Bladder Diverticulum","[disease]","C0156273","Digestive System Diseases (C06) | Pathological Conditions, Signs and Symptoms (C23)","Anatomical Abnormality (T190)","disease of anatomical entity (7)","Abnormality of the genitourinary system (00119)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Comprehensive evaluation of the child with intellectual disability or global developmental delays.","Comprehensive evaluation of the child with intellectual disability or global developmental delays.",2014,0.45,NA,"PMID","25157020","","",NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","Other sphingolipidosis","[disease]","C0348489","Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7) | disease of metabolism (0014667) | syndrome (225)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Neurodevelopmental Disorders","[disease]","C1535926","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma of childhood","[disease]","C2981140","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","Autosomal recessive non-syndromic intellectual disability","[disease]","C5680181","","Disease or Syndrome (T047)","genetic disease (630) | disease of mental health (150)","","GENCC","GeneticVariation","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.",2019,0.45,NA,"PMID","31607425","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Juvenile Myelomonocytic Leukemia","[disease]","C0349639","Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of blood and blood-forming tissues (01871) | Abnormality of the immune system (02715) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","The genomic landscape of juvenile myelomonocytic leukemia.","The genomic landscape of juvenile myelomonocytic leukemia.",2015,0.45,NA,"PMID","26457647","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","DiGeorge Syndrome","[disease]","C0012236","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Endocrine System Diseases (C19) | Musculoskeletal Diseases (C05) | Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","GENCC","GeneticVariation","Histone Modifier Genes Alter Conotruncal Heart Phenotypes in 22q11.2 Deletion Syndrome.","Histone Modifier Genes Alter Conotruncal Heart Phenotypes in 22q11.2 Deletion Syndrome.",2015,0.45,NA,"PMID","26608785","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Prostatic Neoplasms","[disease]","C0033578","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.45,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.",2012,0.45,NA,"PMID","22983686","Chinese,Tibetan,Han in China (HGDP)","HANCESTRO:0021,HANCESTRO:0582,HANCESTRO:0715",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.45,NA,"PMID","20975617","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.",2021,0.45,NA,"PMID","32860008","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.45,NA,"PMID","12402338","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].",2016,0.45,NA,"PMID","27264814","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.",1999,0.45,NA,"PMID","9929972","Japanese","HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.","Neonatal hyperbilirubinemia and Gly71Arg mutation of UGT1A1 gene: a Chinese case-control study followed by systematic review of existing evidence.",2011,0.45,NA,"PMID","21272068","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.",2012,0.45,NA,"PMID","22325916","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.45,NA,"PMID","15372086","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.45,NA,"PMID","11425418","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.",2003,0.45,NA,"PMID","14616765","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.45,NA,"PMID","20975617","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.45,NA,"PMID","9342374","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.45,NA,"PMID","9375768","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Generalized hypotonia","[phenotype]","C1858120","Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Finding (T033)","","Abnormality of the musculoskeletal system (33127)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","Asthenozoospermia (finding)","[phenotype]","C4082176","","Finding (T033)","","Abnormality of the genitourinary system (00119)","CLINVAR","CausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.45,NA,"PMID","30929735","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E","[disease]","C3148763","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Severe myopia","[disease]","C0271183","Eye Diseases (C11)","Disease or Syndrome (T047)","","Abnormality of the eye (00478)","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","Autosomal recessive non-syndromic intellectual disability","[disease]","C5680181","","Disease or Syndrome (T047)","genetic disease (630) | disease of mental health (150)","","ORPHANET","GermlineCausalMutation","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.","Bi-allelic Variants in IQSEC1 Cause Intellectual Disability, Developmental Delay, and Short Stature.",2019,0.45,NA,"PMID","31607425","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.45,NA,"PMID","28520360","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.","Association of neonatal hyperbilirubinemia with uridine diphosphate-glucuronosyltransferase 1A1 gene polymorphisms: meta-analysis.",2011,0.45,NA,"PMID","21342357","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.",2013,0.45,NA,"PMID","23014115","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.","Successful application of genome sequencing in a diagnostic setting: 1007 index cases from a clinically heterogeneous cohort.",2021,0.45,NA,"PMID","32860008","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes.","Analysis of the UDP-glucuronosyltransferase gene in Portuguese patients with a clinical diagnosis of Gilbert and Crigler-Najjar syndromes.",2006,0.45,NA,"PMID","16269258","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.",2013,0.45,NA,"PMID","24390994","Han Chinese,Chinese,Tibetan","HANCESTRO:0027,HANCESTRO:0021,HANCESTRO:0582",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].","[Genetic analysis of a child affected with Crigler-Najjar syndrome type II].",2016,0.45,NA,"PMID","27264814","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.45,NA,"PMID","11906189","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.45,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.45,NA,"PMID","9639672","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.45,NA,"PMID","11003624","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.45,NA,"PMID","15857854","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.",2013,0.45,NA,"PMID","23997956","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.",1999,0.45,NA,"PMID","10472535","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.45,NA,"PMID","9630669","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.45,NA,"PMID","10968441","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.45,NA,"PMID","11003624","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.45,NA,"PMID","9639672","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.45,NA,"PMID","25200497","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.",2013,0.45,NA,"PMID","23290513","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.45,NA,"PMID","12850492","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Aortic Valve Insufficiency","[disease]","C0003504","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.","Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.",2011,0.45,NA,"PMID","21216836","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Generalized arterial tortuosity","[phenotype]","C1836651","","Finding (T033)","","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"RARS1",5917,"ENSG00000113643","protein-coding",0.575,0.87,1.1477e-16,"P54136","","","Other sphingolipidosis","[disease]","C0348489","Nutritional and Metabolic Diseases (C18)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7) | disease of metabolism (0014667) | syndrome (225)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E","[disease]","C3148763","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Lymphoid neoplasm (morphologic abnormality)","[disease]","C0598798","Immune System Diseases (C20) | Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Precursor Lymphoid Neoplasm","[disease]","C1335469","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Glaucoma of childhood","[disease]","C2981140","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the eye (00478)","ORPHANET","GermlineCausalMutation","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.","EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.",2022,0.45,NA,"PMID","34923728","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Neurodevelopmental Disorders","[disease]","C1535926","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","CLINVAR","GeneticVariation","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.",2016,0.45,NA,"PMID","26181491","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Neurodevelopmental Disorders","[disease]","C1535926","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","CLINVAR","GeneticVariation","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.",2020,0.45,NA,"PMID","31954878","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).","Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).",2021,0.45,NA,"PMID","34211152","American","HANCESTRO:0463",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).",2021,0.45,NA,"PMID","34131312","American","HANCESTRO:0463",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.","Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.",2011,0.45,NA,"PMID","21956720","American","HANCESTRO:0463",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Paranoid Schizophrenia","[disease]","C0036349","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.45,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.45,NA,"PMID","12181437","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.45,NA,"PMID","12181437","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.",1998,0.45,NA,"PMID","9784835","Japanese,Korean,Chinese","HANCESTRO:0019,HANCESTRO:0022,HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.45,NA,"PMID","7565971","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.","Clinical Significance of UGT1A1 Genetic Analysis in Chinese Neonates with Severe Hyperbilirubinemia.",2016,0.45,NA,"PMID","26727668","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.",1993,0.45,NA,"PMID","8276413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.45,NA,"PMID","18004206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","CausalMutation","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.",1995,0.45,NA,"PMID","8528206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.",1984,0.45,NA,"PMID","6480579","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.45,NA,"PMID","9630669","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.",2006,0.45,NA,"PMID","16610035","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.45,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.45,NA,"PMID","17496722","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.45,NA,"PMID","9446675","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Gilbert Disease","[disease]","C0017551","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of metabolism (0014667)","","CLINVAR","GeneticVariation","Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article.","Exome-Wide Association Study Identifies New Low-Frequency and Rare UGT1A1 Coding Variants and UGT1A6 Coding Variants Influencing Serum Bilirubin in Elderly Subjects: A Strobe Compliant Article.",2015,0.45,NA,"PMID","26039129","","",NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Proximal 16p11.2 microdeletion syndrome (disorder)","[disease]","C4273657","Mental Disorders (F03) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Behavior and Behavior Mechanisms (F01) | Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630)","","ORPHANET","ChromosomalRearrangement",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Ventricular Fibrillation, Paroxysmal Familial, 1","[disease]","C2751898","Cardiovascular Diseases (C14) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Heterotopia, Periventricular, Associated With Chromosome 5q Deletion","[disease]","C2752071","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.4,NA,"PMID","28520360","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Hereditary Prostate Carcinoma","[disease]","C4722328","","Neoplastic Process (T191)","","","GENCC","GeneticVariation","Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.","Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.",2022,0.4,NA,"PMID","36322655","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.","Evidence report: Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.",2011,0.4,NA,"PMID","21956720","American","HANCESTRO:0463",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).",2021,0.4,NA,"PMID","34131312","American","HANCESTRO:0463",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Adenocarcinoma of colon","[disease]","C0338106","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the digestive system (25031) | Neoplasm (02664)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial or idiopathic dilated cardiomyopathy","[disease]","C5679590","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Dilated Cardiomyopathy Overview","Dilated Cardiomyopathy Overview",1993,0.4,NA,"PMID","20301486","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Prostate cancer, familial","[disease]","C2931456","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","","","RGD_HUMAN","CausalOrContributing","Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.","Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.",2018,0.4,NA,"PMID","29892016","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.",2003,0.4,NA,"PMID","12485959","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.",2006,0.4,NA,"PMID","16610035","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.4,NA,"PMID","12859413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.4,NA,"PMID","9653159","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.4,NA,"PMID","26467199","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2002,0.4,NA,"PMID","11983459","European","HANCESTRO:0005",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.",1993,0.4,NA,"PMID","8276413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.",1995,0.4,NA,"PMID","8528206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8280139","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome.","Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome.",2007,0.4,NA,"PMID","18058623","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.4,NA,"PMID","9435989","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.4,NA,"PMID","9342374","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.",2015,0.4,NA,"PMID","25993113","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.",2017,0.4,NA,"PMID","29137095","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.4,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.",2006,0.4,NA,"PMID","16610035","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.4,NA,"PMID","15372086","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2000,0.4,NA,"PMID","11182932","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8280139","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.","Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.",2000,0.4,NA,"PMID","11013440","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Two unrelated patients with rare Crigler-Najjar syndrome type I: two novel mutations and a patient with loss of heterozygosity of UGT1A1 gene.","Two unrelated patients with rare Crigler-Najjar syndrome type I: two novel mutations and a patient with loss of heterozygosity of UGT1A1 gene.",2014,0.4,NA,"PMID","24793765","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.4,NA,"PMID","19830808","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia.","Seven novel mutations of the UGT1A1 gene in patients with unconjugated hyperbilirubinemia.",2007,0.4,NA,"PMID","17229650","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","ovarian neoplasm","[disease]","C0919267","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","CausalMutation","National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.","National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.",2008,0.4,NA,"PMID","19042984","","",NA,NA
"PRMT5",10419,"ENSG00000100462","protein-coding",0.486,0.87,1,"O14744","DTO_05007378","Epigenetic regulator","Localized Primitive Neuroectodermal Tumor","[disease]","C1334410","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma.","Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma.",2019,0.4,NA,"PMID","31694585","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.4,NA,"PMID","12402338","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.4,NA,"PMID","17496722","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.4,NA,"PMID","12850492","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8514037","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.4,NA,"PMID","10190918","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.",1998,0.4,NA,"PMID","9784835","Japanese,Korean,Chinese","HANCESTRO:0019,HANCESTRO:0022,HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Pleural effusion (disorder)","[phenotype]","C0032227","Respiratory Tract Diseases (C08)","Pathologic Function (T046)","","Abnormality of metabolism/homeostasis (01939) | Abnormality of the respiratory system (02086)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Optic Atrophy","[disease]","C0029124","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Optic Disk Drusen","[disease]","C0029128","Eye Diseases (C11) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","GILBERT SYNDROME, SUSCEPTIBILITY TO","[phenotype]","C4016425","","Finding (T033)","","","CLINVAR","SusceptibilityMutation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory Autonomic Neuropathy, Type 1","[disease]","C0020071","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.4,NA,"PMID","19838196","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Malignant neoplasm of body of pancreas","[disease]","C0153459","Digestive System Diseases (C06) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.",2009,0.4,NA,"PMID","19208748","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Congenital aneurysm of ascending aorta","[disease]","C0345050","Cardiovascular Diseases (C14)","Congenital Abnormality (T019)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Hepatoblastoma","[disease]","C0206624","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Neoplasm (02664) | Abnormality of the digestive system (25031)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","Adenocarcinoma of lung (disorder)","[disease]","C0152013","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Neoplasm (02664) | Abnormality of the respiratory system (02086)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Congenital anomaly of face","[disease]","C0266617","Musculoskeletal Diseases (C05) | Urogenital Diseases (C12) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Congenital Abnormality (T019)","","Abnormality of head or neck (00152)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Lymphedema distichiasis syndrome","[disease]","C0265345","Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Juvenile Chronic Polyarthritis","[disease]","C0409667","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Prenatal Injuries","[disease]","C0086468","Urogenital Diseases (C12)","Injury or Poisoning (T037)","","","RGD_HUMAN","CausalOrContributing","Dithiocarbamates are teratogenic to developing zebrafish through inhibition of lysyl oxidase activity.","Dithiocarbamates are teratogenic to developing zebrafish through inhibition of lysyl oxidase activity.",2010,0.4,NA,"PMID","20045017","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Meniere Disease","[disease]","C0025281","Otorhinolaryngologic Diseases (C09)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.4,NA,"PMID","19830808","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.4,NA,"PMID","15857854","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.",2012,0.4,NA,"PMID","22983686","Chinese,Tibetan,Han in China (HGDP)","HANCESTRO:0021,HANCESTRO:0582,HANCESTRO:0715",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.4,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.",1998,0.4,NA,"PMID","9784835","Japanese,Korean,Chinese","HANCESTRO:0019,HANCESTRO:0022,HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.4,NA,"PMID","23875061","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.4,NA,"PMID","17496722","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8514037","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.4,NA,"PMID","11425418","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.4,NA,"PMID","25200497","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.4,NA,"PMID","15857854","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.4,NA,"PMID","12859413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.4,NA,"PMID","9653159","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.4,NA,"PMID","16114182","","",NA,NA
"ADARB2",105,"ENSG00000185736","protein-coding",0.62,0.87,0.0043883,"Q9NS39","DTO_05007624","Enzyme","Colorectal Carcinoma","[disease]","C0009402","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","UNIPROT","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Proximal muscle weakness","[phenotype]","C0221629","Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10) | Musculoskeletal Diseases (C05)","Finding (T033)","","Abnormality of the musculoskeletal system (33127)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Monoarticular juvenile rheumatoid arthritis","[disease]","C0157918","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Monoarticular juvenile rheumatoid arthritis","[disease]","C0157918","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.",2020,0.4,NA,"PMID","31954878","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Silicosis","[disease]","C0037116","Respiratory Tract Diseases (C08)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Cuproptosis-associated hub gene identification and immune cell infiltration patterns in silicosis.","Cuproptosis-associated hub gene identification and immune cell infiltration patterns in silicosis.",2024,0.4,NA,"PMID","38403151","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.",2015,0.4,NA,"PMID","26697581","Iranian","HANCESTRO:0438",NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Distal 16p11.2 microdeletion syndrome","[disease]","C4518824","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630)","","ORPHANET","ChromosomalRearrangement",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","ARTERIAL TORTUOSITY SYNDROME","[disease]","C1859726","Musculoskeletal Diseases (C05) | Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","ARTERIAL TORTUOSITY SYNDROME","[disease]","C1859726","Musculoskeletal Diseases (C05) | Cardiovascular Diseases (C14) | Skin and Connective Tissue Diseases (C17) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","Abnormality of the musculature","[disease]","C4021745","","Anatomical Abnormality (T190)","","Abnormality of the musculoskeletal system (33127)","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Comprehensive evaluation of the child with intellectual disability or global developmental delays.","Comprehensive evaluation of the child with intellectual disability or global developmental delays.",2014,0.4,NA,"PMID","25157020","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","Developmental Disabilities","[disease]","C0008073","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","Abnormal peripheral nervous system morphology","[disease]","C4025831","","Anatomical Abnormality (T190)","","Abnormality of the nervous system (00707)","CLINPGX","Pharmacogenomics","Allele G is associated with increased likelihood of Peripheral Nervous System Diseases when treated with cyclophosphamide, epirubicin and paclitaxel in women with Breast Neoplasms as compared to allele A.","Allele G is associated with increased likelihood of Peripheral Nervous System Diseases when treated with cyclophosphamide, epirubicin and paclitaxel in women with Breast Neoplasms as compared to allele A.",2015,0.4,NA,"PMID","24599932","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","Rare genetic premature ovarian failure","[disease]","C5925042","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.","UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.",2018,0.4,NA,"PMID","30544479","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","What is Gilbert's syndrome? Lesson from genetic polymorphisms of UGT1A1 in Gilbert's syndrome from Asia.","What is Gilbert's syndrome? Lesson from genetic polymorphisms of UGT1A1 in Gilbert's syndrome from Asia.",2004,0.4,NA,"PMID","15304109","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient.","Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient.",1995,0.4,NA,"PMID","7852413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.",2006,0.4,NA,"PMID","16610035","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.",2016,0.4,NA,"PMID","26250421","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.4,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.",1984,0.4,NA,"PMID","6480579","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.",2017,0.4,NA,"PMID","29137095","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.4,NA,"PMID","15372086","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).",2008,0.4,NA,"PMID","18816295","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.4,NA,"PMID","9375768","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.","Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.",1995,0.4,NA,"PMID","7715297","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2002,0.4,NA,"PMID","11983459","European","HANCESTRO:0005",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.",2016,0.4,NA,"PMID","26250421","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.4,NA,"PMID","9639672","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.4,NA,"PMID","9435989","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.4,NA,"PMID","10968441","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.4,NA,"PMID","9446675","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.",2015,0.4,NA,"PMID","25993113","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2002,0.4,NA,"PMID","11983459","European","HANCESTRO:0005",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.4,NA,"PMID","11425418","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9630669","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.4,NA,"PMID","15857854","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.4,NA,"PMID","16114182","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.4,NA,"PMID","12181437","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.","Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase.",1995,0.4,NA,"PMID","8528206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.","UGT1A1 genotypes and unconjugated hyperbilirubinemia phenotypes in post-neonatal Chinese children: A retrospective analysis and quantitative correlation.",2018,0.4,NA,"PMID","30544479","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.","A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.",1996,0.4,NA,"PMID","8706880","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II in a caucasian patient resulting from two mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2002,0.4,NA,"PMID","11983459","European","HANCESTRO:0005",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Retinal pigment epithelial atrophy","[phenotype]","C1840457","","Finding (T033)","","Abnormality of the eye (00478)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","CARDIOMYOPATHY, DILATED, 1S","[disease]","C1834481","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","Oligospermia","[disease]","C0028960","Urogenital Diseases (C12)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","CausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.4,NA,"PMID","30929735","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.4,NA,"PMID","9375768","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.4,NA,"PMID","12859413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.4,NA,"PMID","11425418","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.4,NA,"PMID","9446675","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.4,NA,"PMID","9342374","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.4,NA,"PMID","10190918","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Genome-wide association meta-analysis for total serum bilirubin levels.","Genome-wide association meta-analysis for total serum bilirubin levels.",2009,0.4,NA,"PMID","19414484","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.4,NA,"PMID","12859413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.4,NA,"PMID","16114182","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.",1999,0.4,NA,"PMID","10412811","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.4,NA,"PMID","10968441","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.4,NA,"PMID","9446675","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Genome-wide association meta-analysis for total serum bilirubin levels.","Genome-wide association meta-analysis for total serum bilirubin levels.",2009,0.4,NA,"PMID","19414484","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","PARKINSON DISEASE, LATE-ONSET","[disease]","C3160718","","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","EFNS guidelines on diagnosis and treatment of primary dystonias.","EFNS guidelines on diagnosis and treatment of primary dystonias.",2011,0.4,NA,"PMID","20482602","","",NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","Gonadal Dysgenesis, 46,XX","[disease]","C0949595","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Congenital Abnormality (T019)","genetic disease (630) | disease of anatomical entity (7)","","ORPHANET","GermlineCausalMutation","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.",2017,0.4,NA,"PMID","27967308","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Asbestos-Related Malignant Mesothelioma","[disease]","C1332338","Respiratory Tract Diseases (C08) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.",2016,0.4,NA,"PMID","27032653","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","DISSECTION, AORTIC ACUTE","[disease]","C0241868","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Diffuse malignant mesothelioma","[disease]","C0392400","Neoplasms (C04) | Respiratory Tract Diseases (C08)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.",2016,0.4,NA,"PMID","27032653","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","ovarian neoplasm","[disease]","C0919267","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","CausalMutation","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.",2019,0.4,NA,"PMID","31130282","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","GILBERT SYNDROME, SUSCEPTIBILITY TO","[phenotype]","C4016425","","Finding (T033)","","","CLINVAR","SusceptibilityMutation","Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome.","Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome.",2004,0.4,NA,"PMID","15378351","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Increased bilirubin level (finding)","[phenotype]","C0311468","","Finding (T033)","","Abnormality of metabolism/homeostasis (01939)","CLINVAR","GeneticVariation","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.",2008,0.4,NA,"PMID","18414213","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.",2013,0.4,NA,"PMID","23997956","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.4,NA,"PMID","23875061","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2000,0.4,NA,"PMID","11182932","","",NA,NA
"PRMT5",10419,"ENSG00000100462","protein-coding",0.486,0.87,1,"O14744","DTO_05007378","Epigenetic regulator","Neuroectodermal Tumor, Primitive","[disease]","C0206663","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma.","Role of protein arginine methyltransferase 5 in group 3 (MYC-driven) Medulloblastoma.",2019,0.4,NA,"PMID","31694585","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Sensory Neuropathy, Hereditary","[disease]","C0699739","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.4,NA,"PMID","19838196","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Pyloric Stenosis","[phenotype]","C0034194","Digestive System Diseases (C06)","Pathologic Function (T046)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.4,NA,"PMID","19830808","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.4,NA,"PMID","23875061","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Molecular analysis of patients of Sardinian descent with Crigler-Najjar syndrome type I.","Molecular analysis of patients of Sardinian descent with Crigler-Najjar syndrome type I.",1997,0.4,NA,"PMID","9039987","Sardinian","HANCESTRO:0309",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.4,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.4,NA,"PMID","20975617","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.","Cosegregation of intragenic markers with a novel mutation that causes Crigler-Najjar syndrome type I: implication in carrier detection and prenatal diagnosis.",1993,0.4,NA,"PMID","8102509","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2000,0.4,NA,"PMID","11182932","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Mitral and aortic incompetence","[disease]","C0264774","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.","Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.",2011,0.4,NA,"PMID","21216836","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","Lung Neoplasms","[disease]","C0024121","Respiratory Tract Diseases (C08) | Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","Neoplasm (02664) | Abnormality of the respiratory system (02086)","RGD_HUMAN","CausalOrContributing","Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.","Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.",2017,0.4,NA,"PMID","27935865","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Juvenile Chronic Polyarthritis","[disease]","C0409667","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","Desbuquois syndrome","[disease]","C0432242","Endocrine System Diseases (C19) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Pathological Conditions, Signs and Symptoms (C23) | Musculoskeletal Diseases (C05)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","malignant neoplasm of head of pancreas","[disease]","C0153458","Digestive System Diseases (C06) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.",2009,0.4,NA,"PMID","19208748","","",NA,NA
"ADARB2",105,"ENSG00000185736","protein-coding",0.62,0.87,0.0043883,"Q9NS39","DTO_05007624","Enzyme","Substance-Related Disorders","[disease]","C0236969","Mental Disorders (F03) | Chemically-Induced Disorders (C25)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","RGD_HUMAN","CausalOrContributing","Genome wide association for addiction: replicated results and comparisons of two analytic approaches.","Genome wide association for addiction: replicated results and comparisons of two analytic approaches.",2010,0.4,NA,"PMID","20098672","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary sensory neuropathy of Denny-Brown","[disease]","C0086405","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.4,NA,"PMID","19838196","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Patterns and rates of exonic de novo mutations in autism spectrum disorders.","Patterns and rates of exonic de novo mutations in autism spectrum disorders.",2012,0.4,NA,"PMID","22495311","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Spastic Paraplegia, Hereditary","[disease]","C0037773","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Hereditary Spastic Paraplegia Overview","Hereditary Spastic Paraplegia Overview",1993,0.4,NA,"PMID","20301682","","",NA,NA
"HCP5",10866,"ENSG00000206337","ncRNA",0.432,0.87,NA,"","","","Drug Allergy","[phenotype]","C0013182","Chemically-Induced Disorders (C25)","Pathologic Function (T046)","","","CLINPGX","Pharmacogenomics","Allele G is associated with increased likelihood of Drug Hypersensitivity in healthy individuals as compared to allele T.","Allele G is associated with increased likelihood of Drug Hypersensitivity in healthy individuals as compared to allele T.",2015,0.4,NA,"PMID","26083016","","",NA,NA
"MAGI1",9223,"ENSG00000151276","protein-coding",0.586,0.913,0.85449,"Q96QZ7","","","Adenoid Cystic Carcinoma","[disease]","C0010606","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","The mutational landscape of adenoid cystic carcinoma.","The mutational landscape of adenoid cystic carcinoma.",2013,0.4,NA,"PMID","23685749","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Hepatitis B","[disease]","C0019163","Digestive System Diseases (C06) | Infections (C01)","Disease or Syndrome (T047)","disease by infectious agent (0050117) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.",2005,0.4,NA,"PMID","16023247","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Neoplasm Invasiveness","[phenotype]","C0027626","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23)","Pathologic Function (T046)","","","RGD_HUMAN","CausalOrContributing","MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.","MCF-7 cells expressing nuclear associated lysyl oxidase-like 2 (LOXL2) exhibit an epithelial-to-mesenchymal transition (EMT) phenotype and are highly invasive in vitro.",2013,0.4,NA,"PMID","24014025","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.",2013,0.4,NA,"PMID","24390994","Han Chinese,Chinese,Tibetan","HANCESTRO:0027,HANCESTRO:0021,HANCESTRO:0582",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.",1999,0.4,NA,"PMID","10412811","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.",2013,0.4,NA,"PMID","23290513","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.",2015,0.4,NA,"PMID","26716871","Indian","HANCESTRO:0487",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.4,NA,"PMID","12850492","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.",1999,0.4,NA,"PMID","10472535","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.","Identification of Promotor and Exonic Variations, and Functional Characterization of a Splice Site Mutation in Indian Patients with Unconjugated Hyperbilirubinemia.",2015,0.4,NA,"PMID","26716871","Indian","HANCESTRO:0487",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.4,NA,"PMID","17496722","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.","Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.",2012,0.4,NA,"PMID","22983686","Chinese,Tibetan,Han in China (HGDP)","HANCESTRO:0021,HANCESTRO:0582,HANCESTRO:0715",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.4,NA,"PMID","9446675","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.","Meta-analysis diagnostic accuracy of SNP-based pathogenicity detection tools: a case of UTG1A1 gene mutations.",2013,0.4,NA,"PMID","23875061","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.",1999,0.4,NA,"PMID","10472535","Asian","HANCESTRO:0008",NA,NA
"COPS3",8533,"ENSG00000141030","protein-coding",0.688,0.609,0.99999,"Q9UNS2","DTO_05007584","Enzyme modulator","Hepatomegaly","[phenotype]","C0019209","Digestive System Diseases (C06) | Pathological Conditions, Signs and Symptoms (C23)","Finding (T033)","","Abnormality of the digestive system (25031)","RGD_HUMAN","CausalOrContributing","Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.","Discriminating between adaptive and carcinogenic liver hypertrophy in rat studies using logistic ridge regression analysis of toxicogenomic data: The mode of action and predictive models.",2017,0.4,NA,"PMID","28108177","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Colorectal Neoplasms","[disease]","C0009404","Digestive System Diseases (C06) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the digestive system (25031) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.","Comparing the DNA hypermethylome with gene mutations in human colorectal cancer.",2007,0.4,NA,"PMID","17892325","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Hepatitis C","[disease]","C0019196","Digestive System Diseases (C06) | Infections (C01)","Disease or Syndrome (T047)","disease by infectious agent (0050117) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.",2005,0.4,NA,"PMID","16023247","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Mental Retardation","[disease]","C0025362","Mental Disorders (F03) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Behavior and Behavior Mechanisms (F01) | Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Deep sequencing reveals 50 novel genes for recessive cognitive disorders.","Deep sequencing reveals 50 novel genes for recessive cognitive disorders.",2011,0.4,NA,"PMID","21937992","","",NA,NA
"ARAP1",116985,"ENSG00000186635","protein-coding",0.639,0.609,1.0276e-06,"Q96P48","","","Autistic Disorder","[disease]","C0004352","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).","Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).",2021,0.4,NA,"PMID","34131312","American","HANCESTRO:0463",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Diarrheal disorder","[disease]","C1290807","Pathological Conditions, Signs and Symptoms (C23) | Digestive System Diseases (C06)","Disease or Syndrome (T047)","","","CLINPGX","Pharmacogenomics","Genotype CC is associated with increased risk of Diarrhea when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to genotypes CG + GG.","Genotype CC is associated with increased risk of Diarrhea when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to genotypes CG + GG.",2010,0.4,NA,"PMID","20565459","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Intellectual Disability","[disease]","C3714756","Mental Disorders (F03) | Pathological Conditions, Signs and Symptoms (C23) | Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10)","Mental or Behavioral Dysfunction (T048)","","Abnormality of the nervous system (00707)","CLINVAR","GeneticVariation","Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).","Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).",2021,0.4,NA,"PMID","34211152","American","HANCESTRO:0463",NA,NA
"KCNN3",3782,"ENSG00000143603","protein-coding",0.52,0.913,0.99999,"Q9UGI6","DTO_01300327","Ion channel","Esophageal Atresia","[disease]","C0014850","Digestive System Diseases (C06) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Congenital Abnormality (T019)","disease of anatomical entity (7)","Abnormality of the digestive system (25031)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Neuropathy, Hereditary Sensory And Autonomic, Type IIA","[disease]","C2752089","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Hereditary Sensory and Autonomic Neuropathy Type II","Hereditary Sensory and Autonomic Neuropathy Type II",1993,0.4,NA,"PMID","21089229","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.4,NA,"PMID","28520360","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Range of joint movement increased","[phenotype]","C1844820","","Finding (T033)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB","[disease]","C3150701","","Disease or Syndrome (T047)","genetic disease (630)","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"PRDM15",63977,"ENSG00000141956","protein-coding",0.691,0.609,1.2573e-06,"P57071","DTO_05007542","Transcription factor","Pervasive Development Disorder","[disease]","C0524528","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Interphalangeal joint contracture of finger","[disease]","C4021784","","Anatomical Abnormality (T190)","","Abnormality of the musculoskeletal system (33127) | Abnormality of limbs (40064)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.4,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.",2013,0.4,NA,"PMID","23014115","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.4,NA,"PMID","15372086","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.",1999,0.4,NA,"PMID","10472535","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.","Intermittent jaundice in patients with acute leukaemia: a common mutation of the bilirubin uridine-diphosphate glucuronosyltransferase gene among Asians.",1999,0.4,NA,"PMID","10472535","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.4,NA,"PMID","15372086","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.",2013,0.4,NA,"PMID","23014115","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.4,NA,"PMID","9653159","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).",2008,0.4,NA,"PMID","18816295","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.4,NA,"PMID","25200497","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.","A mutation which disrupts the hydrophobic core of the signal peptide of bilirubin UDP-glucuronosyltransferase, an endoplasmic reticulum membrane protein, causes Crigler-Najjar type II.",1996,0.4,NA,"PMID","8706880","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.4,NA,"PMID","12181437","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9621515","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome.","Clinical utility of electrophysiological evaluation in Crigler-Najjar syndrome.",2007,0.4,NA,"PMID","18058623","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.4,NA,"PMID","9435989","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.4,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.4,NA,"PMID","12859413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.4,NA,"PMID","9446675","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.",2003,0.4,NA,"PMID","12485959","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.",1993,0.4,NA,"PMID","8276413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8514037","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.4,NA,"PMID","9639672","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.4,NA,"PMID","12850492","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Epithelioma","[disease]","C1368683","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.","cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.",2002,0.4,NA,"PMID","12376462","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","ovarian neoplasm","[disease]","C0919267","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","CausalMutation","Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.","Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement.",2018,0.4,NA,"PMID","29450531","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","ovarian neoplasm","[disease]","C0919267","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","CausalMutation","A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.","A human oncogene of the RAS superfamily unmasked by expression cDNA cloning.",1994,0.4,NA,"PMID","8052619","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Central Nervous System Germinoma","[disease]","C1333813","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","ORPHANET","SusceptibilityMutation","Novel somatic and germline mutations in intracranial germ cell tumours.","Novel somatic and germline mutations in intracranial germ cell tumours.",2014,0.4,NA,"PMID","24896186","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","RASopathy","[disease]","C5555857","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.","Activating Mutations of RRAS2 Are a Rare Cause of Noonan Syndrome.",2019,0.4,NA,"PMID","31130282","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.",1994,0.4,NA,"PMID","7906695","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.",2005,0.4,NA,"PMID","15712364","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.",1992,0.4,NA,"PMID","1634050","","",NA,NA
"C5AR1",728,"ENSG00000197405","protein-coding",0.497,0.87,0.37999,"P21730","DTO_02300001","G-protein coupled receptor","Toxic Shock Syndrome","[disease]","C0600327","Infections (C01) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","disease by infectious agent (0050117)","","RGD_HUMAN","CausalOrContributing","Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.","Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.",2008,0.4,NA,"PMID","18063050","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Cocaine dependence","[disease]","C0600427","Mental Disorders (F03) | Chemically-Induced Disorders (C25)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","CLINPGX","Pharmacogenomics","Allele G is associated with increased risk of Cocaine-Related Disorders due to cocaine as compared to allele A.","Allele G is associated with increased risk of Cocaine-Related Disorders due to cocaine as compared to allele A.",2019,0.4,NA,"PMID","31059723","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Malignant neoplasm of other specified sites of pancreas","[disease]","C0153463","Digestive System Diseases (C06) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.",2009,0.4,NA,"PMID","19208748","","",NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","Pure gonadal dysgenesis 46,XX","[disease]","C0685837","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Congenital Abnormality (T019)","","","GENCC","GeneticVariation","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.","A Biallelic Mutation in the Homologous Recombination Repair Gene SPIDR Is Associated With Human Gonadal Dysgenesis.",2017,0.4,NA,"PMID","27967308","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Congenital hypoplastic anemia","[disease]","C0949116","Hemic and Lymphatic Diseases (C15) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.",1979,0.4,NA,"PMID","38827","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Increased bilirubin level (finding)","[phenotype]","C0311468","","Finding (T033)","","Abnormality of metabolism/homeostasis (01939)","CLINVAR","CausalMutation","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.","ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007.",2008,0.4,NA,"PMID","18414213","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","PROSTATE CANCER, SOMATIC","[disease]","C4015779","","Neoplastic Process (T191)","","","CLINVAR","CausalMutation","Mutations in the mitotic check point gene, MAD1L1, in human cancers.","Mutations in the mitotic check point gene, MAD1L1, in human cancers.",2001,0.4,NA,"PMID","11423979","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","GILBERT SYNDROME, SUSCEPTIBILITY TO","[phenotype]","C4016425","","Finding (T033)","","","CLINVAR","SusceptibilityMutation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"NTM",50863,"ENSG00000182667","protein-coding",0.586,0.913,0.98694,"Q9P121","","","Hypertensive disease","[disease]","C0020538","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Wolff-Parkinson-White Syndrome","[disease]","C0043202","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"CLIC6",54102,"ENSG00000159212","protein-coding",0.721,0.478,7.6453e-14,"Q96NY7","DTO_01300327","Ion channel","Myoepithelioma","[disease]","C0027070","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Acute polyarticular juvenile rheumatoid arthritis","[disease]","C0157916","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.",2013,0.4,NA,"PMID","23997956","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9630669","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.4,NA,"PMID","9342374","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.4,NA,"PMID","10190918","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.4,NA,"PMID","12402338","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.",2013,0.4,NA,"PMID","23014115","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9630669","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.4,NA,"PMID","11425418","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.4,NA,"PMID","12402338","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.",1999,0.4,NA,"PMID","9929972","Japanese","HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.4,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.","UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.",2013,0.4,NA,"PMID","23290513","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.4,NA,"PMID","10190918","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.4,NA,"PMID","9375768","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Constitutional aplastic anemia","[disease]","C0702159","Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.",1979,0.4,NA,"PMID","38827","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Hereditary Sensory Autonomic Neuropathy, Type 5","[disease]","C0020075","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.4,NA,"PMID","19838196","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Cocaine-Related Disorders","[disease]","C0236736","Mental Disorders (F03) | Chemically-Induced Disorders (C25)","Mental or Behavioral Dysfunction (T048)","","","CLINPGX","Pharmacogenomics","Allele G is associated with increased risk of Cocaine-Related Disorders due to cocaine as compared to allele A.","Allele G is associated with increased risk of Cocaine-Related Disorders due to cocaine as compared to allele A.",2019,0.4,NA,"PMID","31059723","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Hyperalgesia","[phenotype]","C0020429","Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Sign or Symptom (T184)","","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Systemic lidocaine inhibits remifentanil-induced hyperalgesia via the inhibition of cPKCgamma membrane translocation in spinal dorsal horn of rats.","Systemic lidocaine inhibits remifentanil-induced hyperalgesia via the inhibition of cPKCgamma membrane translocation in spinal dorsal horn of rats.",2009,0.4,NA,"PMID","19955894","","",NA,NA
"SPIDR",23514,"ENSG00000164808","protein-coding",0.646,0.783,9.7061e-20,"Q14159","","","Peripheral Neuropathy","[disease]","C0031117","Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the nervous system (00707)","CLINPGX","Pharmacogenomics","Allele G is associated with increased likelihood of Peripheral Nervous System Diseases when treated with cyclophosphamide, epirubicin and paclitaxel in women with Breast Neoplasms as compared to allele A.","Allele G is associated with increased likelihood of Peripheral Nervous System Diseases when treated with cyclophosphamide, epirubicin and paclitaxel in women with Breast Neoplasms as compared to allele A.",2015,0.4,NA,"PMID","24599932","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.",2003,0.4,NA,"PMID","14616765","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","A new type of defect in the gene for bilirubin uridine 5'-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.","A new type of defect in the gene for bilirubin uridine 5'-diphosphate-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type I.",1994,0.4,NA,"PMID","7936809","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.","Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.",1992,0.4,NA,"PMID","1634606","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9630669","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Biliary cirrhosis","[disease]","C0023892","Pathological Conditions, Signs and Symptoms (C23) | Digestive System Diseases (C06)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the digestive system (25031)","RGD_HUMAN","CausalOrContributing","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.",2005,0.4,NA,"PMID","16023247","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","beta Thalassemia","[disease]","C0005283","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.",1979,0.4,NA,"PMID","38827","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Telomere maintenance 2-related intellectual disability, neurodevelopmental disorder (disorder)","[disease]","C4310778","Nervous System Diseases (C10) | Mental Disorders (F03) | Behavior and Behavior Mechanisms (F01) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.",2020,0.4,NA,"PMID","31954878","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Increased bilirubin level (finding)","[phenotype]","C0311468","","Finding (T033)","","Abnormality of metabolism/homeostasis (01939)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.4,NA,"PMID","10968441","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.",1998,0.4,NA,"PMID","9784835","Japanese,Korean,Chinese","HANCESTRO:0019,HANCESTRO:0022,HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9621515","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.4,NA,"PMID","9653159","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.4,NA,"PMID","16114182","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.4,NA,"PMID","12850492","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8514037","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.",1999,0.4,NA,"PMID","9929972","Japanese","HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.4,NA,"PMID","12402338","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.4,NA,"PMID","9342374","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.4,NA,"PMID","15857854","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.4,NA,"PMID","17496722","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9621515","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.4,NA,"PMID","28520360","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","PARKINSON DISEASE, LATE-ONSET","[disease]","C3160718","","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Gaucher Disease","Gaucher Disease",1993,0.4,NA,"PMID","20301446","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","CARDIOMYOPATHY, DILATED, 1S","[disease]","C1834481","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Mosaic variegated aneuploidy syndrome 1","[disease]","C1850343","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | syndrome (225)","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.",2015,0.4,NA,"PMID","25993113","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.",2003,0.4,NA,"PMID","12485959","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.4,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.4,NA,"PMID","26467199","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.4,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.4,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.4,NA,"PMID","17496722","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8514037","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.4,NA,"PMID","11425418","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Co-inheritance of G6PD and PK deficiencies in a neonate carrying a Novel UGT1A1 genotype associated to Crigler-Najjar type II syndrome.","Co-inheritance of G6PD and PK deficiencies in a neonate carrying a Novel UGT1A1 genotype associated to Crigler-Najjar type II syndrome.",2015,0.4,NA,"PMID","25822733","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8280139","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.","Crigler-Najjar syndrome type II resulting from three different mutations in the bilirubin uridine 5'-diphosphate-glucuronosyltransferase (UGT1A1) gene.",2000,0.4,NA,"PMID","11182932","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.4,NA,"PMID","15857854","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.",2017,0.4,NA,"PMID","29137095","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.4,NA,"PMID","12181437","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.","Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.",2003,0.4,NA,"PMID","14550264","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.4,NA,"PMID","9342374","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.","Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.",1995,0.4,NA,"PMID","7715297","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.","The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.",1995,0.4,NA,"PMID","7565971","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.4,NA,"PMID","9375768","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.4,NA,"PMID","26467199","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.","Gilbert's syndrome: High frequency of the (TA)7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene.",2006,0.4,NA,"PMID","16610035","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.4,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.","Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.",2003,0.4,NA,"PMID","12485959","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).",2008,0.4,NA,"PMID","18816295","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient.","Altered coding for a strictly conserved di-glycine in the major bilirubin UDP-glucuronosyltransferase of a Crigler-Najjar type I patient.",1995,0.4,NA,"PMID","7852413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.","Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.",2007,0.4,NA,"PMID","17496722","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.4,NA,"PMID","9653159","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.4,NA,"PMID","9639672","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.","Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.",2004,0.4,NA,"PMID","15304120","Japanese,Japanese","HANCESTRO:0019,HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.","Association of Neonatal Hyperbilirubinemia with UGT1A1 Gene Polymorphisms: A Meta-Analysis.",2015,0.4,NA,"PMID","26467199","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.","Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II.",2017,0.4,NA,"PMID","29137095","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.","Rapid proteasomal degradation of translocation-deficient UDP-glucuronosyltransferase 1A1 proteins in patients with Crigler-Najjar type II.",2003,0.4,NA,"PMID","14550264","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).","Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).",2002,0.4,NA,"PMID","12181437","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.4,NA,"PMID","20975617","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Hypertrophic, Familial","[disease]","C0949658","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Hypertrophic Cardiomyopathy Overview","Hypertrophic Cardiomyopathy Overview",1993,0.4,NA,"PMID","20301725","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Distal 22q11.2 microdeletion syndrome","[disease]","C4518343","","Disease or Syndrome (T047)","","","ORPHANET","ChromosomalRearrangement",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"FAM83D",81610,"ENSG00000101447","protein-coding",0.658,0.478,3.3088e-11,"Q9H4H8","","","Primary Glioblastoma","[disease]","C1514422","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway.","Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway.",2022,0.4,NA,"PMID","35150198","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Autism Spectrum Disorders","[disease]","C1510586","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics.","A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics.",2022,0.4,NA,"PMID","35663546","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Cardiomyopathy, Hypertrophic, Familial","[disease]","C0949658","Cardiovascular Diseases (C14) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.","American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.",2003,0.4,NA,"PMID","14607462","American,European,American,European","HANCESTRO:0463,HANCESTRO:0005,HANCESTRO:0463,HANCESTRO:0005",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","ovarian neoplasm","[disease]","C0919267","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","CausalMutation","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.","Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.",2019,0.4,NA,"PMID","31130285","","",NA,NA
"RRAS2",22800,"ENSG00000133818","protein-coding",0.509,0.87,0.030991,"P62070","DTO_05007584","Enzyme modulator","ovarian neoplasm","[disease]","C0919267","Urogenital Diseases (C12) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","CLINVAR","CausalMutation","Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.","Screening for ovarian cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement.",2012,0.4,NA,"PMID","22964825","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Familial or idiopathic dilated cardiomyopathy","[disease]","C5679590","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.","Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy.",2009,0.4,NA,"PMID","19712804","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Mammary Neoplasms","[disease]","C1458155","Skin and Connective Tissue Diseases (C17) | Neoplasms (C04)","Neoplastic Process (T191)","","Abnormality of the breast (00769) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.","Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.",2009,0.4,NA,"PMID","19115204","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","GILBERT SYNDROME, SUSCEPTIBILITY TO","[phenotype]","C4016425","","Finding (T033)","","","CLINVAR","SusceptibilityMutation","Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome.","Two linked polymorphic mutations (A(TA)7TAA and T-3279G) of UGT1A1 as the principal cause of Gilbert syndrome.",2004,0.4,NA,"PMID","15378351","","",NA,NA
"RBM20",282996,"ENSG00000203867","protein-coding",0.606,0.696,0.010899,"Q5T481","","","Conduction disorder of the heart","[disease]","C0264886","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Trigeminal Neuralgia","[disease]","C0040997","Stomatognathic Diseases (C07) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the nervous system (00707) | Constitutional symptom (25142)","RGD_HUMAN","CausalOrContributing","Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK.","Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK.",2016,0.4,NA,"PMID","27093858","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Malignant epithelioma","[disease]","C0553707","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.","cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene.",2002,0.4,NA,"PMID","12376462","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Non-specific syndromic intellectual disability","[disease]","C5568766","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","GENCC","GeneticVariation","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.",2016,0.4,NA,"PMID","26181491","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.","Spectrum of UGT1A1 mutations in Crigler-Najjar (CN) syndrome patients: identification of twelve novel alleles and genotype-phenotype correlation.",2005,0.4,NA,"PMID","15712364","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler-Najjar syndrome","[disease]","C5551003","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.","Two Different UGT1A1 Mutations causing Crigler-Najjar Syndrome types I and II in an Iranian Family.",2015,0.4,NA,"PMID","26697581","Iranian","HANCESTRO:0438",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Neoplasms, Bone Tissue","[disease]","C0206639","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Interactive effect of bisphenol A (BPA) exposure with -22G/C polymorphism in LOX gene on the risk of osteosarcoma.","Interactive effect of bisphenol A (BPA) exposure with -22G/C polymorphism in LOX gene on the risk of osteosarcoma.",2013,0.4,NA,"PMID","23886186","","",NA,NA
"VIPR2",7434,"ENSG00000106018","protein-coding",0.565,0.87,8.2204e-13,"P41587","DTO_02300001","G-protein coupled receptor","Myoepithelioma","[disease]","C0027070","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","RETINITIS PIGMENTOSA 1","[disease]","C0220701","Eye Diseases (C11) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"JMJD1C-AS1",84989,"ENSG00000272767","ncRNA",0.782,0.348,NA,"","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"FAM83D",81610,"ENSG00000101447","protein-coding",0.658,0.478,3.3088e-11,"Q9H4H8","","","Adult Glioblastoma","[disease]","C0278878","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway.","Inhibition of FAM83D displays antitumor effects in glioblastoma via down-regulation of the AKT/Wnt/β-catenin pathway.",2022,0.4,NA,"PMID","35150198","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.4,NA,"PMID","25200497","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.4,NA,"PMID","16114182","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.4,NA,"PMID","20975617","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.","UDP-glucuronosyltransferase 1 gene promoter polymorphism is associated with increased serum bilirubin levels and cholecystectomy in patients with sickle cell anemia.",2003,0.4,NA,"PMID","12859413","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.4,NA,"PMID","15372086","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.4,NA,"PMID","12850492","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.",1999,0.4,NA,"PMID","10412811","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.","Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia.",1997,0.4,NA,"PMID","9342374","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.","Differences in frequencies of UGT1A9, 1A7, and 1A1 genetic polymorphisms in Chinese Tibetan versus Han Chinese populations.",2013,0.4,NA,"PMID","24390994","Han Chinese,Chinese,Tibetan","HANCESTRO:0027,HANCESTRO:0021,HANCESTRO:0582",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.","Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese.",1998,0.4,NA,"PMID","9784835","Japanese,Korean,Chinese","HANCESTRO:0019,HANCESTRO:0022,HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.","Association of breast-fed neonatal hyperbilirubinemia with UGT1A1 polymorphisms: 211G>A (G71R) mutation becomes a risk factor under inadequate feeding.",2013,0.4,NA,"PMID","23014115","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","UGT1A1 gene mutations and neonatal hyperbilirubinemia in Guangxi Heiyi Zhuang and Han populations.","UGT1A1 gene mutations and neonatal hyperbilirubinemia in Guangxi Heiyi Zhuang and Han populations.",2015,0.4,NA,"PMID","26200705","Han in China (HGDP)","HANCESTRO:0715",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.4,NA,"PMID","10968441","","",NA,NA
"THSD7A",221981,"ENSG00000005108","protein-coding",0.555,0.826,0.011926,"Q9UPZ6","DTO_05007621","Extracellular structure","Mixed bipolar I disorder","[disease]","C0236780","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","RGD_HUMAN","CausalOrContributing","Genome-wide association study identifies 30 loci associated with bipolar disorder.","Genome-wide association study identifies 30 loci associated with bipolar disorder.",2019,0.4,NA,"PMID","31043756","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Rheumatic aortic regurgitation","[disease]","C0155568","Cardiovascular Diseases (C14) | Infections (C01)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.","Usefulness of carvedilol in the treatment of chronic aortic valve regurgitation.",2011,0.4,NA,"PMID","21216836","","",NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","B-ALL with t(9;22)(q34.1;q11.2)","[disease]","C5680319","","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","ORPHANET","FusionGene","Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.","Simultaneous occurrence of ETV6-RUNX1 and BCR-ABL1 (e1a2) transcripts in a child with B-cell acute lymphoblastic leukemia.",2013,0.4,NA,"PMID","23491079","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","HSAN Type IV","[disease]","C0020074","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.4,NA,"PMID","19838196","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Paternal isodisomy for chromosome 2 as the cause of Crigler-Najjar type I syndrome.","Paternal isodisomy for chromosome 2 as the cause of Crigler-Najjar type I syndrome.",2005,0.4,NA,"PMID","15586176","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.","Identification of an A-to-G missense mutation in exon 2 of the UGT1 gene complex that causes Crigler-Najjar syndrome type 2.",1993,0.4,NA,"PMID","8276413","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.","A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.",1993,0.4,NA,"PMID","8226884","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.","The cDNA sequence and expression of a variant 17 beta-hydroxysteroid UDP-glucuronosyltransferase.",1990,0.4,NA,"PMID","1692835","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.","Crigler-Najjar syndrome type I in Tunisia may be associated with a founder effect related to the Q357R mutation within the UGT1 gene.",2002,0.4,NA,"PMID","11968090","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.","Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.",2002,0.4,NA,"PMID","11906189","","",NA,NA
"NEDD4L",23327,"ENSG00000049759","protein-coding",0.487,0.87,0.99878,"Q96PU5","DTO_05007624","Enzyme","Endometriosis","[disease]","C0014175","Urogenital Diseases (C12)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the genitourinary system (00119)","RGD_HUMAN","CausalOrContributing","Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.","Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.",2011,0.4,NA,"PMID","20864642","","",NA,NA
"MICA",100507436,"ENSG00000204520","protein-coding",0.405,0.913,0.0031713,"Q29983","","","Oral submucosal fibrosis, including of tongue","[disease]","C0029171","","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Oral submucous fibrosis: review on aetiology and pathogenesis.","Oral submucous fibrosis: review on aetiology and pathogenesis.",2006,0.4,NA,"PMID","16311067","","",NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Hyperalgesia","[phenotype]","C0020429","Pathological Conditions, Signs and Symptoms (C23) | Nervous System Diseases (C10)","Sign or Symptom (T184)","","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK.","Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK.",2016,0.4,NA,"PMID","27093858","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Malignant neoplasm of tail of pancreas","[disease]","C0153460","Digestive System Diseases (C06) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.",2009,0.4,NA,"PMID","19208748","","",NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Pancreatic Neoplasm","[disease]","C0030297","Digestive System Diseases (C06) | Endocrine System Diseases (C19) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the digestive system (25031) | Neoplasm (02664)","RGD_HUMAN","CausalOrContributing","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.","EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinoma.",2009,0.4,NA,"PMID","19208748","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Biliary cirrhosis","[disease]","C0023892","Pathological Conditions, Signs and Symptoms (C23) | Digestive System Diseases (C06)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the digestive system (25031)","RGD_HUMAN","CausalOrContributing","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.",2005,0.4,NA,"PMID","16023247","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Hereditary spherocytosis","[disease]","C0037889","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.",1979,0.4,NA,"PMID","38827","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Pauciarticular juvenile rheumatoid arthritis","[disease]","C0157917","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Pauciarticular juvenile rheumatoid arthritis","[disease]","C0157917","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"THSD7A",221981,"ENSG00000005108","protein-coding",0.555,0.826,0.011926,"Q9UPZ6","DTO_05007621","Extracellular structure","Bipolar I disorder, most recent episode manic (disorder)","[disease]","C0024713","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","RGD_HUMAN","CausalOrContributing","Genome-wide association study identifies 30 loci associated with bipolar disorder.","Genome-wide association study identifies 30 loci associated with bipolar disorder.",2019,0.4,NA,"PMID","31043756","","",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Charcot-Marie-Tooth Disease","[disease]","C0007959","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.","Mutation in FAM134B causing hereditary sensory neuropathy with spasticity in a Turkish family.",2014,0.4,NA,"PMID","24327336","Turkish","HANCESTRO:0451",NA,NA
"RETREG1",54463,"ENSG00000154153","protein-coding",0.581,0.696,3.7806e-05,"Q9H6L5","","","Charcot-Marie-Tooth Disease","[disease]","C0007959","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.","Mutations in FAM134B, encoding a newly identified Golgi protein, cause severe sensory and autonomic neuropathy.",2009,0.4,NA,"PMID","19838196","","",NA,NA
"DNAJB6",10049,"ENSG00000105993","protein-coding",0.562,0.826,0.00076341,"O75190","","","PARKINSON DISEASE, LATE-ONSET","[disease]","C3160718","","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation","Parkinson Disease Overview","Parkinson Disease Overview",1993,0.4,NA,"PMID","20301402","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Coronary Artery Disease, Autosomal Dominant 2","[disease]","C1970440","Cardiovascular Diseases (C14) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Increased number of skin folds","[phenotype]","C4024853","","Finding (T033)","","Abnormality of the integument (01574)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"PRKCG",5582,"ENSG00000126583","protein-coding",0.566,0.913,0.99413,"P05129","DTO_03300101","Kinase","Spectrin-associated autosomal recessive cerebellar ataxia","[disease]","C4706415","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nervous System Diseases (C10)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Irinotecan Therapy and UGT1A1 Genotype","Irinotecan Therapy and UGT1A1 Genotype",2012,0.4,NA,"PMID","28520360","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.",1999,0.4,NA,"PMID","9929972","Japanese","HANCESTRO:0019",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Global gene expression as a function of germline genetic variation.","Global gene expression as a function of germline genetic variation.",2005,0.4,NA,"PMID","15857854","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.","A case of anorexia nervosa with hyperbilirubinaemia in a patient homozygous for a mutation in the bilirubin UDP-glucuronosyltransferase gene.",1999,0.4,NA,"PMID","10412811","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.","Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects.",2000,0.4,NA,"PMID","11003624","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.","Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia.",2001,0.4,NA,"PMID","11425418","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.4,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.4,NA,"PMID","9375768","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1","[phenotype]","C1866173","","Finding (T033)","","","CLINVAR","GeneticVariation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"IQSEC1",9922,"ENSG00000144711","protein-coding",0.619,0.783,0.99606,"Q6DN90","","","Non-Small Cell Adenocarcinoma","[disease]","C1335060","Neoplasms (C04)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","MGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"BCR",613,"ENSG00000186716","protein-coding",0.445,0.913,5.9807e-06,"P11274","DTO_05007584","Enzyme modulator","Transitional cell carcinoma of bladder","[disease]","C0279680","Urogenital Diseases (C12) | Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119) | Neoplasm (02664)","UNIPROT","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.","Spectrum of UGT1A1 Variations in Chinese Patients with Crigler-Najjar Syndrome Type II.",2015,0.4,NA,"PMID","25993113","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.",2003,0.4,NA,"PMID","14616765","Chinese","HANCESTRO:0021",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.4,NA,"PMID","12402338","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.4,NA,"PMID","10190918","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.","Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9630669","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.","Hyperbilirubinemia in homozygous HbE disease is associated with the UGT1A1 gene polymorphism.",2005,0.4,NA,"PMID","16114182","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.4,NA,"PMID","19830808","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.4,NA,"PMID","20975617","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.","The global distribution of length polymorphisms of the promoters of the glucuronosyltransferase 1 gene (UGT1A1): hematologic and evolutionary implications.",2003,0.4,NA,"PMID","12850492","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.","Coding defect and a TATA box mutation at the bilirubin UDP-glucuronosyltransferase gene cause Crigler-Najjar type I disease.",1998,0.4,NA,"PMID","9639672","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.",2016,0.4,NA,"PMID","26250421","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).","Effect of D256N and Y483D on propofol glucuronidation by human uridine 5'-diphosphate glucuronosyltransferase (UGT1A9).",2008,0.4,NA,"PMID","18816295","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.","The molecular weights of UDP-glucuronyltransferase determined with radiation-inactivation analysis. A molecular model of bilirubin UDP-glucuronyltransferase.",1984,0.4,NA,"PMID","6480579","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Co-inheritance of G6PD and PK deficiencies in a neonate carrying a Novel UGT1A1 genotype associated to Crigler-Najjar type II syndrome.","Co-inheritance of G6PD and PK deficiencies in a neonate carrying a Novel UGT1A1 genotype associated to Crigler-Najjar type II syndrome.",2015,0.4,NA,"PMID","25822733","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.4,NA,"PMID","19830808","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","What is Gilbert's syndrome? Lesson from genetic polymorphisms of UGT1A1 in Gilbert's syndrome from Asia.","What is Gilbert's syndrome? Lesson from genetic polymorphisms of UGT1A1 in Gilbert's syndrome from Asia.",2004,0.4,NA,"PMID","15304109","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.","Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.",2007,0.4,NA,"PMID","18004206","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.","Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome.",2002,0.4,NA,"PMID","12402338","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.","Identification of defect in the genes for bilirubin UDP-glucuronosyl-transferase in a patient with Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8280139","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.4,NA,"PMID","25200497","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.","Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.",1999,0.4,NA,"PMID","10190918","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9621515","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.","Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias.",1997,0.4,NA,"PMID","9435989","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.","Co-occurrence of three different mutations in the bilirubin UDP-glucuronosyltransferase gene in a Chinese family with Crigler-Najjar syndrome type I and Gilbert's syndrome.",2003,0.4,NA,"PMID","14616765","Chinese","HANCESTRO:0021",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.","Genotype of UGT1A1 and phenotype correlation between Crigler-Najjar syndrome type II and Gilbert syndrome.",2016,0.4,NA,"PMID","26250421","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 2","[disease]","C2931132","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.4,NA,"PMID","10968441","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Non-specific syndromic intellectual disability","[disease]","C5568766","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","GENCC","GeneticVariation","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.","Jumonji domain containing 1C (JMJD1C) sequence variants in seven patients with autism spectrum disorder, intellectual disability and seizures.",2020,0.4,NA,"PMID","31954878","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Non-specific syndromic intellectual disability","[disease]","C5568766","Behavior and Behavior Mechanisms (F01) | Nervous System Diseases (C10) | Pathological Conditions, Signs and Symptoms (C23) | Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","","GENCC","GeneticVariation","Histone Lysine Methylation and Neurodevelopmental Disorders.","Histone Lysine Methylation and Neurodevelopmental Disorders.",2018,0.4,NA,"PMID","28665350","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Dysmorphic facies","[phenotype]","C0424503","","Finding (T033)","","Abnormality of head or neck (00152)","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Erythroleukemia (Erythroid/Myeloid)","[disease]","C4520840","Neoplasms (C04) | Hemic and Lymphatic Diseases (C15)","Neoplastic Process (T191)","disease of anatomical entity (7) | disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.",1979,0.4,NA,"PMID","38827","","",NA,NA
"LOX",4015,"ENSG00000113083","protein-coding",0.408,0.913,0.97953,"P28300","","","Congenital contractural arachnodactyly","[disease]","C0220668","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Musculoskeletal Diseases (C05)","Congenital Abnormality (T019)","physical disorder (0080015) | genetic disease (630) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"SH2B1",25970,"ENSG00000178188","protein-coding",0.534,0.87,0.99999,"Q9NRF2","","","Ovarian Failure, Premature","[disease]","C0085215","Urogenital Diseases (C12) | Endocrine System Diseases (C19)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","CLINVAR","GeneticVariation",NA,NA,NA,0.4,NA,NA,NA,NA,NA,NA,NA
"EFEMP1",2202,"ENSG00000115380","protein-coding",0.431,0.913,1,"Q12805","DTO_05007621","Extracellular structure","Mesothelioma malignant advanced","[disease]","C0278752","","Neoplastic Process (T191)","disease of cellular proliferation (14566)","","RGD_HUMAN","CausalOrContributing","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.","Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.",2016,0.4,NA,"PMID","27032653","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.","Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate- glucuronosyltransferase gene.",2000,0.4,NA,"PMID","11061796","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.","Gilbert's syndrome and hyperbilirubinaemia in ABO-incompatible neonates.",2000,0.4,NA,"PMID","10968441","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.","UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis.",1998,0.4,NA,"PMID","9446675","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.","Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinaemia and may lead to neonatal kernicterus.",2001,0.4,NA,"PMID","11370628","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.","Association of polymorphisms in four bilirubin metabolism genes with serum bilirubin in three Asian populations.",2009,0.4,NA,"PMID","19243019","Asian","HANCESTRO:0008",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","UGT1A1 gene mutations and neonatal hyperbilirubinemia in Guangxi Heiyi Zhuang and Han populations.","UGT1A1 gene mutations and neonatal hyperbilirubinemia in Guangxi Heiyi Zhuang and Han populations.",2015,0.4,NA,"PMID","26200705","Han in China (HGDP)","HANCESTRO:0715",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.","Hyperbilirubinaemia in heterozygous beta-thalassaemia is related to co-inherited Gilbert's syndrome.",1997,0.4,NA,"PMID","9375768","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9621515","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?","Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?",1998,0.4,NA,"PMID","9653159","","",NA,NA
"UGT1A10",54575,"ENSG00000242515","protein-coding",0.624,0.652,1.6232e-17,"Q9HAW8","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.","Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese.",1999,0.4,NA,"PMID","9929972","Japanese","HANCESTRO:0019",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.","Regression Modeling and Meta-Analysis of Diagnostic Accuracy of SNP-Based Pathogenicity Detection Tools for UGT1A1 Gene Mutation.",2013,0.4,NA,"PMID","23997956","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.","A mutation in bilirubin uridine 5'-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II.",1993,0.4,NA,"PMID","8514037","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.","Analysis of bilirubin uridine 5'-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II.",1998,0.4,NA,"PMID","9621515","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.","Genetic polymorphisms in Thai neonates with hyperbilirubinemia.",2009,0.4,NA,"PMID","19397531","Thai","HANCESTRO:0500",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.","Crigler-Najjar syndrome in The Netherlands: identification of four novel UGT1A1 alleles, genotype-phenotype correlation, and functional analysis of 10 missense mutants.",2010,0.4,NA,"PMID","19830808","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.","211 G to a variation of UDP-glucuronosyl transferase 1A1 gene and neonatal breastfeeding jaundice.",2011,0.4,NA,"PMID","20975617","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Lucey-Driscoll syndrome (disorder)","[disease]","C0270210","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Nutritional and Metabolic Diseases (C18) | Pathological Conditions, Signs and Symptoms (C23)","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","Pharmacogenetics and drug development: the path to safer and more effective drugs.","Pharmacogenetics and drug development: the path to safer and more effective drugs.",2004,0.4,NA,"PMID","15372086","","",NA,NA
"SYT1",6857,"ENSG00000067715","protein-coding",0.526,0.913,0.99999,"P21579","DTO_05007405","Transporter","Rare genetic syndromic intellectual disability","[disease]","C5680525","","Disease or Syndrome (T047)","","","CLINVAR","CausalMutation","SYT1-associated neurodevelopmental disorder: a case series.","SYT1-associated neurodevelopmental disorder: a case series.",2018,0.4,NA,"PMID","30107533","","",NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","Teratozoospermia","[disease]","C0403824","Urogenital Diseases (C12)","Disease or Syndrome (T047)","genetic disease (630) | disease of anatomical entity (7)","Abnormality of the genitourinary system (00119)","CLINVAR","CausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.4,NA,"PMID","30929735","","",NA,NA
"TTC21A",199223,"ENSG00000168026","protein-coding",0.681,0.565,4.2204e-32,"Q8NDW8","","","Congenital impairment of spermatozoa motility","[disease]","C0403811","Urogenital Diseases (C12) | Endocrine System Diseases (C19)","Disease or Syndrome (T047)","","","ORPHANET","GermlineCausalMutation","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.","Bi-allelic Mutations in TTC21A Induce Asthenoteratospermia in Humans and Mice.",2019,0.4,NA,"PMID","30929735","","",NA,NA
"KLRC4",8302,"ENSG00000183542","protein-coding",0.606,0.783,0.10803,"O43908","","","Agranulocytosis","[disease]","C0001824","Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","physical disorder (0080015) | disease of anatomical entity (7)","Abnormality of blood and blood-forming tissues (01871) | Abnormality of the immune system (02715)","CLINPGX","Pharmacogenomics","Allele C is associated with increased likelihood of Agranulocytosis when treated with Antithyroid Preparations, methimazole or propylthiouracil in people with Graves Disease as compared to allele T.","Allele C is associated with increased likelihood of Agranulocytosis when treated with Antithyroid Preparations, methimazole or propylthiouracil in people with Graves Disease as compared to allele T.",2024,0.4,NA,"PMID","38237612","","",NA,NA
"LOXL2",4017,"ENSG00000134013","protein-coding",0.504,0.783,3.7873e-16,"Q9Y4K0","","","Hepatitis B","[disease]","C0019163","Digestive System Diseases (C06) | Infections (C01)","Disease or Syndrome (T047)","disease by infectious agent (0050117) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.","Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.",2005,0.4,NA,"PMID","16023247","","",NA,NA
"SLC6A12",6539,"ENSG00000111181","protein-coding",0.688,0.522,8.1403e-10,"P48065","DTO_05007405","Transporter","Neoplasm Invasiveness","[phenotype]","C0027626","Neoplasms (C04) | Pathological Conditions, Signs and Symptoms (C23)","Pathologic Function (T046)","","","RGD_HUMAN","CausalOrContributing","DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.","DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer.",2015,0.4,NA,"PMID","26213588","","",NA,NA
"MAD1L1",8379,"ENSG00000002822","protein-coding",0.507,0.913,4.0532e-33,"Q9Y6D9","","","Acute polyarticular juvenile rheumatoid arthritis","[disease]","C0157916","Immune System Diseases (C20) | Musculoskeletal Diseases (C05) | Skin and Connective Tissue Diseases (C17)","Disease or Syndrome (T047)","disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.","Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.",2009,0.4,NA,"PMID","19565504","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Adenoid Cystic Carcinoma","[disease]","C0010606","Neoplasms (C04)","Neoplastic Process (T191)","disease of cellular proliferation (14566) | disease of anatomical entity (7)","","RGD_HUMAN","CausalOrContributing","The mutational landscape of adenoid cystic carcinoma.","The mutational landscape of adenoid cystic carcinoma.",2013,0.4,NA,"PMID","23685749","","",NA,NA
"CAD",790,"ENSG00000084774","protein-coding",0.574,0.826,1,"P27708","DTO_05007624","Enzyme","Anemia, Sickle Cell","[disease]","C0002895","Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16) | Hemic and Lymphatic Diseases (C15)","Disease or Syndrome (T047)","disease of anatomical entity (7) | genetic disease (630)","","RGD_HUMAN","CausalOrContributing","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.","Elevation of pyrimidine enzyme activities in the RBC of patients with congenital hypoplastic anaemia and their parents.",1979,0.4,NA,"PMID","38827","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.","Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.",2016,0.4,NA,"PMID","26181491","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders.","Sex-Based Analysis of De Novo Variants in Neurodevelopmental Disorders.",2019,0.4,NA,"PMID","31785789","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.","Pathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.",2017,0.4,NA,"PMID","28166811","","",NA,NA
"JMJD1C",221037,"ENSG00000171988","protein-coding",0.49,0.913,1,"Q15652","","","Early myoclonic encephalopathy","[disease]","C0270855","Nervous System Diseases (C10)","Disease or Syndrome (T047)","","","CLINVAR","GeneticVariation","Novel somatic and germline mutations in intracranial germ cell tumours.","Novel somatic and germline mutations in intracranial germ cell tumours.",2014,0.4,NA,"PMID","24896186","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.","UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.",2014,0.4,NA,"PMID","25200497","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.","Identification of two single base substitutions in the UGT1 gene locus which abolish bilirubin uridine diphosphate glucuronosyltransferase activity in vitro.",1994,0.4,NA,"PMID","7906695","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","CausalMutation","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.","Mechanisms of inherited deficiencies of multiple UDP-glucuronosyltransferase isoforms in two patients with Crigler-Najjar syndrome, type I.",1992,0.4,NA,"PMID","1634050","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.","Impact of UGT1A1 gene variants on total bilirubin levels in Gilbert syndrome patients and in healthy subjects.",2012,0.4,NA,"PMID","22325916","","",NA,NA
"UGT1A8",54576,"ENSG00000242366","protein-coding",0.639,0.609,1.0698e-11,"Q9HAW9","","","Crigler Najjar syndrome, type 1","[disease]","C0010324","Nutritional and Metabolic Diseases (C18) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)","Disease or Syndrome (T047)","disease of metabolism (0014667) | genetic disease (630)","","CLINVAR","GeneticVariation","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.","Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.",1998,0.4,NA,"PMID","9497253","","",NA,NA
"MICA",100507436,"ENSG00000204520","protein-coding",0.405,0.913,0.0031713,"Q29983","","","Coronary Aneurysm","[disease]","C0010051","Cardiovascular Diseases (C14)","Disease or Syndrome (T047)","disease of anatomical entity (7)","Abnormality of the cardiovascular system (01626)","RGD_HUMAN","CausalOrContributing","Polymorphism of transmembrane region of MICA gene and Kawasaki disease.","Polymorphism of transmembrane region of MICA gene and Kawasaki disease.",2000,0.4,NA,"PMID","10899738","","",NA,NA
"THSD7A",221981,"ENSG00000005108","protein-coding",0.555,0.826,0.011926,"Q9UPZ6","DTO_05007621","Extracellular structure","Depression, Bipolar","[disease]","C0005587","Mental Disorders (F03)","Mental or Behavioral Dysfunction (T048)","disease of mental health (150)","Abnormality of the nervous system (00707)","RGD_HUMAN","CausalOrContributing","Genome-wide association study identifies 30 loci associated with bipolar disorder.","Genome-wide association study identifies 30 loci associated with bipolar disorder.",2019,0.4,NA,"PMID","31043756","","",NA,NA
